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Understanding the behavior of a cell requires that its molecular constituents, such as mRNA
or protein levels, be profiled quantitatively. Typically, these measurements are performed in
bulk and represent values aggregated from thousands of cells. Insights from such data can
be very useful, but the loss of single-cell resolution can prove misleading for heterogeneous
tissues and in diseases like cancer.
Recently, technological advances have allowed us to profile multiple cellular parame-
ters simultaneously at single-cell resolution, for thousands to millions of cells. While this
provides an unprecedented opportunity to learn new biology, analyzing such massive and
high-dimensional data requires efficient and accurate computational tools to extract the un-
derlying biological phenomena. Such methods must take into account biological properties
such as non-linear dependencies between measured parameters.
In this dissertation, I contribute to the development of tools from harmonic analysis
and computational geometry to study the shape and geometry of single-cell data collected
using mass cytometry and single-cell RNA sequencing (scRNA-seq). In particular, I focus
on diffusion maps, which can learn the underlying structure of the data by modeling cells
as lying on a low-dimensional phenotype manifold embedded in high dimensions. Diffusion
maps allow non-linear transformation of the data into a low-dimensional Euclidean space,
in which pairwise distances robustly represent distances in the high-dimensional space. In
addition to the underlying geometry, this work also attempts to study the shape of the
data using archetype analysis. Archetype analysis characterizes extreme states in the data
and complements traditional approaches such as clustering. It facilitates analysis at the
boundary of the data enabling potentially novel insights about the system.
I use these tools to study how the negative costimulatory molecules Ctla4 and Pdcd1
affect T-cell differentiation. Negative costimulatory molecules play a vital role in attenu-
ating T-cell activation, in order to maintain activity within a desired physiological range
and prevent autoimmunity. However, their potential role in T cell differentiation remains
unknown. In this work, I analyze mass cytometry data profiling T cells in control and
Ctla4- or Pdcd1-deficient mice and analyze differences using the tools above. I find that
genetic loss of Ctla4 constrains CD4+ T-cell differentiation states, whereas loss of Pdcd1
subtly constrains CD8+ T-cell differentiation states. I propose that negative costimulatory
molecules place limits on maximal protein expression levels to restrain differentiation states.
I use similar approaches to study breast cancer cells, which are profiled using scRNA-
seq as they undergo the pathological epithelial-to-mesenchymal transition (EMT). For this
work, I introduce Markov Affinity based Graph Imputation of Cells (MAGIC), a novel
algorithm designed in our lab to denoise and impute sparse single-cell data. The mRNA
content of each cell is currently massively undersampled by scRNA-seq, resulting in ‘zero’
expression values for the majority of genes in a large fraction of cells. MAGIC circumvents
this problem by using a diffusion process along the data to share information between similar
cells and thereby denoise and impute expression values. In addition to MAGIC, I apply
archetype analysis to study various cellular stages during EMT, and I find novel biological
processes in the previously unstudied intermediate states.
The work presented here introduces a mathematical modeling framework and advanced
geometric tools to analyze single-cell data. These ideas can be generally applied to various
biological systems. Here, I apply them to answer important biological questions in T cell dif-
ferentiation and EMT. The obtained knowledge has applications in our basic understanding
of the process of EMT, T cell biology and in cancer treatment.
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The cell is the fundamental structural and functional unit of life. They are dynamic entities
that can proliferate, change shape, differentiate into different types and interact with their
environment. Cells are in constant exposure to various stimuli, appropriate response to
which maintains the physiological homeostasis and growth of the organism. The processing
of incoming signals and generation of a response takes place at the cellular level. So in some
sense, cells are similar to computers in that they receive an input, process it and provide
an output. As such, any aberrant response to stimuli could harm the cell and organism.
The integration of cellular responses determines the phenotype or the observable char-
acteristics of the organism. The immense diversity in life-forms we see around us is a direct
consequence of differences in cellular activities in different organisms. Interestingly, while
there exists a great diversity at the organism level, there is a remarkable similarity between
organisms at the cellular level. Therefore, understanding cellular behavior is the key step
towards understanding biology at many scales. Just like cells comprise an organism, cells
are composed of hundreds of organelles each with their unique morphology, characteristics
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and functions. A common theme of this thesis will be to characterize these constituents of
cells in various contexts and use that to understand cellular behavior. Next, we begin by
discussing some important features of a cell.
1.1.1 Constituents of a cell
Every eukaryotic cell contains a nucleus where the DNA (DeoxyriboNucleic Acid) of the
cell resides. A DNA is a complex molecule composed of long chains of nucleotides and
contains the hereditary code of the organism. Certain sequences of the DNA contain code
for specific molecules and such sequences are called genes. The set of all genes inside a
cell is called the genome. An enzyme called the RNA (RiboNucleic Acid) polymerase can
read the code in a gene and produce mRNA (messenger RiboNucleic Acid) molecules. This
process of reading a gene into an mRNA molecule is called transcription and the gene is
said to be expressed or transcribed. The set of all mRNA transcripts present inside the
cell is called the transcriptome. The resulting mRNA molecule can then be converted by
ribosomes into proteins in a process called translation. The produced proteins are long
chains of amino acids, whose structure and function is dictated by the chemical properties
of the amino acids. This model of transcription followed by translation is termed the central
dogma of molecular biology [1, 2] and provides a firm basis for our understanding of the cell,
its characteristics and functions.
Proteins are responsible for virtually every activity inside the cell. They are the work-
force of a cell as they are involved in maintaining cellular shape and structure, during
metabolism, for cell-cell communication or in defense against foreign pathogens. They also
form the core of processing unit of a cell that analyzes incoming signal to generate an
appropriate output. Therefore, the key to understanding cellular behavior is to understand
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the protein content of a cell. Equivalently, because proteins are translated from mRNA
molecules, the mRNA content of a cell can also be used to infer cellular behavior.
1.1.2 Characterization of cells
The mRNA or protein content of a cell defines the notion of cellular phenotype. The
phenotype of a cell is indicative of both the type and state of the cell. While it still remains
to be more precisely defined, we recognize cell type as being a more stable property of the
cell, such as an immune cell type or an intestinal cell type, based on expression pattern of
a subset of proteins on the surface or mRNA inside the cell [3]. On the other hand, we
recognize cell state as a more transient property which can have some functional ability
associated with it, such as an activated immune cell or a cell in M-phase during cell cycle
[3]. This idea of learning cellular characteristics (state, type or function) by measuring a
cell’s content is a core theme of this thesis. We will try to learn information about cells
and the underlying biological process from expression patterns of multiple proteins or genes
measured for each cell.
The idea of characterizing cells from its contents has been around since the discovery
of cells. Initially, characterization of cells into distinct types was focused around their
morphology including their shape and location in the tissue [4, 5]. The discovery of synthetic
dyes that stained cellular constituents in distinct ways led to a molecular basis of cell type
identification [3, 6]. This essentially shaped the landscape of cell biology research up until
the second half of the 20th century; the main emphasis being on obtaining the molecular
profiles of the constituents (proteins being the objects of primary interest) of several cell
types. The techniques often involved isolation and protein precipitation stemming from
organic chemistry and biochemistry [7]. Subsequently important discoveries were made
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in the study of physiology of the blood and generally in immunology, the study of the
immune system [8]. However, such experiments were often restricted in the number of
cellular components that could be profiled (mostly one or two) and limited a more precise
cataloging of cells.
One of the most important insights from such experiments was the realization that
cellular processes actually are more complicated than previously thought. There was an
increasing support for the notion of cell being a very complex entity and the whole not nec-
essarily being the sum of its individual parts. Any biological process can involve multiple
components, often interacting with each other in a complex way. To put this in context,
understanding cellular behavior required probing multiple cellular components simultane-
ously.
1.1.3 The need to measure multiple cellular parameters
It is almost never the case that a biological function or type of a cell can be determined
by a single gene or its product; instead they are dictated by coordinated behavior of many
intra-cellular components. These components often act in modules, where a single module
performs a specific task and interacts with another module, and their combined performance
determines the properties of a cell [9]. As a result, understanding the type or state of a cell
requires profiling multiple parameters from the same cell.
Moreover, cells from the same tissue can display immense heterogeneity. The state
and type of a cell can change depending on the stimuli it receives (for example when a cell
differentiates), which results in changes in the phenotype of the cell due to altered expression
patterns of genes or proteins. Deciphering the different types of cells within a tissue thus
is not possible from one or two of cellular parameters. One of the clearest examples of
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complexity in cell type identification comes from the immune system. The immune system
consists of many cell types each with a unique function. Some are part of the innate system1
while some comprise the adaptive immune system2. Among the adaptive immune cells are
the αβ-T cells, which are characterized by the increased expression of CD3 protein on their
surface (typically denoted as CD3+ or expressing high amounts of CD3 proteins). αβ-T
cells can be further delineated as CD3+CD4+ T cells3 or CD3+CD8+ T cells based on
the expression of CD4 or CD8 protein on the surface of the T cell. CD3+CD4+ T cells
can in turn be further recognized as either T-helper 1 (Th1) based on their expression of
IFN-γ protein, or T-helper 2 (Th2) based on their expression of IL-4 protein or regulatory
T cells (Treg) based on their expression of Foxp3 protein or T-helper 17 (Th17) based
on their expression of IL-17 [11]. And yet, this is not a complete classification as there
are other sets of proteins that need to be considered to obtain a precise identification of
the subtype of CD3+CD4+ T cells [12]. This basic example illustrates the complexity
of just one of many types of immune cells in our body. Therefore, to obtain a precise
classification of immune cells to better understand their properties in various context (for
example those that infiltrate a tumor), we must profile multiple cellular parameters. This
notion of complexity also holds true for other cell types in our body (see for example [13,
14]).
As a result, the emphasis in cell biology research has shifted from trying to understand
what a single gene does to how all genes and their products work together to process
stimuli [9]. Major strides have been undertaken to develop novel technologies that allow us
1Innate immune system is non-specific and acts immediately once a threat is detected.
2Adaptive immune system is highly specific and acts on threats that sustain innate immunity.
3The nomenclature of immune cells is organized using the Cluster of Differentiation or “CD” naming
system [10].
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to profile multiple parameters from cells, which has given rise to the -omics revolution in
biology research. The suffix -omics is used to describe various technologies based on which
cellular parameters they measure. For example, prote-omics refers to technologies that
measure levels of protein expression, transcript-omics refers to technologies that measure
mRNA transcript expression levels, and so on. Each of these technologies collect information
on multiple components inside cells. For instance, bulk RNA-sequencing [15] measures the
abundance of all the mRNA transcripts present inside a collection of cells. This is a powerful
tool to characterize genes, or understand response to stimulus and normal physiology at
the genome level. For example, by measuring mRNA content from cells under control and
under perturbation, we can learn the genes that are expressed or repressed in either of the
conditions. This can be a source of great information to learn about genes that go awry in
diseases. More importantly, since the expression pattern of all the genes is measured we can
take a holistic approach to understand how genes interact with each other in either context.
However, such wealth of information comes at a price. Millions of cells must be pooled
together to ensure that cellular components are captured robustly, and only an average
value can be obtained. This results in the loss of the single-cell level granularity and can
provide misleading or incomplete information about the system.
1.1.4 Why single cells?
Most of the techniques developed up until early 21st century quantified abundances of cel-
lular parameters in a tissue sample by pooling together millions of cells. These experiments
(such as bulk RNA-sequencing [15] or blotting techniques [16]) involve assays where millions
of cells are treated uniformly and the average behavior or response of the cells is provided
as an output [17]. In this process, information at the single-cell level resolution and any
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associated heterogeneity is lost as it is masked by the aggregate. Figure 1.1 shows a simu-
lated example of the distribution of mRNA count for a hypothetical gene in two cell types.
From bulk measurement the gene expression would be interpreted as the middle line, which
is the average behavior of the gene across the two cell types. But it is misleading as the
true expression of the gene in both the cell types is very different from the average.
Figure 1.1: A synthetic example illustrating the mRNA count distribution of a gene in two
cell types (blue and red). Bulk measurements report value corresponding to the dotted line.
The loss of single-cell level resolution is more apparent in the context of tissue hetero-
geneity. As we have highlighted, cells within a tissue show immense diversity (for example
neuronal cells [18], liver hepatocytes [19]). Even cells of the same type maintain variability
between them, owing to the inherent stochasticity in gene expression pattern in single cells
[20]. This is even more highlighted in the context of cancer biology. Cancer is a very het-
erogeneous disease [21, 22] and it is important to identify the various types of cells involved
for proper diagnostics and effective treatment. In such cases profiling tissues at the bulk
level can be both incomplete and incorrect.
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Similarly, bulk measurements can also be inappropriate when the dynamics of cellular
activities is different among individual cells. For example, the levels of p53 gene after DNA
damage shows a dampened oscillatory behavior when studied over a population of cells. On
the contrary, the response was found to be undampened ‘digital’ pulses at the single-cell level
(with variability between cells), which reflected as dampened behavior when averaged out
over a population [23] (see Figure 1.2). Such differing dynamics are also prevalent when the
population of interest is undergoing cellular development or differentiation. So it is crucial
to profile cells individually to get an accurate picture of their dynamics. Furthermore, from
a conceptual point of view as well it is important to characterize cells at the single-cell level




Figure 1.2: p53 dynamics is digital under DNA damage. A) Schematic depicting the inter-
action between p53 and MDM2. After DNA damage the MDM2-p53 edge is weakened. B)
Response of p53 after DNA damage averaged over a population of cells. C) Response of
p53 after DNA damage in each individual cell. Adapted from [23, 24].
Characterizing tissues at the single-cell level is not a new idea. Initial studies of cells
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involved viewing them under the microscope with different staining conditions, which in-
evitably preserves the individuality of the cells. With advances in biochemistry that allowed
scientists to chemically profile intracellular components (by essentially breaking down a cell),
it became necessary to combine hundreds of cells to ensure robust and quantifiable mea-
surements. Because of the powerful approach to quantitatively describe the contents of a
cell, such bulk level experiments became more widely used and studies at the single-cell
level became ignored.
Novel single-cell level experiments only became possible in the 1960s with the introduc-
tion of flow cytometry. Flow cytometry is a laser based technology that can count and profile
proteins present inside cells (a more detailed description is provided in the next section).
Since then, multiple technologies have been proposed to measure different facets of tissues
at single cell level. For example, Quantitative Polymerase Chain Reaction (Q-PCR) can be
used to obtain mRNA abundance of pre-specified genes at the single-cell level [25]. Single-
cell RNA sequencing can be used to profile the abundance of the entire mRNA content in
each cell [26, 27]. Cytometry by Time Of Flight (CyTOF) can be used to quantify the abun-
dance of up to 40 proteins respectively in single-cells [28]. Multiplexed Ion Beam Imaging
(MIBI) can be used to image theoretically up to 100 expressed proteins at the single-cell level
[29]. Single-cell Hi-C can be used to study the conformation of DNA inside the nucleus in
3-dimensions [30, 31]. Single-cell ATAC-seq (Assay for Transposase-Accessible Chromatin
with high-throughput Sequencing) can be used to interrogate chromatin accessibility [31,
32]. These technologies have already contributed to new discoveries in oncology, immunol-
ogy and basic biology. For example, single-cell data have been used to identify novel and
rare cell types in different systems [33–36], align cells undergoing a developmental process
onto a trajectory to infer regulatory mechanisms governing the process [36–38], trace lin-
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eage of a particular subpopulation to pinpoint where they originate from [39] and study
protein-protein interaction at a network level [40] among many others. Single-cell analysis
is already altering the landscape of biomedical research [41], and has been established as a
powerful technique that holds great potential to help us in many other contexts.
This thesis will discuss computational analyses of two such data modalities namely
a) CyTOF, a mass spectrometry based method that quantifies the protein content in a
cell and b) single-cell RNA-sequencing (scRNA-seq), a sequencing based technology that
quantifies the mRNA content of a cell. The realization that the measured proteins or
mRNA expression levels for each single cell define the phenotype, state, type and various
regulatory mechanisms at play inside the cell will enable us to extract underlying biology
of the associated systems.
1.2 Cytometry by Time Of Flight
Cytometry by Time Of Flight (CyTOF) is a mass spectrometry based technique which
measures the abundance of a pre-specified set of up to 40 proteins simultaneously in millions
of cells at single-cell level resolution [28, 42]. It is an extension of an already established
single-cell technique called flow cytomety [43].
As discussed above, flow cytometry uses techniques from optics to profile proteins inside
cells. The proteins of interest are typically stained using antibodies4, which themselves are
tagged with a fluorescent compound. Although their natural role is in immunity, antibodies
have been engineered to recognize specific sites in proteins present on the surface and inside a
4Antibodies are proteins that are produced by plasma B-cells - a type of adaptive immune cells - inside
an organism to counter any foreign particles or antigens. They generally function by recognizing certain
regions or sequences of peptides, called epitopes, in the antigens and neutralizing their ability to cause any
harm.
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normal cell [44], and typically they target only the activated proteins5. In flow cytometry, a
pre-specified set of proteins are targeted by their known antibodies each of which is tagged
with a fluorescent dye. A laser of specific wavelength excites the dye as the cell passes
through a narrow tube (hence maintaining single-cell level granularity) and causes the dye
to emit light at different wavelength [44]. A detector detects the light emitted by each of the
dyes and processes them to report a corresponding number that is directly correlated with
the intensity of the associated fluorescence, which in turn is correlated with the abundance of
the associated protein for that specific cell. This way, flow cytometry provides quantitative
information on the expression levels of several proteins via the amount of fluorescence in
the antibodies bound to each protein at a single-cell level. While it started with the use of
a single dye, today one can measure up to 14 channels in a single experiment.
While powerful, flow cytometry is limited by the numbers of proteins it can measure
(currently at 14), due to limitations in the quality and types of dyes that can be used.
Secondly, data from flow cytometry are impacted by ‘autofluorescence’ of the dyes, which
needs to be compensated for computationally. More importantly, flow cytometry data is
hampered by spectral overlap, which occurs due to the overlap between the wavelength
of each emitted light. Each wavelength occupies a certain region in the electromagnetic
spectrum, so the overlap is inevitable as more dyes are added. The overlap can lead to
biased results on abundance of proteins and therefore must be compensated before any
analysis of the data is performed. Several computational tools have been proposed to
address this but they become ineffective as it is impossible to disentangle the overlaps after
5The activation state of a protein is generally determined by the presence or absence of a phosphate
group bound to the protein. For example, extracellular regulated kinases (ERK) is a protein which becomes
activated when a phosphate group binds a specific region of ERK, making it phospho-ERK or pERK.
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a certain number of dyes.
To circumvent this issue, CyTOF replaces fluorescent compounds by heavy metal iso-
topes typically not found in a cell to tag antibodies [28]. In CyTOF, first the metal isotope
chelated antibody tagged cells are passed through a narrow channel, but instead of being
excited by a laser, the cells are ionized in a hot plasma. The ionized isotopes are then
detected and quantified by a time of flight mass spectrometer. The abundance of detected
ions is directly correlated with the expression levels of the proteins that are bound to the
antibodies. The resulting mass spectra are very precise measurements with no overlap
between two isotopes. Thus, CyTOF effectively gets around the issue of spectral overlap
prevalent in flow cytometry (Figure 1.3). Furthermore, up to 40 proteins can be profiled
using CyTOF, allowing us to perform a deeper and more precise investigation of the system.
Additionally, CyTOF can process millions of cells simultaneously, which provides a lot of
statistical power to any analyses and inferences made downstream.
Thus, CyTOF enables the quantification of multiple proteins, which together define the
phenotype of each single cell. Nevertheless CyTOF is still limited by the number of metal
isotopes that are stable, can be accurately measured and are not present in a cell [47], which
is currently set up to 40. In addition, due to the need to choose proteins to be analyzed,
we are limited in the aspects of the underlying biology we can investigate. Nevertheless,
CyTOF is a precise and powerful technique that can provide a lot of information about the
cells and processes under question. In Chapters 3 and 4, we will apply CyTOF in the context
of αβ-T cells, where we will study the impact of genetically turning off certain genes (Ctla4
and Pdcd1) in the differentiation ability of the cells. We will present novel computational
techniques to study the geometry of such high-dimensional data and generate developmental
molecular pathways.
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(a) Spectral overlap in flow cytometry. Taken from
[45].
(b) CyTOF overcomes issue of spectral overlap.
Taken from [46].
Figure 1.3: (a) Spectral overlap in flow cytometry due to the broad range of wavelength
emitted by fluorescent dyes. (b) CyTOF uses elemental isotopes that show distinct spectra
in a mass spectrometer.
1.3 Single-cell RNA-sequencing
Single-cell RNA-sequencing (scRNA-seq henceforth) is a sequencing based technology that
measures the abundance of all mRNA transcripts present inside a cell. It provides a quan-
titative information on what genes are being expressed and by how much, which allows us
to learn the phenotype, state and type of the cell. The first protocol to perform scRNA-seq
was proposed in 2009 [48] when it was feasible to measure only tens of single cells. Today,
there are different improved protocols and cell handling techniques available, which enable
us to measure mRNA content simultaneously in thousands of single cells [26, 27, 49, 50].
In this thesis, we will work with data collected from a microfluidic based technology called
inDrop [26].
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Briefly, in scRNA-seq, individual cells are isolated from their tissue environment, so
that any downstream analysis is performed on each cell separately. This step is commonly
performed mechanically or enzymatically; and is crucial to ensure that the output is least
affected by technical artifacts or noise. If the cells are not isolated properly, two or more
cells may clump onto each other (also called the “doublet” problem) and more mRNA
content will be read out as a final product than there really is, which can obscure biological
interpretation. This is followed by cell lysis, which refers to the process of breaking a cell
down and releasing it’s molecular contents. By capturing the released mRNA transcripts
we can infer the genes that are active in the system, as a transcript will be present only
if the associated gene is expressed. In inDrop, each cell is encapsulated and lysed inside a
droplet in oil emulsion; hence, any mRNA transcripts inside the cell will be released within
the droplet. Current technology can only perform DNA based sequencing, so the released
mRNA must be converted into complementary DNA or cDNA. To achieve this, the droplet
also contains beads with each bead containing a barcoded primer6. The primer hybridizes
with the mRNA molecules present after cell lysis and thus a cDNA is constructed. It is
important to note that not all mRNAs - such as tRNA and rRNA - are useful for inferring
the phenotypic state and type of the cell. Thus, the primers are designed in such a way that
they hybridize only with the polyadenylated RNA, which are the matured messenger RNA
ready to be translated into proteins [49]. Furthermore, the primers also contain a unique
cellular barcode (a short strand of nucleotides) that allows identification of the source cell
for each mRNA molecule. Once the cDNAs are prepared, they are linearly amplified to
ensure a sufficient amount of material for sequencing, because just the amount of mRNA
6A primer is a short strand of DNA or RNA, which initiates DNA synthesis in vivo but can also be
synthesized in the laboratory.
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molecules that is captured is not enough to perform sequencing robustly. To mitigate any
sources of technical bias due to amplification of cDNA, the beads also contain a Unique
Molecule Identifier (UMI; very short strands of random nucleotides) which get amplified
with the cDNA. By counting unique UMI only and the frequency of UMIs per gene, we
obtain a more accurate abundance of all mRNA molecules for each cell [51].
scRNA-seq has already made big contributions to our understanding about the nature
of cells in varied contexts. For example, it has been used to decipher novel cell types in
blood, gut and nervous system, characterize cells using properties such as the variance of
mRNA expression levels and study heterogeneity in cancer [52]. In general, scRNA-seq has
the potential to help us learn much more about the biology of cells. It is expected to play
a major role in the recently launched Human Cell Atlas, which is an international effort
to construct an atlas of all cell types present in a healthy human body [3]. The resulting
atlas can serve as a reference map to compare against disease conditions and help us make
rational design choices to make treatments more effective.
In this thesis, we will apply scRNA-seq to study breast cancer cells undergoing a cell
state transition called the Epithelial to Mesenchymal Transition. We will discuss novel
computational tools to work with scRNA-seq data and use them to extract new biology
about cells especially in the intermediate phase during the transition.
1.4 Outline of the dissertation
This dissertation will describe and apply novel computational methods to work with the
aforementioned modalities of single-cell data sets. Chapter 2 will present a detailed outline
of the computational tools we will be using throughout this work. We will discuss varied
shapes and geometries single-cell data display, followed by an exploration of computational
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methods suited for specific types of data. Chapter 3 will apply the presented tools in the
context of differentiating αβ-T cells, where we will study the impact of genetic loss of Ctla4
on the geometry of the data. Chapter 4 will deal with a follow up of similar computational
techniques but applied to differentiating αβ-T cells with genetic loss of Pdcd1. Chapter 5
will discuss tools to work with scRNA-seq data sets, followed by an application to study
geometry of data collected from breast cancer cells undergoing Epithelial to Mesenchymal
Transition. Finally, we will conclude and discuss future work in Chapter 6.




CyTOF and scRNA-seq measure a large number of features in each single-cell, which results
in very high-dimensional data. Analyzing such data requires advanced algorithms that
can account for all the measured features and their inter-dependencies. From a biological
point of view, the underlying relationships between cellular parameters puts constraints in
protein or mRNA expression of the cells. This manifests as constraints on the structure
of the resulting data. Therefore, studying the structure of the data can shed light on the
underlying biology of the system.
In this chapter, we will discuss in detail some computational tools to analyze CyTOF
and scRNA-seq datasets. We will begin by describing properties of single-cell data and
the underlying forces that define its structure and distribution. We will highlight the idea
of cell phenotypes residing on a low-dimensional manifold embedded into high-dimensions
representing the measured parameters. We then discuss methods that can be applied to
understand the manifold structure of the data, and how we can tinker with them to learn
the underlying biological process.
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2.1 Cellular processes are well-regulated
Cells are in constant exposure to a mixture of diverse set of stimuli, which must be processed
to derive an appropriate response. As a result, intra-cellular processing must be able to
adapt, amplify, denoise and provide robust response to a wide variety of environmental
signals [9]. In practice, cells process signals through hundreds of interacting proteins acting
in unison. Such interacting components can be summarized through a protein (or gene)
network diagram where if entity A influences entity B then there is an edge connecting A
and B. Influences in such networks can be positive (A increases expression of B, denoted
by “→” from A to B) or negative (A suppresses expression of B, denoted by “a” from A to
B). Figure 2.1 shows a simplified example of interacting proteins in naive CD4+ T cells.
Figure 2.1: A simplified illustration of network of interacting proteins in CD4+ naive T cells.
The annotated ellipses represent proteins while the arrows indicate interactions between
them. Adapted from [40].
Proteins and genes form modules within a network that appropriately organizes intra-
cellular signaling to produce a desired outcome [9, 53, 54]. A module is a component in
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a network that performs a specific task independent of other modules. Such modules of-
ten display interaction patterns (network topologies) called motifs that appear much more
frequently in a network than by chance. Some common examples of motifs include sim-
ple regulation, feedforward, feedback loop, single-input modules etc. [55] (see Figure 2.2).
Under normal circumstances, motifs make cellular processing adaptive, accurate and ro-
bust towards incoming signals. For example, a negative auto-regulation can allow a protein
or a gene to reach it’s steady state expression level much faster than a simple regulation
(Figure 2.2A-B). A feedforward loop (Figure 2.2C) can manifest a sign-sensitive delayed
response, in a double positive feedback loop (Figure 2.2D), even a transient signal is suffi-
cient for the system to reach steady state. A negative feedback loop (Figure 2.2E) can help
stabilize response and when embedded with other motifs can result in oscillatory response
[55]. Thus, motifs and higher order modules of proteins and genes enable an organized
manipulation of incoming stimuli to produce a robust and meaningful output.
Figure 2.2: A simplified illustration of some common motifs that appear in biological net-
works. Shown are A) Simple regulation B) Negative auto-regulation C) Feedforward loop
D) Double positive feedback loop E) Negative feedback loop. Adpated from [55].
In addition, there are other constraints called checkpoints in place during cellular infor-
mation processing. For example, cell cycle checkpoints ensure that all conditions - such as
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cell size, integrity of chromosomes - are favorable during several stages of cell cycle for a
successful division of a cell into two daughter cells [56, 57]. Similarly, there are checkpoints
in the immune system that forbid uninterrupted activation of T-cells and thereby prevent
T-cells from attacking our own healthy cells [58, 59]. They keep the system under control,
maintain protein expression levels within a desired physiological range and do not allow
haphazard processing of any erroneous signal.
In this way, modules and checkpoints appropriately regulate cellular processing. As
a consequence, during any biological process the abundance of proteins and interactions
between them is tightly maintained. This property manifests as constraints on the structure
of the data we measure. Because proteins define the phenotypic state of a cell, a regulation
on protein behavior reflects as a constraint on the available phenotypes to the cell. From a
modeling perspective, if a cell is a point on a state space that defines cellular phenotype in
terms of its measured parameters, such constraints imply some regions of the state space as
more favorable than others. Under this assumption, we want to study the nature of these
available states and infer the underlying biological processes.
In this work, we use CyTOF and scRNA-seq to quantify the abundances of the proteins
or mRNA molecules in a cell respectively, which can be analyzed to characterize a cell and
the system as a whole. The integer valued abundances are usually transformed so that a cell
phenotype is defined by continuous valued expression levels of the measured components
(Appendix A for CyTOF and Appendix B for scRNA-seq data). This implies that if n
components are measured, then an Rn dimensional space can be defined, where each axis
is the expression level of any one measured cellular component. The location of each cell is
then defined by a vector whose entries are the expression levels profiled for the cell. Such
a vector is called the cell phenotype vector and the state space occupied by all the cells is
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called the cellular phenotype space. But the cloud of cells that constitute the phenotype
space is likely not generated from some parametric distribution (such as Gaussian ball)
neither is it simply a random collection of points. Due to the checks and balances in place
during cellular processing, the expression levels of proteins or genes are tightly controlled
and vary coherently. Hence, the phenotype space is a precisely regulated structure with
a certain geometric shape, which can be informative of the underlying biological process.
For example, perturbation in some major protein or gene in a network can cause disruption
in the network which should be reflected in the changes in the structure of the phenotype
space. In such a case, analysis of the perturbed space and comparison with the control case
could reveal the importance and role of the altered entity.
It is remarkable that simultaneous measurement of single-cells in one experiment is
sufficient to showcase the phenotype space of the biological process. This is entirely due to
the asynchronous nature of cellular responses, even in the case of identical cells. We discuss
this property briefly below.
2.1.1 Learning from a single time-point
Cellular mechanisms are highly asynchronous in nature. In other words, cells within the
same tissue and under the same environment can respond differently to any stimuli. This
suggests that cells of different types and in varied states can be profiled from a single sample.
The difference in response can be attributed to stochasticity in gene expression, variation
in timing and amount of signal a cell receives and so forth. Also, cellular history - the state
a cell was previously in - is asynchronous within a sample of cells, which also contributes
the asynchrony at present. So, even one snapshot of single-cell data is a heterogeneous
mixture of cells in almost all possible states pertaining to the system. Added to this, a
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large number of cells and their constituents are acquired during any experiment of CyTOF
and scRNA-seq, which implicates that by treating each cell as a point of information we
can learn dependencies between the measured features and thereby learn the underlying
biological phenomenon. This hypothesis has been implicitly used successfully in previous
single-cell data analyses. To name a couple, in [37] cells of various types and in different
states during early blood development were profiled, in [38] the authors were able to capture
CD3+ T cells that were differentiating into CD4+ T cells and CD8+ T cells in a single
snapshot. Thus, it is possible to learn a holistic picture of a biological phenomenon by
profiling cells at a single time-point, thanks to asynchronous distribution of cells across all
possible states in the phenotype space. In addition, biological experiments at the single-cell
level are typically expensive to conduct. So, profiling cells at various time-points during a
biological process can be economically prohibitive.
Furthermore, the asynchronously distributed cells are also constrained to occupy phe-
notype space of lower-dimensionality compared to dimensionality of the ambient space (the
number features that are measured). This is a result of the regulations present inside the
cells. We discuss this next in more detail.
2.2 The data manifold
Another aspect of the modularity of biological networks is that the expression of genes or
proteins are correlated and inter-dependent. The genes or proteins that are co-regulated
by a common transcription factor (or some other protein) display correlated expression
pattern. So while there are many entities involved in intra-cellular processing, there exists
redundancy among them. In other words, the underlying biology is being driven by only a
handful of components or latent variables. Therefore, though we may measure many differ-
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ent features of each cell to get a holistic picture of the system, there are only a few degrees
of freedom at play and our goal is to understand them. Interestingly, the variables that
determine the underlying biology need not simply be a subset of the measured components,
hence the term latent.
One consequence of this realization is that the cellular phenotype space is really a low-
dimensional object embedded onto a high-dimensional space. We call the low dimensional
object the data manifold or the biological manifold of the system. It refers to the true
structure of the data irrespective of how it is embedded; and understanding the manifold
holds the key to uncovering the underlying biology. In fact, our goal in following chapters
will be to learn the structure and shape of the data manifold under different contexts and
extract novel biological information.
The expression pattern of proteins (or genes) define the manifold structure, so cells
with similar expression profiles are close to each other on the manifold. In other words,
the local neighborhood of each cell on the manifold consists of cells similar to the cell.
This is a remarkable property as it establishes a criteria any method will need to satisfy to
accurately capture the structure of the manifold. Furthermore, the manifold only depends
on the connectivity of the data points - defined via pairwise distances - and not on how
the points are arranged in space. For example, Figure 2.3 (adapted from [47]) shows a set
of points that lie along a one-dimensional manifold embedded onto two dimensions. While
the spatial embedding is different, the underlying manifold is the same. We will try to use
these properties of the manifold to characterize it.
In the context of single-cell biology, the data manifold is a characterization of the avail-
able space of phenotypes for any cell in that context. Exploring the manifold is therefore
equivalent to exploring the possible cellular states. Imagining the manifold as a landscape,
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(a) (b)
Figure 2.3: (a) Data points lie on a one-dimensional manifold that is spatially embedded as
a straight line. (b) Data points lie on a one-dimensional manifold that is spatially embedded
as a semi-circle.
being able to maneuver around it, from one point to another may hold the key to under-
standing why cells align the way they do in the phenotype space. Especially in the context
of cells developing from one phenotype to another, navigating paths along the manifold can
lead to characterization of molecular changes a cell undergoes to achieve the transforma-
tion. Any defect in the molecular processes should reflect as a change in the phenotype
landscape, characterizing which can help us pinpoint where and what went wrong. For
example, it has been established that certain transcription factors and interactions between
them maintain normal development of myeloid cells (part of the immune system) and dys-
regulation in the activity of any of the transcription factor can cause cells to deviate from
their normal course and result in deadly diseases such as leukemia [60]. This deviation from
normal expression would reflect as a change in characteristics of the data manifold, such as
volume or variance or regions of occupancy, analyzing which can help us understand the
cause and consequences of the changes.
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Understanding the manifold of a high-dimensional data is a problem that pervades
several disciplines. As a result, many methods have been proposed to tackle this problem.
It is easier to obtain the structure if the underlying manifold is linear - that is, the observed
features can be written as a linear combination of the latent variables. Linear methods
such as Principal Component Analysis (PCA) have been successfully applied in such cases.
However, in single-cell biological data, genes or proteins often display non-linear behavior.
The non-linearity is a result of the measured components themselves being a non-linear
combination of the latent variables driving the process, which is in turn a result of the
cascades of interactions, checkpoints and feedback mechanisms a cell has in place. Thus,
characterization of the manifold requires us to involve methods that take into account the
non-linearity present in a single-cell data.
As with any other non-linear or noisy systems, characterizing the manifold structure is
a hard problem to solve. Nevertheless, a classical approach of “divide and conquer” have
proven to be very useful in this context. We observe that in a local neighborhood of any given
point, the manifold is congruent to a Euclidean space. This implies that, we should be able
to characterize the data manifold by first analyzing data locally around every point, and then
combining them. For example, Figure 2.3a shows cells on a Euclidean manifold - a straight
line - but Figure 2.3b shows cells along a curved, non-Euclidean line. In Figure 2.3b, locally
around every point, the space looks Euclidean and the connectivity determined by pairwise
distances is congruent to its counterpart in Figure 2.3a. This notion of analyzing data
locally around every point and aggregating that information to characterize the underlying
manifold has proven beneficial in single-cell data analysis and will form the backbone of
many of the methods we will discuss here.
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2.2.1 Graphs approximate the data manifold
The true underlying biological manifold is a smooth continuous surface, but from a single-
cell experiment we only receive a noisy non-uniform sampling of cells from the manifold.
To this end, we use the cells to build graphs to approximate the manifold [61]. A graph is
defined as a set G = {V,E,W} consisting of a set of nodes or vertices V , a set of edges E
connecting all or some of the vertices and weights W assigned to each of the edges. In the
context of single-cell data, each cell comprises a vertex or node in the graph, two cells are
connected if they are similar to each other and the weight between them is the quantification
of similarity between them. The similarity between two cells can be obtained by measuring
the distance between them, while other metrics such as correlation could also be used. The
choice of distance metric, however, is context dependent but due to its easiness and useful
properties, Euclidean distance seems to be the preferred choice in the single-cell field. Let
ci = (pi,1, pi,2, . . . pi,M ) denote the i
th cell which has M total features, pi,n denote the n
th
measured feature of the ith cell, and cj = (pj,1, pj,2, . . . pj,M ) denote the j
th cell. Then the
Euclidean distance between the two cells is defined as,
Dist(i, j) =
√
(pi,1 − pj,1)2 + (pi,2 − pj,2)2 + · · ·+ (pi,M − pj,M )2. (2.1)
However, computing Euclidean distance among all the cells to define similarity can often be
misleading, when the cells lie on a non-linear manifold. Figure 2.4 illustrates an example,
where Euclidean distance can wrongly assign two cells as being similar while they are
actually dissimilar based on distance along the manifold, which we call the phenotypic
distance.
Nevertheless, the manifold is congruent to a Euclidean space locally around any given
point. So it is sensible to use Euclidean distances to compute similarity in the small neigh-
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Figure 2.4: Euclidean distance can wrongly assign phenotypically distinct cells as being
similar.
borhood of a point and we use this idea to build graphs on the cells. In particular, for every
cell we first find the k nearest neighbors (typically k is set to < 1% of the total number
of cells profiled) based on Euclidean distance, which will comprise the local neighborhood.
Each cell is thus connected to its k nearest neighbors by an edge and the constructed graph
approximates the underlying manifold. The phenotypic distance between any two cells on
such graph is then defined by geodesics along the graph, which more accurately captures
biological differences between cells.
Almost all the methods developed to analyze single-cell data use graphs to parametrize
the data in one form or another. This idea provides a general framework to develop meth-
ods to extract interesting and meaningful biological information from the data. One such
method that is almost exclusively used by everyone to visualize high-dimensional single-
cell data is called tSNE (t-distributed Stochastic Neighborhood Embedding) [62]. It is a
non-linear dimensionality reduction technique that maps each high-dimensional point onto
low-dimensions. tSNE uses local Euclidean distance measure to identify similar points in
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high-dimensions and places them near each other in the projection, while ensuring dissimi-
lar points are placed far from each other. Visualization of the data using tSNE has proven
to be insightful in various contexts and continues to be an important part of analyzing
single-cell data. While alternative non-linear projection techniques such as kernel-PCA or
Isomap could also be applied, tSNE generally has been more effective in handling single-cell
data [63]. This is because tSNE takes into account both the local and global structure of
the data, unlike other projection techniques, which focus on primarily capturing the local
structure around each data point [62, 63].
2.2.2 Discrete or continuous phenotype space
One of the most revealing facets of high-dimensional single-cell data has been that cells
seem to occupy either a discrete set of states or lie along a continuum in the phenotype
space. While a more rigorous quantification is needed to establish the structure of the data,
we provide a simple visualization using tSNE to illustrate the idea.
(a) (b)
Figure 2.5: (a) tSNE plot of 8,000 human PBMCs. Highlighted are some immune cell types.
(b) tSNE plot of 6,000 cells undergoing hematopoiesis.
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Shown in Figure 2.5a is a tSNE visualization of human Peripheral Blood Mononuclear
Cells (PBMC) collected using scRNA-seq [64] with some major types of immune cells high-
lighted. Each dot in the figure represents a single-cell, nearby points are similar cells and
distant points are dissimilar. It is seen that the cells occupy distinct chunks of the phe-
notype space. It is important to note that this is predicated on the assumption that we
have not under-sampled some rare sub-populations of cells that occupy intermediate states
between these clusters. Contrast to this, Figure 2.5b shows tSNE projection of cells under-
going human hematopoiesis, where the cells seem to lie more along a continuum. Briefly,
hematopoiesis is the process by which a hematopoietic stem cell develops and differenti-
ates into all types of cells present in the blood. The highlighted cells above, except for
hematopoietic stem cells, are terminally differentiated, which is to say they do not possess
the ability to further mature and are ready to perform their function. It is clear from the
figure that there is a continuity in the states occupied by the cells along the phenotype
space.
The notion of cells occupying different clusters is often utilized to identify distinct cell
types in the sample being investigated. Conversely, when a sample is a heterogeneous
mixture of different types, the cells have varied expression patterns of surface proteins or
transcription factors, which should reflect as cells occupying disjoint regions of the pheno-
type space. On the other hand, cells lying along a continuum in the phenotype space is
most evident in systems where cells are undergoing some developmental changes. In such a
case, as the cell is progressing, it is the aggregation of minute changes in cellular expression
during the process that result in an overall dramatic shifts in cellular phenotype between
start and end stages. This gradual change is captured on a single snapshot of data thanks
to asynchronous nature of cellular development in a given sample of tissue. Thus, it is
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natural to observe that cells occupy region along a continuum during the process, rather
than discrete separate chunks. From a conceptual point of view, a recent work suggests
that continuum in gene expression can also result from spatial division of cells in tissues
[65] especially in organs such as liver where spatial partitioning of specialist cells is critical.
Two major themes in single-cell biology research has been to uncover all possible cell
types in a certain system or extract the structure of the continuum the data displays. Put
differently, we would like to 1). Identify all clusters of cells, which can then be annotated
as specific cell type or 2). Identify major trends in the data, which can then be used to
understand how cells develop during a biological process. In the following section, we will
discuss some algorithms to analyze data that display a continuum structure for which we
will borrow ideas from harmonic analysis and spectral graph theory [66, 67].
2.3 Diffusion maps to extract underlying manifold structure
Two cells which are similar to each other - in the same cellular state and type - show
a similar gene or protein expression pattern. Under this assumption, understanding the
manifold structure of any single-cell data necessitates that the connectivity or the geometry
within a local neighborhood of each cell be preserved1. This problem of learning structure
of the manifold while preserving local structure of the data is called manifold learning and
has been well-studied using tools from spectral graph theory. It has been shown that the
generalized eigenvectors of the graph Laplacian provide an optimal, in a specific sense, low-
dimensional embedding of the data while preserving the local neighborhood structure of each
data point [68]. Graph Laplacian is a matrix representation of the graph, which captures the
1This notion is also predicated in the assumption that the measured cellular parameters represent majority
of heterogeneity between cells in a sample.
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essential characteristics such as connectivity and affinity between nodes. This in turn allows
computation of other interesting properties of the graph and we will discuss more about
such matrices below. However, as it turns out, such methods can be generalized using the
notion of diffusion processes on the graph structure of the data. The generalized framework
called the diffusion maps [67] is a dimensionality reduction technique that transforms any
high-dimensional data into a lower dimensional Euclidean space by accounting for any non-
linear dependencies between the features. In doing so, it preserves the relationship between
points that are similar in high-dimensional space and discards distant ones. This property
of diffusion maps that makes it very favorable for single-cell data analysis. By preserving
the local neighborhood structure, it provides a platform to incrementally navigate along
the data manifold. Unlike diffusion maps, tSNE while useful to visualize data, does not
accurately preserve high-dimensional pairwise distances in the resulting low-dimensional
representation. This limits the use of tSNE to visualization and does not facilitate any
further analysis.
The success of diffusion maps relies on its ability to truly capture the geometry of the
data. The construction of the diffusion maps begins with the k-nearest neighbor graph.
The distance graph is then converted into an affinity matrix, which quantifies the similarity
between cells. The affinity matrix defines the graph structure and cell neighborhoods and
thus its accurate construction is crucial. The affinity matrix is then normalized into a
Markov matrix, the eigenvectors of which correspond to diffusion maps. We will describe
each of these steps in detail below.
Let Dist(i, j) represent the Euclidean distance between the ith and jth cell. The distance
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graph can then be written as a matrix D where the (i, j)th entry is given by,
D(i, j) =

Dist(i, j), if j is one of the k-nearest neighbors of i
0, otherwise.
The distance matrix is then symmetrized to ensure that the graph is connected and the
Markov matrix (discussed below) can mimic a discrete diffusion process [69, 70],
D = D +DT . (2.2)
The distance matrix is then converted into an affinity matrix A using a Gaussian kernel.
The (i, j)th entry of A is given by,







where σi represents the width of the Gaussian kernel used for cell i. Effectively, we con-
struct a Gaussian kernel centered at each data point and assign similarity score to other cells
using the distribution function. Such probabilistic representation of cell-cell similarity is
more robust to noise, which is typical in single-cell data. We prefer Gaussian kernel against
other kernels for its simplicity, useful mathematical properties - its relationship with the
heat-equation to model diffusion process on the graph - and because it represents the sim-
ilarity between cells continuously that decreases smoothly as the distance between the cell
increases. To this end, the choice of σ is crucial, for example using the same value of σ for
all cells can be detrimental because the cells most likely represent a nonuniform sampling of
states from the underlying manifold2. This is reflected as uneven densities of cells along the
manifold. To circumvent this, for each cell i, we set σi = distance to ka
th neighbor of i,
where ka is often set to bk/3c. This allows σ to adapt to varying data density along the
2Some biological processes are rare or transient, so capturing cells from such states can be difficult.
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manifold. The resulting affinity matrix is finally normalized to a Markov matrix, M as3
M = T−1A, (2.4)
where T is a diagonal matrix, such that T (i, i) =
∑
j A(i, j). In other words, each diagonal
entry of T is the row sum of A. This implies that the rows of M sum to 1, hence making it
row-stochastic. Consequently, M can be used to model a random walk on the graph. Each
row of M can be interpreted as the distribution of probability that a random walker will
move in one step. In other words, M(i, j) quantifies the probability that a random walker
at the ith state will transition to the jth state in one step,
M(i, j) = p(X = j, t = 1|X = i, t = 0), (2.5)
where X is the state of the random walker and t is the timepoint or number of steps. In
summary, each cell represents a state that a random walker can occupy and the Markov
matrix quantifies how the random walker can move along those states. This allows the
Markov matrix to mimic (discrete) diffusion process by raising it to a certain power, which
can be used to share information between cells - this strategy will be harnessed to its fullest
in Chapter 5.
The eigenvectors of the resulting Markov matrix are called diffusion components. The




ψ1,1 ψ1,2 ψ1,3 . . . ψN,N
ψ2,1 ψ2,2 ψ2,3 . . . ψ2,N
ψ3,1 ψ3,2 ψ3,3 . . . ψ3,N
...
...
... . . .
...
ψN,1 ψN,2 ψN,3 . . . ψN,N

, (2.6)
3L = T −A would result in the Graph Laplacian.
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where ψi,j represents the coordinate of i
th cell in the jth eigenvector. The features of the
cells now are eigenvector coordinates as opposed to gene expression levels.
Moreover, various powers of M characterize the data at different scales, via eigenvectors













defines a family of diffusion components for each value of t, hence the term diffusion maps4.
Because the rows of M sum to 1, a unit vector is a trivial eigenvector of M with
corresponding eigenvalue 1. In fact, the eigenvalues λ of M are always less than or equal to 1,
and the multiplicity of eigenvalue equal to 1 indicates the number of connected components
in the graph. From a biological perspective, such components indicate stationary or stable
states from where it is difficult for cells to exit. The eigenvector corresponding to the
second largest eigenvalue - the first non-trivial eigenvector - gives information on the most
dominant signal in the data and highlights the major axis of variation along the phenotype
manifold. Similarly, the next eigenvector highlights the next major axis of variation and so
forth. Figure 2.6 illustrates this via an example of a set of points arranged as a swiss-roll.
The first two eigenvectors of the Markov matrix accurately identify the two major axes of
variation along the manifold.
Therefore, by choosing top few eigenvectors, which represent directions of most variation,
4In this thesis, we do not raise M to any power when computing diffusion components because we would
like the diffusion component to describe the axes of variation on the global scale.
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Figure 2.6: Data points lie along a swiss roll (left). The first non-trivial eigenvector of the
Markov matrix accurately captures the dominant axis along the manifold (middle), and the
second non-trivial eigenvector captures the next dominant axis (right).
a low-dimensional representation of the data can be obtained.
Ψ(X)→

ψ1,1 ψ1,2 ψ1,3 . . . ψ1,n
ψ2,1 ψ2,2 ψ2,3 . . . ψ2,n
ψ3,1 ψ3,2 ψ3,3 . . . ψ3,n
...
...
... . . .
...
ψN,1 ψN,2 ψN,3 . . . ψN,n

, (2.8)
where n << N .
The choice of n is data-dependent and the signal to noise ratio represented by each
diffusion component. For this, one needs to look at the data with the biological context in
mind. However, as a basic guide to the choice of n, we typically consider the eigen-gap in
the eigenvalues of the Markov matrix. This is motivated by the realization that the amount
of information present in each corresponding eigenvector is reflected in the corresponding
eigenvalues of M . For example, Figure 2.7 shows the eigenvalue spectrum of a typical
Markov matrix. It shows a distinct gap between the seventh and eighth eigenvalues, which
suggests that the first seven eigenvectors likely correspond to slow varying trends in data
and are more informative while the latter ones are varying faster. The slow varying modes
in the data are thought of as true biological signals while the fast varying modes as likely
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noise. In a case like Figure 2.7 we would truncate the diffusion maps to include only the
first seven eigenvectors. Our lab is currently working on approaches to make downstream
analyses robust to the choices of number of eigenvectors (for example see the preprint [71]).
Figure 2.7: An example of the eigenvalue spectrum of a Markov matrix. Each dot is an
eigenvalue; the eigenvalues are in descending order.
Diffusion maps have been successfully used in single-cell data analysis to understand
the structure of the data. Because the embedding aims to preserve the local neighborhood
of each cell, the diffusion components form a natural coordinate system for cells along a
continuum. As a result, they have been most successfully employed to align cells undergo-
ing development along a trajectory. Some notable applications include trajectory of cells
during early blood development [37], T-cells differentiating into CD4+ and CD8+ T cells
[38], maturation trajectory of ganglionic eminences [72] and multi-branching trajectories of
conventional dendritic cells [73] among many more. In addition, diffusion maps can be used
for other purposes, some of which we discuss below and use in subsequent chapters.
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2.3.1 Diffusion distances
Diffusion maps also provide a natural metric of distance called diffusion distance between
cells in the new coordinate framework. The diffusion distance V between two cells x and y
is the difference between the probability distributions of a random walker starting at x and
y after t steps. Mathematically [74],
V 2(x, y; t) =
∑
z
(p(z, t|x)− p(z, t|y))2w(y), (2.9)
where t is the time parameter denoting the number of diffusion steps of the random walker,
p(z, t|x) denotes the probability that the random walker is at state z after t steps given that
it was initially at x and w(z) =
∑
j T (j, j)
T (z)
(T is defined in Equation 2.4 above). In other
words, the diffusion distance between two cells x and y is the weighted sum over all states
z of squared-differences between the probability of random walker hopping from x to z and
from y to z in exactly t steps. Intuitively, diffusion distances take into account all possible
paths of t steps from x and y, which means that cells that share a lot of neighbors will have
smaller diffusion distance between them. This property makes diffusion distances robust to
noise in the graph such as short-circuits (see Figure 2.4) and is generally more accurate than
geodesics or shortest paths along the graph [75] to measure phenotypic distances between
cells.
It has been shown [74] that the diffusion distance can be alternatively defined as the
Euclidean distance in the diffusion maps coordinates. Thus,
V 2(x, y; t) =
∑
j>1
λ2tj (ψj(x)− ψj(y))2 , (2.10)
where ψj is the j
th non-trivial eigenvector of the Markov matrix and λj is the associated
eigenvalue. We note here that computing diffusion distance at time t using Equation 2.10
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is equivalent to computing the Euclidean distance on the space defined by the scaled eigen-
vectors λt ~ψi.
We will use diffusion distances in Chapter 3 and 4 to robustly quantify the density of
cells along the phenotype manifold of differentiating T cells.
2.4 Shape of data
As discussed, the phenotype space of single-cell data is a well-regulated structure with a
specific geometric shape. In the case where cells lie along a continuum in the phenotype
space, studying the shape of the data, such as its convexity and concavity in different
regions can provide valuable information on the nature of biological constraints in place in
the system. In a more general context, efforts have been made to approximate the shape of
the data using convex polytopes. While the shape of a biological phenotype space is highly
non-linear, approximating its shape with the closest polytopes provides a solid starting
point for further exploration. In this regards, Archetype Analysis (AA) has been proposed
to find the polytope that best encapsulates the data.
2.4.1 Archetype Analysis
Archetypal analysis is an unsupervised approach to study geometry of high-dimensional
data [76]. The goal of archetype analysis is to find a convex geometrical object such as
a triangle or a tetrahedron (a polytope in general) that best encapsulates the data (see
Figure 2.8). The vertices of the resulting polytope, called the archetypes, characterize the
extreme states in the data. One is tempted to say that the archetypes provide a rough
approximation to the convex hull of the data in the sense that it tries to enclose as much of
the data as possible. Recently, archetype analysis has been proposed as a tool to analyze
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high-dimensional biological data sets [77–79], in addition to dimensionality reduction and
clustering.
Figure 2.8: An example of archetype analysis applied to a synthetic data. The blue dots
represent sample points, green lines demarcate the convex hull of the data and the red dots
indicate the archetypes.
To find a polytope that best fits the data, the archetypes should be representatives of the
phenotypic space. To achieve this, each archetype is first expressed as a convex combination
of the data points. Mathematically, given N cells with M measured features { ~x1, . . . , ~xN},





where cij are the convex coefficients, 0 ≤ cij ≤ 1,
∑N
i=1 cij = 1 and j = {1, . . . p} for p
archetypes. In other words, each archetype is a probabilistically weighted sum of the data
points. The set of archetypes can be represented as Z = XC, where X ∈ RM×N is the
data matrix, C ∈ RN×p is the coefficient matrix and Z ∈ RM×p is the matrix of archetypes.
On the other hand, since we are interested in characterizing the extreme states in the data,
we need the archetypes to be on or near the convex hull of the data. This is achieved
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by requiring each data point to be expressed as a convex combination of the archetypes.




sji ~zj , (2.12)
where sji are the convex coefficients, 0 ≤ sji ≤ 1 and
∑N
i=1 sji. In a compact form,
X˜ = ZS = XCS where S ∈ Rp×N is the matrix of coordinates sji. Thus, the first condition
requires each archetype to be a convex combination of the data points thereby pushing the
archetypes in towards the data while the second condition requires each data point to be
a convex combination of the archetypes thereby pushing the archetypes far away from the
boundary to encapsulate the data within their convex hull. The goal in archetype analysis
is to optimize both of these criteria, which is obtained when the archetypes fall on the
boundary of the data. Since we aim to re-approximate the data from the archetypes, this
optimality can be obtained by minimizing the L2-norm of the difference between original
data (X) and the approximated data (X˜), that is, ||X − X˜||2 . The optimization can be
performed using gradient descent on a constrained space (due to constraints placed on C and
S). Here, we will utilize Principal Convex Hull Analysis (PCHA) [80], which has previously
been used successfully in single-cell data analysis [77]. The optimized set of archetypes will
comprise the vertices of a polytope that best encapsulates the data.
Archetype analysis provides a unique opportunity to investigate changes to the pheno-
typic space resulting due to perturbation. In normal conditions, regulatory mechanisms such
as feedback loops and checkpoints maintain a controlled gene expression profile constraining
the structure and boundaries of the phenotype space. However, under perturbations, these
regulatory mechanisms could be dysregulated giving rise to an expansion or disruption in
certain regions of the space. In such circumstances, archetype analysis can be useful to
CHAPTER 2. COMPUTATIONAL METHODS FOR SINGLE-CELL DATA 41
identify and characterize any new extremities. In Chapter 3 and 4, we will utilize archetype
analysis to argue that negative costimulatory molecules CTLA-4 and PD-1 constrain T-cell
differentiation.
Furthermore, it can be a useful tool to analyze various states of cells when they lie along
a continuum where the notion of clustering is not defined. The phenotype space although
along a continuum can be highly non-linear, twisting and turning in the ambient space.
In such a scenario, the idea of extreme states and cellular phenotype around the extreme
states can give an indication of atypical behavior of the system. Such extreme phenotype
can often harbor novel and under-appreciated biological processes. To give a hypothetical
example, one can imagine that few cells can display extreme levels of an important set of
genes. Such cells could be masked by a typical clustering algorithm because when considered
on a genome level the atypicality could be treated as a nuisance. However, application of
archetype analysis could correctly identify the extreme behavior and help pinpoint the cells.
A potential application of such is in identifying stem cell behavior in cancer systems, which
is displayed by only a handful of cells. Here, we will apply archetype analysis to characterize
previously uncharted territory of intermediate states during the Epithelial-to-Mesenchymal
Transition of breast cancer cells in Chapter 5.
We will now apply all the discussed computational tools to obtain important and novel
biological findings in various contexts in the following chapters.
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Chapter 3
CTLA-4 constrains T cell
differentiation states
In this chapter, we will apply the tools discussed in Chapter 2 to study the effects of loss of
Cytotoxic T-Lymphocyte-Associated protein-CTLA-4 (CTLA-4) in T cell differentiation.
3.1 Background
3.1.1 T cells
T cells (called so because they mature in the thymus) are a highly specialized type of
adaptive immune cells and can be uniquely recognized by the presence of a protein complex
called T cell receptor (TCR) on their surfaces. The T cell receptor complex contains a
variable region and a constant region, which together allow T cells to recognize myriads
of invading foreign antigens. The variable region differs between every T cell of distinct
clones and in majority of the T cells in an adult is comprised by TCR αβ-complex and the
remaining minority by γδ-complex. While the γδ-T cells are also very important, we will
concern ourselves mostly with the αβ-T cells, and refer to them as simply T cells hereafter
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unless specified. The constant region in the T cell receptor is the same for all T cells and
comprises of the transmembrane CD3 protein. Therefore, T cells can be uniquely identified
using CyTOF (for example) by measuring the abundance of CD3 protein on the surface of
blood cells - cells with high expression of CD3 would be categorized as CD3+ T cells or
simply T cells.
CD3+ T cells can be further categorized into two subsets based on the expression of CD4
or CD8 protein on their surface, which are thought to be mutually exclusive1. A CD3+ T
cell that expresses CD4 on its surface is called a CD3+CD4+ T cell or simply CD4+ T cell
and similarly, a CD3+ T cell that expresses CD8 on its surface is called a CD3+CD8+ T cell
or simply CD8+ T cell. CD4 and CD8 proteins are also called co-receptors as they allow T
cells to receive signal from the environment. They help T cells recognize any foreign antigens
by physically linking with the TCR that interacts with antigen presenting complexes on the
surfaces of antigen presenting cells (APC) such as dendritic cells. Receiving a stimulatory
signal from an antigen presenting cell in such a way is absolutely necessary for a T cell
to respond to the threat. Both CD4+ T cells and CD8+ T cell perform their function
by secreting small proteins called cytokines and releasing them towards their targets when
needed.
A less specialized CD3+ T cell becomes a more specialized CD4+ T cell or a CD8+ T cell
by undergoing a biological process called cellular differentiation. While this process takes
place already in the thymus, during development, CD4+ and CD8+ T cells can undergo
further differentiation in the periphery to achieve a more definite phenotypic and functional
state[12]. The differentiated states are commonly referred to as lineages. T cell (CD4+ or
1With exception during maturation of T cells in the thymus where CD4+CD8+ cells develop into CD4+
or CD8+ cells.
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CD8+) that has not received any stimulatory signal is called a na¨ıve T cell and while a
mature cell type, it is functionally inactive and is constantly circulating in the blood waiting
to be activated. When an APC notices a threat, it presents a trace (such as a peptide) of
the threat to a T cell by physically linking up with the TCR. This allows the cognate T
cell that specifically recognizes the antigen complex to become activated, which leads to its
proliferation and differentiation. Differentiation of a T cell is determined by many factors
such as the cytokine environment they are exposed to, the type of APC and so forth [81].
A CD4+ T cell or CD8+ T cell can differentiate to become an effector or memory type.
As the name suggests, memory T cells provide an immunological memory of previously
encountered antigens such that if a same antigen attacks the body again, the T cells can
respond immediately based on memory. Effector T cells are the functionally active T cells
that either kill virus infected cells (effector CD8+ T cells, hence also called cytotoxic T cell)
or help other immune cells neutralize invading pathogens (effector CD4+ T cells, hence also
called helper T cell). Furthermore, effector CD4+ T cells can potentially differentiate into
five types namely T follicular helper (Tfh), T Helper 1 (TH1), T Helper 2 (TH2), T Helper
17 (TH17) and induced regulatory T cell (iTreg) [12]. Tfh typically interact with B cells and
produce InterLeukin-21 (IL-21), TH1 produces IFN-γ and typically activate macrophages
to cause phagocytosis and CD8+ to kill infected cells, TH2 produce IL-4 and interact with
basophils, mast cells and B cells, TH17 produce IL-17 and help activate neutrophils, and
iTreg cells help keep the activity of other immune cells in check via cytokines such as IL-
10 and IL-35 [12, 81]. However, differentiation of T cells to such specific functional state
necessitates the activation of na¨ıve T cells first.
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3.1.2 T cell activation
Stimulatory signal from the TCR is necessary but not sufficient to activate a na¨ıve T cell.
As it turns out, a T cell requires a second signal, also called a co-stimulatory signal, from
CD28 protein present on its surface. An antigen presenting cell must engage both the TCR
and CD28 of the T cell to ensure it is properly activated. While the TCR links up with the
Major Histocompatibility Complex (MHC)-I or II (MHC-I for CD8+ T cells and MHC-II for
CD4+ T cells), CD28 joins with B7 ligands present in the APC as illustrated in Figure 3.1.
Upon ligation by B7, CD28 signals through PI3K protein to reinforce downstream activation
pathways. TCR engagement in the absence of CD28 costimulation leads to T cell anergy,
a state of unresponsiveness. It has been shown that, ligation of CD28 can prevent the
induction of anergy in the absence of costimulation [82]. Thus, effective priming of T cell















Figure 3.1: A schematic of positive and negative costimulation during T cell activation.
(A) Stimulatory signal from the TCR and costimulatory signal from CD28 causes the T
cell to be activated. (B) Following activation, CTLA-4 is upregulated and outcompetes
CD28 to bind to B7, which results in the loss of costimulatory signal. This triggers T cell
de-activation.
Once the T cell is activated, it starts expressing another molecule called CTLA-4 on
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its surface. CTLA-4 principally regulates T cell activation by competing with CD28 for
ligation with B7 and thus, limits positive costimulation [83, 84]. Because CTLA-4 has a
higher affinity and avidity for B7 ligands than CD28, CTLA-4 outcompetes CD28 to bind to
B7 ligands and thus inhibits CD28-mediated positive costimulation. From a physiological
point, CTLA-4 acts as a checkpoint that prohibits over activation of T cells which could
have led them to attack healthy host cells (autoimmunity). CTLA-4 expression is detected
within 1 hour of T cell activation, reaches peak levels within approximately 48 hours, and
is trafficked to rapidly attenuate T cell activation [85, 86]. Due to its ability to negate the
CD28-based costimulatory signal, CTLA-4 is often called a negative costimulatory molecule.
This property of CTLA4 has been harnessed to a great success in cancer immunotherapy
and has also transformed the current landscape of oncology research. By blocking CTLA-
4 using monoclonal antibodies, the inhibitory properties of CTLA-4 are bypassed, which
unleashes the anti-tumor T cell responses. Administration of anti-CTLA-4 checkpoint ther-
apy has shown huge success in the treatment of metastatic melanoma and other cancer
types [59]. The recognition of therapeutic implications of blocking CTLA-4 further led to
development of multiple other therapies some of which have been approved by FDA for
the treatment of many cancer types and many others being tested in several clinical trials.
While the clinical outcomes of checkpoint blockade have largely been positive, we still lack
a clear understanding of the underlying mechanisms. In the context of CTLA-4, it has also
been shown that CTLA-4 can regulate T cell activity via multiple different mechanisms
[87–90], and yet our understanding of CTLA-4 biology remains incomplete.
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3.2 Motivation
We sought to understand whether in addition to its role in attenuating activation, CTLA-
4 also has a related but distinct function in regulating T cell differentiation. As T cell
differentiation is tightly linked to TCR signal strength [91, 92], we hypothesized that atten-
uation of downstream TCR signaling by CTLA-4 may also regulate differentiation. Indeed,
T cell activation does not normally occur without CTLA-4 attenuation and complete loss of
CTLA-4 is lethal [93–95]. Ctla-42 genetic deficiency has been previously shown to modulate
the expansion and function of known T cell populations such as Th2-skewed CD4 helper T
cells [96, 97], TFH, T follicular helper regulatory cell (TFR) [98–100], and T regulatory cell
(Treg) populations [90]. Similarly, antibody blockade of CTLA-4 is sufficient to modulate
TFH development [99] and induce the expansion of a Th1-like CD4 effector population in
the context of tumor immunity [101]. As CTLA-4 up-regulation is intrinsically coupled to
T cell activation, these observations raise the possibility that regulation by CTLA-4 con-
strains the range of phenotypes that can develop. Loss of CTLA-4 negative feedback, either
by antibody blockade or by genetic loss, may permit new types of peripheral T cells to
emerge through positive costimulation beyond normal biological limits. Conceptually, this
possibility represents a completely distinct type of regulation. Whereas there is substantial
evidence that modulation of T cell costimulation affects skewing towards specific lineages,
it is unknown whether the range of possible T cell lineages is controlled by costimulatory
signals. We hypothesized that negative costimulation regulates T cell differentiation by
limiting the range of possible cell states, and that loss of this key regulatory mechanism
enables the acquisition of phenotypes beyond normal limits.
2For mice, gene symbols are italicized and written in lowercase letters with only the first letter capitalized,
while the protein symbols are are not italicized and written in all uppercase letters.
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3.2.1 Design of the study
To address this hypothesis, we employed CyTOF to profile lymphocytes3 derived from
Ctla-4-/- - that is with complete genetic loss of Ctla4 - and littermate control mice and sub-
sequently used clustering methods to classify T cell populations and characterize alterations
in differentiation. Given that germline loss of Ctla-4 leads to a fatal lymphoproliferative
disease [93–95], mice were analyzed early in life prior to the phenotypic manifestation of
uncontrolled lymphoproliferation to minimize the possibility that observed differences are
due to conditions imposed by such autoimmunity. The CyTOF panel was designed with
the specific goals of enabling comprehensive classification of peripheral T cell populations
and identification of alterations in T cell differentiation. As such the mass cytometry panels
included activation markers (e.g. CD44, CD62L, PD-1, CD69, ICOS), surface differentia-
tion markers (e.g. KLRG1, CD127), and importantly, lineage defining transcription factors
(e.g. TBET, EOMES, GATA3, BCL6, RORγT) as well as additional transcription factors
involved in T cell differentiation (e.g. BATF, HELIOS, IRF4, RUNX3). In total, we profiled
37 proteins from more than a million single-cells collected from the lymph node of 15 mice.
For more details on experimental design and a complete set of proteins used, see Appendix
B.
3.3 Results
3.3.1 Visualization and Clustering
We first used tSNE [62] (discussed in Chapter 2) to visualize the high-dimensional data onto
two dimensions. It illustrated dramatic changes in T cell population frequencies and phe-
3Lymphocytes include T cells, B cells and Natural Killer Cells, T cells can be segregated based on CD3
expression on their surface.
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notypes in Ctla-4-/- mice, while no differences between Ctla-4+/+ (wild-type) and Ctla-4+/-
(heterozygous) mice were apparent, see Figure 3.2 A. Interestingly, populations that appear
only to be detectable in Ctla-4-/- mice were entirely contained within the CD4 compartment
(Figure 3.2 B). These CD4 T cell populations expressed high levels of CD44 and ICOS but
displayed variable levels of other activation markers and lineage transcription factors.
To facilitate quantitative assessment, we used PhenoGraph [102] to identify robust T
cell subsets in an unsupervised fashion. A standard value of k = 30 (where k determines the
number of nearest neighbors for graph construction) was used for clustering. PhenoGraph is
a well-validated clustering approach, however we further validated that cluster identification
is robust to changes in input parameters (k nearest neighbors) in this data. To establish
this, we re-ran PhenoGraph by changing the parameter k and measured pairwise cluster
similarity using the Rand Index [103] and normalized mutual information (NMI) [104]. Both
the Rand index and NMI scale between 0 and 1, with 1 indicative of perfect similarity. We
obtained an average Rand Index = 0.8597 and NMI = 0.8839 for the T cell clusters in the
context of Ctla-4 knockout suggesting that the clusters we obtained are robust.
PhenoGraph identified 30 distinct subsets in Ctla-4-/- and littermate control mice in-
cluding 6 CD8, 3 Treg and 14 CD4 effector T cell populations (Figure 3.2 C-D). To enable
interpretation of these quantitatively defined high-dimensional phenotypes, we qualitatively
annotate clusters by differential expression of key markers based on existing knowledge.
Multiple CD8 and CD4 T cell clusters were observed at higher frequencies in Ctla-4-/- mice
compared to controls, while no differences in frequency were observed between Ctla-4+/+
and Ctla-4+/- mice (Figure 3.2 C). The expansion in frequency of the same T cell sub-
sets across multiple replicate mice suggests that loss of CTLA-4 affects T cell pheno-
types in a non-random manner. For example, the frequency of terminally differentiated
CHAPTER 3. CTLA-4 CONSTRAINS T CELL DIFFERENTIATION STATES 50
(TBET+EOMES+CD44+CD62L+) CD8 T cells increases in Ctla-4-/- mice (Figure 3.2C-
D, cluster 7). Similarly, an ICOS+ Treg population that represents a very minor subset
CTLA-4 competent mice (cluster 5) dramatically expands in frequency in Ctla-4-/- mice,
while other Treg populations remain stable (cluster 18) or contract (cluster 9).
Interestingly, three CD4 effector T cell subsets identified were only observed in Ctla-4-/-
mice (Figure 3.2 C-D, clusters 10, 12, 14). These clusters were present in all Ctla-4-/-
mice, suggesting that these phenotypes consistently arise in the absence of CTLA-4. These
findings contrast effects on CD8 T cells, in which loss of CTLA-4 leads to dramatic changes
in expression levels (e.g. EOMES, IRF4, CXCR3), but not emergence of CD8 T cell clusters
that are only present in Ctla-4-/- mice (Figure 3.2 B-C). This suggests that CTLA-4 limits
CD4 T cell phenotypes but not those of CD8 T cells. In addition, similar T cell phenotypes
were detected in 4 week versus 11-day old Ctla-4-/- mice, suggesting that such effects are
not age-dependent or solely induced as a result of lymphoproliferative disease (Figure 3.2
E).
To investigate whether subset expansion is primarily driven by increased proliferation,
we concurrently assessed changes in IdU incorporation and changes in frequency in T cell
subsets due to loss of CTLA-4. Briefly, IdU was systemically administered shortly prior
to analysis, allowing for assessment of actively proliferating T cells at this time point. No
correlation was observed between the change in frequency of each T cell subset due to CTLA-
4 loss and the respective changes in IdU incorporation (Figure 3.2 F). This suggests that
CTLA-4 negative costimulation has a specific role in regulating CD4 T cell differentiation
beyond control of proliferation and raises the possibility that proliferation and differentiation
limits are decoupled, at least partially, as a result of loss of CTLA-4.
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Figure 3.2: (Caption next page.)
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Figure 3.2: (Previous page.) (A) t-SNE plot of T cells overlaid with genotypic source.
CD3+ T cell populations identified by mass cytometry analysis of lymph nodes from 11-
day-old Ctla-4-/- (red, n = 7), Ctla-4+/- (blue, n = 3), and Ctla-4+/+ (green, n = 5) mice.
Dotted lines highlight the expanded population under Ctla-4-/-. An equal number of T cells
from each genotype are displayed. (B) t-SNE plots overlaid with the expression heat maps
of individual markers (red indicates high expression and blue indicates low expression).
CD4, CD8, and other selected markers that display distinct expression patterns in regions
that appear specific to Ctla-4-/- T cells are displayed. Dotted lines highlight the expanded
population under Ctla-4-/-, similar to A. (C) Frequency of T cell clusters as a percentage of
total T cells displayed on a per mouse basis with mean and standard deviation shown for
each group. Clusters are separated into three groups: CD4 effector T cells, regulatory T
cells (Treg) and CD8 T cells based on their average cluster phenotype. *, Ctla-4+/+ versus
Ctla-4-/- and Ctla-4+/- versus Ctla-4-/-; p¡0.05 2-way ANOVA with Tukey’s multiple testing
correction. Clusters detected only in Ctla-4-/- mice are shaded red. (D) Expression heat
map of select markers in the T cell clusters shown in C. Relative mean intensity expression
values, normalized to the maximum (99.5 percentile) and minimum (0.5 percentile) cluster
mean value on a per marker basis are displayed. Clusters detected only in Ctla-4-/- mice are
shaded red. (E) On the left, t-SNE plot of total T cells derived from 11-day old (red) and 29-
day old Ctla-4-/- mice (green) and 11-day control mice (blue). Equal numbers of T cells from
representative mice from each genotype are displayed. Phenotypic expanded regions only
detected in Ctla-4-/- mice are highlighted by a dotted ellipse. On the right, t-SNE plot of T
cell derived from 11-day old Ctla-4-/- mice, 29-day old Ctla-4-/- mice, and 11-day control mice
overlaid with PhenoGraph clusters identified across genotypes is shown. Equal numbers of
T cells from representative mice from each genotype are displayed. (F) Average increase in
IdU incorporation (Log2 fold-change in Ctla-4-/- versus littermate controls) plotted against
the average increase frequency (Log2 fold-change in Ctla-4-/- versus littermate controls) of
individual T cell clusters. Each data point represents one T cell cluster. Linear regression
line is displayed (R2 = 0.027, slope non-zero p = 0.3854).
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3.3.2 Zooming into CD4 compartment
To more precisely distinguish CD4 T cell subsets that can only arise in the absence of CTLA-
4 from subsets that simply modulate in frequency due to loss of CTLA-4 regulation, we
analyzed the CD4 T cell compartment (Figure 3.3). 25 CD4 T cell clusters were identified,
of which seven were present at higher frequencies in Ctla-4-/- mice than controls. These
seven populations stratified into four subsets only detectable in Ctla-4-/- mice (clusters 7, 8,
13, 14) and three populations that increased in relative frequency due to CTLA-4 loss but
were detectable in all control mice (clusters 5, 6, 9). Cluster 6 displayed a Tfh phenotype,
consistent with observations that loss of CTLA-4 leads to a defect in TFR differentiation
and concomitant Tfh expansion [98–100].
Of particular interest are the phenotypic variables that distinguish these three ‘normal’
populations from the four clusters only detectable in Ctla-4-/- mice (Figure 3.3 B-C). The
four populations represented ICOS+ Th1-skewed Treg (cluster 7), ICOS+ Th1-like effector
(cluster 8), unskewed ICOS+ (cluster 13), and Th17-like subsets (cluster 14). These pop-
ulations uniformly expressed high levels of ICOS and variable levels of PD-1, markers that
are normally associated with Tfh cells. However, these clusters did not express high levels of
BCL6 (the defining transcription factor expressed by Tfh cells) or co-expressed BCL6 with
additional lineage transcription factors (e.g. GATA3 and RORγT, cluster 14), suggesting
that these populations are not canonical Tfh. These subsets also displayed features not
normally associated with the canonical T cell populations (e.g. coincident expression of
ICOS and TBET, GATA3 and RORγT). This indicates that non-canonical combinations
of features define in part the latent differences in high-dimensional phenotypes of T cell
subsets that expand in absence of CTLA-4.





















































CD4 T cell clusters
C
Figure 3.3: (A) Density t-SNE plots of peripheral CD4 T cell populations derived from
Ctla-4-/- (blue) and Ctla-4+/+ (red) mice. Equal numbers of cells from each genotype are
displayed. (B) Frequency of clusters as a percentage of total CD4 T cells displayed on a
per mouse basis with mean and standard deviation shown for each group. *, control versus
Ctla-4-/-; #, Ctla-4+/- versus Ctla-4+/+ mice; ˆ, Ctla-4+/+ versus Ctla-4-/- mice; p < 0.05
2-way ANOVA with Tukey’s multiple testing correction. Clusters detected only in Ctla-4-/-
mice are shaded green. Only clusters of 0.5% total frequency are displayed. (C) Expression
heat map of CD4 T cell clusters. Mean intensity normalized between 0.5% and 99.5% of
maximum cluster mean on a per marker basis is displayed. Only clusters of 0.5% total
frequency are displayed. Clusters detected only in Ctla-4-/- mice are shaded green.
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3.3.3 Archetypal analysis reveals that loss of CTLA-4 expands CD4 but
not CD8 T cell phenotypic space
So far, the data suggest that loss of CTLA-4 expands the range of phenotypes into which
peripheral T cells can differentiate within lymph node tissues. We sought to explicitly
address this possibility and understand whether alterations in signaling pathways (e.g. loss
of negative feedback loops) due to the absence of CTLA-4 allows cells to occupy otherwise
unattainable phenotype states. To address this computationally, we applied archetypal
analysis [76, 80], as discussed in Chapter 2. Archetypal analysis complements clustering
analyses because in contrast to clustering approaches, which identify the average behavior
(i.e. phenotypes) of populations, archetypal analysis allows us to understand behavior
of cells at the boundaries of populations. Here, we sought to systematically define the
most extreme T cell phenotypes (i.e. archetypes) present under normal and genetically
perturbed conditions (Figure 3.4 A). Archetypes can then be leveraged to assess whether
the identified cells at the boundary are condition-dependent, and thus attribute changes in
biological capability to specific experimental conditions (e.g. loss of CTLA-4).
CD4 and CD8 T cell compartments - identified based on PhenoGraph clustering of the
data - were analyzed separately given the bifurcation of CD4 and CD8 T cells occurs in the
thymus and thus is not captured by these analyses of peripheral lymph nodes. Essentially,
this also serves as a filtering step to remove any noisy and outlier cells making our analysis
more robust. The removal of such technical noise in the data using this clean up step is
particularly important for archetype analysis given the sensitivity to technical artifacts.
Thus, using pre-existing knowledge of the biological system (i.e. mutually exclusive expres-
sion of CD4 and CD8 co-receptors in peripheral tissues) the robustness of this analysis is
significantly increased.
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Figure 3.4: (Caption next page.)
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Figure 3.4: (Previous page.) (A) Schematic of workflow to identify archetypes, discern
relationships between archetypes, and assess their neighborhood cellular occupancy in per-
turbed biological systems. In parallel with cluster analyses, the single-cell data was also
analyzed using Archetypal Analysis. Following identification of archetypes, the phenotypic
neighborhood of each archetype was characterized. To assess the frequency of cells asso-
ciated with each archetype, the volume around each archetype within a given radius near
the archetype, was determined. The radius was computed using graph distance as opposed
to Euclidean distance to accommodate for non-linearity in the data. (B) CD8 and CD4
T cell archetypes are overlaid on a t-SNE plot of total T cells from Ctla-4+/+ (green),
Ctla-4+/- (blue), and Ctla-4-/- (red) mice. Archetypes were identified on total CD8 T cell
and CD4 T cell data separately. (C) Expression heat map of CD8 (left) and CD4 (right)
T cell archetypes, computed as the median expression of thirty nearest neighbors for each
archetype. Relative mean intensity expression values are displayed, normalized to the max-
imum (99.5 percentile) and minimum (0.5 percentile) across archetypes on a per marker
basis. Archetypes detected only in Ctla-4-/- mice are shaded red. (D) The frequencies of
cells from each genotype associated with each CD4 (left) and CD8 (right) archetype are dis-
played. The number of cells within a volume defined by 2-percentile diffusion distance from
each archetype are displayed on a per mouse basis with mean and standard deviation shown
for each group. *, Ctla-4+/+ versus Ctla-4-/- and Ctla-4+/- versus Ctla-4-/-; p < 0.05 2-way
ANOVA with Tukey’s multiple testing correction. Archetypes detected only in Ctla-4-/-
mice are shaded red.
To determine the optimal number of archetypes, we considered the error normalized by
the norm of the original data for various number of archetypes and took the knee-point of the
curve (Figure 3.5 A). To compute the knee-point, at each point along the error curve, we fit
two straight lines one to the left and one to the right of the point. The knee-point is derived
as the bisection point where the root-mean-squared error of the two fitted lines is minimum.
We confirmed that archetype identification is highly robust and identifies similar archetypes
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upon independent runs. To test this, we ran Archetype Analysis 50 times with a random
restart every time and correlated the expression of the obtained archetypes between each
pair of iterations. The output of each iteration is a matrix of p archetypes and d proteins
but the ordering of the archetypes could be altered between iterations. So, given archetype
matrices from two different iterations, we first find the closest match of each archetype in
one iteration to the other. For this, we compute the distance between each archetype from
one iteration to all archetypes from the other iteration. The best match then minimizes the
sum of the pairwise distance, which can be obtained using the Kuhn-Munkres algorithm
[105]. Once the archetypes are matched, we compute the correlation per entry between the
two archetype matrices and report the average correlation over all possible pairs (among
the 50 iterations). We obtained a Spearman correlation of > 0.96 with a standard deviation
of < 0.08, indicating robustness of the identified archetypes (Figure 3.5 B).
Applying the method on this data identified seven CD4 and eight CD8 T cell archetypes
(Figure 3.4 B-C). Strikingly, CD4 effector archetypes 5 and 7, and Treg archetype 6 appear
to reside in Ctla-4-/- specific regions. These CD4 T cell archetypes displayed
ICOS+BCL6+GATA3+ (archetype 5), ICOS+CD44+CD62L+ Treg (archetype 6), and
ICOS+TBET+ (archetype 7) phenotypes. Conversely, CD8 archetypes appear to reside in
regions populated by T cells from all genotypes, suggesting that CTLA-4 constrains CD4
but not CD8 phenotypes.
To directly assess whether cells associated with archetypes are derived by specific geno-
types, the number of cells in the neighborhood of each archetype was quantified . Since
the archetypes characterize extreme phenotypic states, an abundance of cells of a certain
genotype would indicate genotype specific expansion towards the archetypal phenotype. In
the present context, we are primarily interested in KO-specific expansion. To quantify the































Figure 3.5: (Caption next page.)
CHAPTER 3. CTLA-4 CONSTRAINS T CELL DIFFERENTIATION STATES 60
Figure 3.5: (Previous page.) Archetype analysis robustly detects population boundaries
and reveals an expansion in CD4 T cell phenotypic space in the absence of CTLA-4. (A)
The error between the archetype solution and the actual data plotted as a function of the
number of archetypes identified in the CD8 (top) and CD4 (bottom) T cell compartments
in Ctla-4-/- and littermate control mice. Mean and standard deviation derived from 50
random restarts are displayed. The identified ‘knee-point’ is marked with an arrow. (B)
Principal component analysis (PCA) plots of merged T cell data (combined from Ctla-4-/-,
Ctla-4+/-, and Ctla-4+/+) overlaid with CD8 archetypes (left) and CD4 archetypes (right)
identified in multiple independent runs. Each plot represents an independent run. The
expression profiles of archetypes across 50 random restarts were robust, with a Spearman
correlation of > 0.96 with a standard deviation of < 0.08. (C) Average Pearson correlation
between the distance to all cells from all CD8 archetypes (top) and CD4 archetypes (bottom)
using different values of t (where t is the scale parameter such that all paths of length t
between any two points determine the diffusion distance between them; see Chapter 2.3.1)
over multiple runs displayed as a pairwise matrix. Average Pearson correlation > 0.81 and
0.90 for CD8 and CD4 archetypes, respectively for t < 20. (D) Average Pearson correlation
between the distance to all cells from all CD8 archetypes (top) and CD4 archetypes (bottom)
using different values of k (number of nearest neighbors) over multiple runs displayed as
a pairwise matrix. (E) The frequency of cells within a specific distance from CD4 T cell
archetypes plotted as a function of diffusion distance. Cells derived from Ctla-4-/- (red),
Ctla-4+/- (blue), and Ctla-4+/+ (green) are displayed.
genotype specific abundance, we compute cell density around each archetype defined as the
percentage of cells per genotype within a fixed distance from the archetype. This can be
generalized to study the genotype specific composition as a function of distance from an
archetype. To do this, we first calculate graph distance from each archetype to all the other
cells. As discussed in Chapter 2, graph distances have been shown to robustly capture the
phenotypic distance between cells. Then the cells are binned based on their distance from
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the archetype (as percentile of the maximum distance) and finally the percentage of cells
per genotype is determined at each bin. In particular, we use diffusion distance [67, 74] to
measure the phenotypic distance from an archetype to all the other cells.
Different patterns of genotype specific association with archetypes were observed. Most
interestingly and consistent with clustering and t-SNE visualization, phenotypic space
around CD4 archetypes 5, 6, and 7 are exclusively occupied by Ctla-4-/- T cells (Figure 3.4
D). This indicates that these phenotypes do not exist in the presence of intact CTLA-4
signaling. Thus, loss of CTLA-4 causes an expansion in the phenotypic states that a CD4
T cell can occupy in an otherwise normal T cell development. In contrast, CD4 archetype
1 (displaying a CD62L+CD44lowCD127+ phenotype) is nearly absent in Ctla-4-/- T cells.
It stands to reason that resting na¨ıve or memory cells are aberrantly permitted to expand
in the absence of CTLA-4 and thus, would adopt activated phenotypes. A phenotypically
similar CD8 T cell archetype is also nearly absent in Ctla-4-/- T cells, further consistent
with this notion (Figure 3.4 B-D, CD8 archetype 2).
In contrast to observations in the CD4 compartment, no CD8 T cell archetypes were
associated specifically with Ctla-4-/- cells. Although CD8 archetype 6 potentially resides
in a knockout specific region based on t-SNE visualization (Figure 3.4 B), quantitative
assessment reveals an association with CTLA-4 competent cells (Figure 3.4 D). This suggests
that loss of CTLA-4 skews CD8 T cell populations, as evidenced by changes in the relative
proportion of cells associated with each archetype, but does not alter CD8 T cell phenotypic
boundaries. Importantly, skewing of differentiation that can result in changes in relative
frequencies of populations is conceptually distinct from effects on phenotypic boundaries
that can alter the range of attainable cell states. These data suggest that all CD8 T cell
states are achievable under normal conditions and that loss of CTLA-4 may even reduce
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CD8 T cell phenotypic space (i.e. loss of na¨ıve or resting memory phenotypes).
We assess that our results based on diffusion distances are robust to choices of the
parameters. First, we show robustness to t (see Chapter 2.3.1) by re-computing diffusion
distances for various values of t. In particular, we correlate the diffusion distances from an
archetype to all the cells for various values of t (with k = 30). We report the correlation
averaged over all archetypes (Figure 3.5 C). Around the value of t used (t < 20) the average
correlation is high (average Pearson correlation > 0.90 for Ctla-4 KO CD4 archetypes, 0.81
for Ctla-4 KO CD8 archetypes. The average correlation slightly declines for t > 20. Overall,
average correlation > 0.77 Ctla-4 KO CD4 archetypes, 0.70 Ctla-4 KO CD8 archetypes, 0.74
Pdcd-1 KO CD4 archetypes, and 0.64 Pdcd-1 KO CD8 archetypes, indicating that the results
are robust around the value of optimal t. Second, to show robustness of our results to the
number of nearest neighbors (k), we compute the correlation of the diffusion distances (at
t = toptimal, which was 14 and 10 for CD4 and CD8 respectively) from an archetype to all
the cells for various values of k. We then report the correlation averaged over all archetypes
(Figure 3.5 D), average correlation > 0.9 for all cases.
3.3.4 Non-canonical T cells arise through mechanisms distinct from in-
creased activation
We next sought to rule out the possibility that aberrant populations arise solely due to
increased proliferation. For this, we immunized Ctla-4-/- and littermate controls with oval-
bumin (Ova) in complete Freund’s adjuvant (CFA) to induce a strong T cell response against
a spectrum of antigens. We identify T cell subsets using clustering to assess if this pertur-
bation induces similar phenotypes observed in knockout mice. We classify T cell subsets
into 3 groups: i) homeostatic subsets detected in all mice, ii) activation-dependent subsets
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that are detected at in Ctla-4-/- mice and CTLA-4 competent mice upon immunization, and
iii) phenotypically expanded subsets that are present in Ctla-4-/- but not in control mice
under any condition (Figure 3.6 A-B).
Eleven CD4, two Treg, and six CD8 T cell clusters were identified. The phenotypes of
clusters were remarkably similar to those in unmanipulated 11-13 day old Ctla-4-/- mice,
despite analysis of older mice in immunization experiments (Figure 3.2 D, Figure 3.6 C,
Figure 3.7 B). No differences in the frequency of T cell subsets were observed between
unimmunized and immunized Ctla-4-/- mice. Notably though, multiple CD4 and CD8 T
cell populations expanded in response to immunization in control mice (Figure 3.6 B-C,
Figure 3.7). This indicates that this assay enables us to distinguish phenotypes that can
be attained through activation alone. Three activation-dependent CD4 effector popula-
tions significantly expanded in immunized control mice (Figure 3.6 C, clusters 1, 4, and
6). This, together with detection in resting control mice, indicates that the increase in
frequency of these subsets in Ctla-4-/- mice is due to increased proliferation rather than a
change in phenotypic limits. Clusters 11 and 14 are detected in resting control mice, are
observed at increased frequency in Ctla-4-/- mice but are not impacted by immunization.
This suggests their expansion is driven by homeostatic processes. In contrast, clusters 12,
15, and 16 increase in Ctla-4-/- mice but are not detected in either resting or immunized
control mice, indicating that their expansion is a direct consequence of the loss of CTLA-
4, rather than a by-product of increased activation. Notably, the phenotypes of clusters
12 (ICOS+TBET+ Th1-like) and 16 (PD-1+ICOS+GATA3+ RORγT+) relate directly
to CD4 effector archetypes 7 and 5, respectively (Figure 3.4 and Figure 3.6). It remains
possible that even more extreme phenotypes relating to the pathogenesis may be observed
in older mice or with other adjuvants. However, the similarity of T cell clusters identified
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Categorize T cell populations
Immunized
Figure 3.6: Ctla-4 knockout non-canonical T cell subsets are distinct from canonical ac-
tivated T cell populations. (A) Schematic of the experimental approach to distinguish
homeostatic, activation dependent, and Ctla-4 knockout specific T cell populations. T cell
populations are categorized based on the combined responses to loss of CTLA-4 and OVA-
immunization: homeostatic (blue), activated-induced (yellow), and phenotypic expansion
(red) populations. (B) Density t-SNE plots of CD3+ T cells from Ctla-4-/- and littermate
control mice (Ctla-4+/- and Ctla-4+/+). Arrows indicate activation dependent T cell pop-
ulations that are enriched in wild-type mice following immunization but are occupied in
Ctla-4 KO mice (regardless of immunization). (C) Frequency of clusters identified within
the CD3+ T cell compartment displayed on a per mouse basis with mean and standard
deviation shown for each group. Clusters are separated into three groups: CD4 effector T
cells, regulatory T cells (Treg) and CD8 T cells based on the average cluster phenotype.
*, unimmunized control compared to immunized control; #, unimmunized and immunized
control groups compared to unimmunized Ctla-4-/-; ˆ, unimmunized Ctla-4-/- compared to
immunized Ctla-4-/-; ∼, unimmunized control compared to unimmunized Ctla-4-/-; p < 0.05
2-way ANOVA with Holm-Sidak multiple testing correction. Clusters are denoted as be-
longing to classifications of homeostatic (shaded blue), activation-induced (shaded yellow),
and Ctla-4-/- specific (shaded red) populations.
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in unmanipulated 11 day old and immunized 21 day old mice further supports the notion
that extension of phenotypic limits is independent of age and derives directly from loss of
CTLA-4 rather than indirect effects of its deletion.
3.3.5 Differentiation paths reveals distinct patterns of ordered and coor-
dinated changes in protein expression
We then sought to identify molecular events normally restricted by CTLA-4, but permitted
to occur in its absence. To accomplish this, we reconstructed differentiation trajectories
between the na¨ıve CD4 T cell archetype (archetype 4)and each differentiated CD4 T cell
archetype (archetypes 5, 6 and 7). A trajectory from a start-point (i.e. na¨ıve) and end-point
(i.e. differentiated) archetype approximates the transition between cell states involved in
differentiation from the start to end phenotypes. This approach assumes that the cells are
progressing along the same direction and that there is no trans-differentiation. While this
is a relatively safe assumption in the case of an otherwise healthy development, it can be
invalid in complex diseases such as cancer. To achieve this, we build upon prior works
demonstrating that shortest paths through a nearest-neighbor graph faithfully recapitulate
cellular differentiation trajectories [36–38]. For example, such approaches can accurately
reconstruct thymic differentiation between given cell-states using a static time point sample
without a priori knowledge of development paths [38]. Given the remarkable fidelity of
estimated trajectories compared to ground-truth knowledge of thymic differentiation, we
reasoned that a similar approach could identify biologically relevant differentiation paths
that exist in the absence of CTLA-4. Using this approach, the cells along each trajectory
are aligned on a pseudo-time axis that approximates the underlying differentiation paths
(Figure 3.8 A). It is important to note that these analyses are predicated on the assumptions
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Figure 3.7: Phenotypic profile of T cells clusters identified in immunized mice. (A) Fre-
quency of IdU incorporation in each T cell cluster independent of immunization group
displayed on a per mouse basis. Mean and standard deviation per group are displayed. *,
control unimmunized compared to control immunized; #, control unimmunized compared
to Ctla-4-/-; p < 0.05 2-way ANOVA with Holm-Sidak multiple testing correction. Unim-
munized and immunized mice are displayed as a single group in this analysis. Clusters
are denoted as belonging to classifications of homeostatic (shaded blue), activated-induced
(shaded yellow), and Ctla-4-/- specific (shaded red) populations. (B) Expression heatmap
of T cell clusters identified in combined unimmunized and immunized data. Mean intensity
normalized between 0.5% and 99.5% of maximum is displayed. (C) Density t-SNE plots
of CD4 T cells displaying equal numbers of cells from immunized (blue) and unimmunized
(blue) mice of either control (top) and Ctla-4-/- (bottom) genotypic groups.
CHAPTER 3. CTLA-4 CONSTRAINS T CELL DIFFERENTIATION STATES 67
that the dataset represents an uninterrupted sampling of cells between points a and b,
protein expression changes are continuous in nature, and that cellular differentiation takes
the shortest path possible. From a broader perspective, our work is based on the assumption
that the cells lie along a continuum in the manifold (see Chapter 2 for more discussion).
To construct paths along the data manifold that reflect the differentiation trajectories
cells could potentially follow to reach the aberrant archetypes, we begin by constructing a
k-nearest neighbor graph based on the diffusion distance. We note that a major obstacle
while constructing graph-based trajectories is short-circuits, which could lead to misleading
conclusions if not handled properly [36]. Short-circuits in graphs are spurious edges that
connect phenotypically distinct cells. This can result due to application of linear approaches
to discern relationships in a non-linear manifold (See Figure 2.4 for an example). In our
case, while the data likely lives on a non-linear manifold, application of k-nearest neighbor
graph based diffusion distance [38] largely mitigates this issue (see Chapter 2). To increase
robustness and get around this even further, we construct an ensemble of graphs, which
has previously been shown to be effective against short-circuits [36]. In particular, from the
original graph where each cell has 30 neighbors, we randomly subsample neighbors. The
resulting sparser graph is then symmetrized to obtain an undirected graph. Finally, we
compute shortest path (using Dijkstra algorithm) from the na¨ıve archetype to all the other
archetypes. We repeat the procedure (of randomly subsampling neighbors and constructing
shortest paths) 100 times (Figure 3.8 A, Figure 3.9 A). At each iteration, we get an ex-
pression profile of a protein along the shortest path, which we then smooth using a sliding
Gaussian window [36, 38]. To do this, the cells along the shortest paths were first linearly
mapped to the unit interval [0, 1], which was then partitioned into 100 equal sized bins.
Then the weighted average of each marker is computed using a Gaussian filter centered at
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Figure 3.8: (Caption next page.)
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Figure 3.8: (Previous page.) Pseudo-time reconstruction of CD4 T cell differentiation
paths indicates that CTLA-4 imposes maximal expression limits during differentiation. (A)
Schematic of the method used to reconstruct T cell differentiation paths from the na¨ıve
CD4 T cell archetype to each differentiated archetype. First, a k-nearest neighbor graph
(k = 30) was computed. To ensure that the differentiation paths are not impacted by
short-circuits (i.e. erroneous connections) in the graph, we randomly subsample m out of
k edges. In this subsampled graph we compute the shortest path from na¨ıve archetype
to each of the expanded archetypes. This process of subsampling and computing short-
est paths is repeated 100 times for robustness. The final output is the smoothed protein
expression computed along each of the shortest paths. (B) The derivatives (slopes) of in-
dividual marker expression plotted as a function of the T cell differentiation paths (i.e.
along pseudo-time) to CD4 archetypes 5, 6, and 7 identified in the context of Ctla-4-/- and
littermate control mice. Slope values displayed are from the averaged expression derived
from an ensemble of 100 paths where m (the number of graph edges selected) of k nearest
neighbors were utilized for path construction. Slope values were computed based on protein
expression levels, which were smoothed using a sliding Gaussian window. Derivatives are
displayed as a heat map from left (close to the na¨ıve CD4 archetype) to right (close to the
differentiated archetype). A dotted vertical line demarcates the boundary of normal phe-
notypes along the differentiation trajectory beyond which only Ctla-4-/- T cells are present.
Only markers whose average expression reached 0.5 arcsinh transformed value along any
point of the specified trajectory are displayed. (C) Plot displaying the relative frequencies
of CD4 T cells derived from Ctla-4+/+ (green), Ctla-4+/- (blue), and Ctla-4-/- (red) mice
along the differentiation trajectory plotted as a function of pseudo-time. Volumes were com-
puted using a 2-percentile diffusion distance from the average differentiation paths to CD4
archetypes 5, 6, and 7 from the na¨ıve CD4 archetype. A dotted vertical line demarcates the
boundary of normal phenotypes. (D) Ratios of pairs of lineage transcription factors (TF)
along the differentiation pseudo-trajectories to CD4 archetypes 6 and 7 identified in the
CTLA-4 dataset. The y-axis shows the arctangent of the ratio, where a value of 90 degrees
corresponds to a high expression of the numerator TF compared to the denominator TF,
and vice versa for a value of 0 degrees. Average ratio (mean, bolded line) and standard
deviation (shaded region) are displayed.
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where gi is the marker expression of cell i, g¯j is the mean marker expression value in bin
j and σ is the bandwidth of the Gaussian chosen using Silverman’s rule of thumb [106].
The smoothed average at bin j is then given by Cj =
∑
i Pij × gi. Finally, we compute the
derivative of the resulting smoothed expression profile, and average the derivatives over all
the iterations (Figure 3.8 B, Figure 3.9 B). To facilitate robust biological interpretations
that are not biased by technical noise in protein markers with very low signal, we filtered
out proteins whose averaged expression over all the iterations did not exceed an arcsinh
transformed value of 0.5.
We ensured that our results are robust to the choice of subsample size (m). For this,
we repeat the above procedure for various values of and report the correlation of the mean
expression averaged over all the proteins (Figure 3.9 C). We note that the average correlation
is high (e.g. > 0.96 for archetypes 5, 6 and 7).
Approximation of trajectory of transition from na¨ıve to expanded phenotype in this way
allows for characterization of expression changes as T cells gradually differentiate towards
archetypal phenotypes. Importantly, by identifying the point at which CTLA-4 competent
T cells are no longer found along these differentiation paths, we can identify the limits of T
cell phenotypes imposed by CTLA-4 regulation. We can then infer the expression changes
that occur leading up to and beyond these boundaries underlying phenotypic expansion
observed in Ctla-4-/- T cells. So, we sought to demarcate the boundary of normal phenotypic
manifold (Figure 3.8 C). For this, we first took the average shortest path from the ensemble
of 100 shortest paths. To do this, we computed the average protein expression across the



























Figure 3.9: CD4 T cell differentiation trajectories identified in the context of loss of CTLA-
4 reveal coordinated gene expression patterns. (A) Diffusion map plots displaying T cells
(blue) from Ctla-4-/- and littermate control mice overlaid with 100 ensemble paths (red)
between the na¨ıve archetype and CD4 archetypes 5, 6, and 7. (B) The expression of
CD44 and PD-1 plotted along differentiation trajectories to CD4 archetypes 5, 6, and 7.
Normalized expression is plotted, displaying the mean (bolded line) and standard deviation
(shaded region) of expression of 100 ensembles. A dotted vertical line demarcates the
boundary of normal phenotypes along the differentiation trajectory at which only Ctla-4-/-T
cells are present. (C) Robustness plots displaying average Pearson’s correlations across all
markers along each trajectory in an ensemble (100 trajectories) as the variable m (the
number of graph edges selected) is varied for CD4 archetypes 5, 6, and 7. Average Pearson
correlation > 0.96 for archetypes 5, 6, and 7.
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ensemble of paths, and correlated it with protein expression along each of the constituent
path. The average shortest path is then defined as the one that maximizes this correlation.
For each cell along the shortest path we found all the cells in its neighborhood that are
within 0.5 percentile diffusion distance (compared to the maximum). We then computed
the genotype specific composition at each step along the path. This is then plotted as a
function of the trajectory towards each archetype. To approximate the boundary position,
we demarcate the position along each trajectory for which the frequency of both wild-type
and heterozygous derived cells are less than 0.1%. This boundary is then drawn as a visual
guide on each plot.
Analysis of Ctla-4 knockout dataset revealed distinct patterns of gene expression changes
as cells differentiate along each trajectory in pseudotime (Figure 3.8 A-C, Figure 3.9).
These regulatory patterns included both co-regulation and sequential regulation of protein
expression, and were highly distinct between archetypes in terms of the markers involved and
kinetics. To visualize changes in expression as cells differentiate, the slope of each marker’s
expression was plotted along each trajectory as a function of pseudotime (Figure 3.8 B).
This enables identification of sustained increases or decreases in expression, as defined by
positive or negative slope, respectively. We also observed that only Ctla-4-/- T cells were
associated with distal regions of the paths close to archetypes 5-7 (Figure 3.8 C), while
cells from all genotypes were present along the entirety of paths to archetypes 1-3. These
findings are fully consistent with our prior analyses and importantly, identify the boundary
of normal CD4 T cell phenotypes imposed by CTLA-4 regulation.
We were particularly interested in changes associated with commitment to the Th1-
skewed archetype 7, given that potentially analogous Th1-skewed cells arise following ther-
apeutic CTLA-4 blockade [101, 107, 108]. A subset of markers (e.g. CD44) display sus-
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tained increases in expression along the paths towards archetype 7, as visualized by the
positive slope in these markers beyond the boundary of CTLA-4 sufficient cells (Figure 3.8
B, Figure 3.9 B). In contrast, PD-1 expression increases early during differentiation towards
archetype 7 but stabilizes beyond the boundary of CTLA-4 sufficient cells. This is in con-
trast with the trajectory of archetype 5, along which PD-1 expression continues to increase
beyond the boundary, suggesting that CTLA-4 imposes a limit on maximum expression
of specific markers (e.g. PD-1, CD44, ICOS). This argues against a model in which loss
of CTLA-4 leads to aberrant activation of pathways normally dormant in T cells. Rather,
these data suggest that a primary mechanism by which CTLA-4 restrains T cell phenotypes
is through imposing maximal limits on already active pathways.
T cell fate decisions are thought to be in large part driven by changes in the balance
between lineage transcription factors (TF) [109]. To determine when cell fate commitment
events occur during the course of differentiation and if loss of CTLA-4 influences these
events, we investigated ratios of lineage transcription factors. Because we were primarily
interested in identifying where lineage specification decision events take place during differ-
entiation (i.e. pseudo-time) towards archetypes (as opposed to identifying new relationships
in de novo fashion), we focused on pairs known to have direct functional relationships that
control T cell differentiation, namely, TBET and GATA3 [110], TBET and BCL6 [111,
112], and FoxP3 and RORγT [113]. We calculated the ratios between these key pairs of
transcription factors to infer where cell fate decisions occur. However, simply computing
the ratios of transcription factor expression levels is likely to be problematic given that
many cells are likely to have 0 expression values (and thus, ratios may harbor zeros in the






. This approach has previously been used successfully to study a contin-
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uum of T cell fates [109]. In the present context, characterizing α continuously along the
differentiation paths can help to identify cell fate choice events. We utilized this approach
to analyze differentiation towards CD4 archetypes 5-7 identified in the context of loss of
CTLA-4, with particular interest in understanding where cell fate decisions (as defined by
transcription factor ratios) occurs relative to the expansion of normal phenotypic bound-
aries due to loss of CTLA-4. Because these analyses were guided by prior knowledge, it
remains a possibility that we did not investigate the pairs of transcription factors most
relevant to differentiation.
To achieve this, we first took the average shortest path over the ensemble previously
constructed (discussed above in the approximation of differentiation paths). Then, for each
cell along the shortest path we find all the cells in its neighborhood that are within 0.5
percentile diffusion distance (compared to the maximum). In each of thus constructed
neighborhoods along the differentiation path, we compute α for each cell. The result is
then smoothed using a sliding Gaussian window [36, 38]. For this, analogous to what was
done previously, cells along the average shortest path were first linearly mapped to the unit
interval [0, 1], which was then partitioned into 100 equal-sized bins. The weighted average









where αi, is the angle for cell i, α¯j , is the mean alpha in bin j and σ is the bandwidth of
the Gaussian chosen using Silverman’s rule of thumb [106]. The smoothed average at bin j
is then given by Cj =
∑
i Pij × αi, as shown in Figure 3.8 D.
The ratios of FoxP3 and RORγT expression exhibited a switch-like change during dif-
ferentiation towards archetype 6, suggestive of a fate-choice event (Figure 3.8 D). Likewise,
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switch-like changes in TBET/GATA3 and TBET/BCL6 expression ratios were observed
during differentiation towards archetype 7. These data support the notion that circuits
composed of functional relationships between transcription factors control lineage fate deci-
sions, with antagonistic interactions influencing decision points and positive feedback loops
stabilizing discrete populations [109, 114]. Importantly, we find that switches in transcrip-
tion factor ratios occur prior the normal boundary (Figure 3.8 D), suggesting that loss of
CTLA-4 does not alter functional relationships between transcription factors (i.e. cell fate
decisions). Rather, loss of CTLA-4 removes maximal expression limits on molecules in-
volved in already active pathways (e.g. CXCR3, CD25, FoxP3, ICOS), which mediates the
expansion of phenotypes available to a given cell fate. This is an important distinction from
the de novo induction of signaling pathways that are normally inactive in these contexts.
3.3.6 Phenotypically expanded T cell subsets are associated with en-
hanced cytokine profiles
To gain insight into the potential biological consequences of expansions in T cell phenotypic
limits, we performed cytokine profiling of lymphocytes derived from Ctla-4-/- or littermate
control mice. We utilized a conventional gating strategy guided by our mass cytometry data
to approximate phenotypically expanded T cells. In particular, CD44+CD25-ICOS+PD-
1+ and CD44+CD25-ICOS+PD-1- gates enrich for expansion of CD4 effector populations
(i.e. archetypes 5 and 7 in Figure 3.4, respectively). This approach enables only an approx-
imation of expanded populations, however this facilitates a comparison of their cytokine
profiles with those of the most phenotypically similar cells that exist in wild-type mice.
The frequency of cytokine+ cells within these two subsets was dramatically higher in Ctla4
knock-out versus control mice (Figure 3.10 A). In contrast, only subtle increases or de-
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creases in the frequency of cytokine+ cells were observed within ICOS-PD-1+ T cells and
ICOS-PD-1- cells.
Such increases in cytokine+ cell frequency could be due to enhanced activation, thus we
sought to investigate whether loss of CTLA-4 regulates the expression levels of cytokines
on a per cell basis. We find that the mean expression level of IFNγ, TNFα, and IL-17α
in cytokine+ cells dramatically increased in Ctla-4-/- cells (Figure 3.10 B), particularly in
ICOS+PD-1+ cells, which resemble expanded effector Th1-like CD4 T cell (Figure 3.4,
archetype 5). This suggests that loss of CTLA4 not only increases the frequency of func-
tionally active CD4 effector cells but also the expression level of cytokines they produce.
On the other hand, loss of CTLA-4 also led to increases in the frequency of cytokine+ Treg
cells but did not increase the level of expression of cytokines (Figure 3.11 A). In contrast,
the frequencies of cytokine+ CD8 T cells and the maximal cytokine expression levels are
very mildly affected by loss of CTLA-4 (Figure 3.11 B). This is in accordance with mass
cytometry findings that loss of CTLA-4 specifically modulates CD4 T cell phenotypic limits.
Together this suggests that extension of T cell phenotypic limits due to loss of CTLA-4 is
associated with superphysiological cytokine output.
In summary, these data indicate that loss of CTLA-4 leads to increases in maximal
cytokine expression limits in CD4 effector but not in regulatory or CD8 T cells. The
extension of CD4 T cell phenotypes and the associated increases in cytokine output provide
a possible cellular explanation for prior findings that depletion of CD4 but not CD8 T cells
attenuates the lethal lymphoproliferative phenotype of Ctla-4-/- mice [93]. The absence
of significant changes in cytokine output of Treg cells despite phenotypic extension in the
absence of CTLA-4 is correlated with findings that deletion of CTLA-4 in Treg leads to
a decrease in suppressive function [90]. Furthermore, these observations also support the
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Figure 3.10: Expanded T cell phenotypes are associated with enhanced cytokine profiles.
(A) Radar plots displaying the frequency of CD4 T cells positive for the denoted cytokines
following a 4-hour restimulation. Frequencies as a percent of total CD4 T cells are displayed
for subpopulations of CD44+CD25- effector CD4 T cells gated based on the expression of
ICOS and PD-1. Data is displayed on a per mouse basis with each data ring representing
the mean average of frequencies from technical triplicates from each mouse. Control (wild-
type and Ctla-4+/-; blue; n = 13) and Ctla-4 KO (red; n = 5 mice) are displayed. *,
p < 0.01 t-test with Holm-Sidak multiple testing correction. Data are representative of
two replicate cohorts of mice. (B) Radar plots displaying the mean fluorescence intensity
(MFI) of cytokine positive cells is displayed using a log10 scale. Data is displayed on a per
mouse basis with each data ring representing the mean average of frequencies from technical
triplicates from each mouse.
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Figure 3.11: Functional analyses of T cells in the context of genetic loss of negative costim-
ulatory signals. (A) Similar to Figure 3.10 A but for cytokine expressing CD44+CD25+
regulatory CD4 T cells are displayed as a function of total CD4 T cells. Data is displayed
on a per mouse basis with each data ring representing the mean average of frequencies
from technical triplicates from each mouse. Control (wild-type and Ctla-4-/-; blue; n = 13)
and Ctla-4-/- (red; n = 5 mice) are displayed. (B) Radar plots displaying the frequency of
cytokine expressing CD44+CD8 T cells as a function of total CD8 T cells.
findings from the discussed trajectory analyses (Figure 3.8). Analogous to the imposition
of maximal limits on active pathways by CTLA-4 during differentiation, these data indicate
that CTLA-4 imposes maximal limits on cytokine expression even in lineage committed T
cells (e.g. those already producing IFNγ).
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3.3.7 CD4 T cell archetypes are enriched following antibody blockade of
CTLA-4
Finally, we sought to address whether antibody blockade of CTLA-4 leads to similar dys-
regulation of T cell differentiation. To address this possibility, we performed archetypal
analyses on mass cytometry data of MC38 murine tumors treated with anti-CTLA-4 ther-
apy [101]. Blockade of CTLA-4 led to specific enrichment of cells associated with a TBET+
TCF1+ CD4 T cell archetype (Figure 3.12; archetype 1). Consistent with observations in
knockout mice, no enrichment of CD8 T cell archetypes was observed (i.e. no change in
CD8 T cell boundaries) due to anti-CTLA-4. This supports the notion of dyresgulation
of differentiation specifically in CD4 T cells following anti-CTLA-4 therapy. In contrast
to the knockout study, cells associated with each archetype are detected in the contexts of
both control and therapy. This less extreme effect on phenotypic limits could be a result of
incomplete loss of signaling due to antibody blockade (versus total loss of function in the
genetic systems). In addition, immune cell states within the tumor microenvironment are
highly diverse and occupy larger phenotypic spaces than in normal contexts [115]. These
findings support the notion that loss of function of CTLA-4 leads to dysregulation of T cell
differentiation.
3.4 Summary
These data suggest that CTLA-4 regulates the limits of T cell differentiation, in particular by
enforcing boundaries on CD4 T cell phenotypes. It does so by imposing maximal expression
limits during the course of differentiation, which opposes an alternative theory that loss of
CTLA-4 gives rise to otherwise dormant signaling pathways in T cells. The notion of
constraint on phenotypic limits is conceptually distinct from the idea that costimulatory
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Figure 3.12: Expression heat map of MC38 murine tumor infiltrating CD4 T cell archetypes
(left). Frequency of cell associated with MC38 murine tumor infiltrating CD4 T cell
archetypes. *, p < 0.05 one-way ANOVA with Tukey’s multiple comparison (right).
signals skew T cell differentiation decisions [96–100], which is also supported by our findings.
Furthermore, our studies suggest that T cell subsets represent a continuum of interrelated
phenotypic states, defined by interaction between lineage transcription factors, rather than
completely discrete lineages. This substantiates the growing appreciation that CD4 T cells
are highly plastic instead of being distinct lineages that do not cross talk [11, 12].
It remains to be determined whether both the cell intrinsic and cell extrinsic effects of
CTLA-4 regulate T cell phenotypic limits. Of interest is whether CTLA-4 imposes this reg-
ulation only at specific developmental times or constitutively through the lifetime of a T cell.
Conditional deletion of Ctla-4 during adulthood leads to a broad range of autoimmunity,
but also paradoxically leads to resistance to experimental autoimmune encephalomyelitis
[116, 117]. This suggests that loss of CTLA-4 may lead to different outcomes depending on
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the developmental stage when CTLA-4 is lost as well as the properties of specific antigens.
It also remains to be assessed whether the expanded phenotypes represent stable termi-
nally differentiated states, or rather transient intermediate states not normally attainable.
Additional modalities of data from different technologies will be needed to assess these
questions.
Furthermore, this study raises the question of whether the impact of loss of negative
costimulation on T cell differentiation is generalizable to other costimulatory molecules.
To this end, PD-1 is another molecule expressed on the surface of T cells that plays a
role in attenuating their activation. We will study the effects of loss of Pdcd-1 on T cell
differentiation in the next chapter.
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Chapter 4
PD-1 only subtly modulates T cell
differentiation states
In the previous chapter, we studied the effects of loss of CTLA-4 on T cell differentiation
and we argued that it constrains the boundaries of differentiation by placing maximal limits
on key regulatory proteins. This raises the question if the impact of negative costimulation
on T cell differentiation is generalizable to other such molecules. PD-1 is one of few other
negative costimulators of T cell activation and similar to CTLA-4, it has had profound
impact in checkpoint blockade therapy [59]. In this chapter, we will address the question of
generalizability by comparing T cells from Pdcd1-/- mice against Pdcd11 competent mice.
4.1 Background
The process of T cell activation is actually more complicated than how we introduced in the
previous chapter. There are multiple other interactions active during the synapse of a T cell
with an APC. For example, in addition to CD28-B7, positive costimulation is also provided
1Pdcd1 gene encodes for PD-1 protein.
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by linkage of CD40 ligand on the T cell surface with CD40 protein on the surface of APC
[118]. Similarly, in addition to CTLA-4, there are other sources of negative costimulation
that try to prevent over activation of T cells and in a normal physiological state, help
prevent autoimmunity. A prime example of this is the interaction between PD-1 molecule
on the surface of the T cell with its ligand on the surface of the APC. The integration of
signals from all these molecules determine the strength and duration of T cell activation.
PD-1 is a protein that is expressed on the surface of activated T cells but is absent on
resting or na¨ıve T cells. PD-1 expression reaches detectable levels after 24h of activation,
but is functionally active even at lower levels [119]. As a T cell receives both stimulatory
signals, PD-1 engages with its ligand, PDL1, on the surface of the APC and acts to suppress
further stimulation of the T cell. It has been shown that PD-1 acts directly via mechanisms
involving SHP1/SHP2 phosphatases to directly inhibit TCR mediated signaling [119]. Sim-
ilar to CTLA-4, PD-1 suppresses the PI3K/AKT pathway but in contrast to CTLA-4, it
does so via a distnct mechanism suggesting that CTLA-4 and PD-1 both negatively regulate
T cell activation in a non-redundant fashion [120].
Interestingly, PD-1\PDL1 interaction can also occur between an already differentiated
T cell and a tumor cell [118]. In such a case, since the T cell has already differentiated, PD-1
does not tend to attenuate further activation of T cells but modulates strength of T cell
activity, which is in fact used by some tumors to prevent an immune attack [118]. Given such
importance of PD-1 in T cell activation and anti-tumor immune response, the development
of anti-PD-1 checkpoint blockade therapy has led to immense success in cancer treatment,
with therapies approved for a broad range of cancers [59]. While the clinical outcomes have
largely been uplifting, we need a better understanding of the underlying mechanisms to help
us design better and more effective antibodies. Further, understanding of the basic biology
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of PD-1 can shed light on the complex architecture of T cell activation and differentiation.
In this chapter, we will study the effect of loss of PD-1 on T cell differentiation, in the same
way as we studied the impact of loss of CTLA-4 in the previous chapter. PD-1 negatively
regulates T cell activation through different mechanisms than CTLA-4 [120] and as such
may impose distinctive restrictions on phenotypes.
4.1.1 Design of the study
We again employed CyTOF to profile lymphocytes derived from Pdcd1-/- and littermate
control mice all of similar age as the Ctla-4 knockout mice profiled previously. In addition,
since germline deletion of Pdcd1 leads to development of autoimmune phenotypes but with
delayed kinetics compared to Ctla-4-/- mice [121, 122], we also collected cells from adult
mice. The CyTOF panel was designed in a similar fashion to the Ctla-4 knockout study,
to allow classification of peripheral T cell populations and analysis of T cell differentiation
states. To repeat, activation markers (e.g. CD44, CD62L, PD-1, CD69, ICOS), surface
differentiation markers (e.g. KLRG1, CD127), and lineage defining transcription factors
(e.g. TBET, EOMES, GATA3, BCL6, RORγT) were included in the CyTOF panels. In
total, we profiled 40 proteins from more than a million individual cells collected from the
lymph node of 20 young mice and 15 adult mice. For more details on experimental design
and a complete set of proteins used, see Appendix B.
CHAPTER 4. PD-1 ONLY SUBTLY MODULATES T CELL DIFFERENTIATION
STATES 85
4.2 Results
4.2.1 Loss of PD-1 leads to a subtle expansion CD8 T cell phenotypic
space and does not affect CD4 T cell phenotypic limits
Application of archetypal analysis on the young cohort, in a similar fashion to the CTLA-4
KO study, identified one CD8 T cell archetype that is enriched in young Pdcd1-/- mice but
still present in control mice (Figure 4.1 A-B, CD8 archetype 5). Additionally, no enrichment
was seen in the CD4 compartment (Figure 4.1 C-D. Cells associated with all archetypes
were detected in PD-1 competent littermates however, suggesting that phenotypic limits
may be not be altered by the absence of PD-1 in young mice. This is consistent with prior
reports that peripheral T cell phenotypes are grossly normal in Pdcd1-/- mice [123].
We then analyzed the adult Pdcd1-/- mice given that autoimmune phenotypes manifest
only in older mice [121, 122]. Archetypal analysis identifies a PD-L1+Sca1+IRF4+ CD8 T
cell archetype that subtly expands in adult Pdcd1-/- mice and is not detected in control mice
(Figure 4.2 A-E; archetype 3). This phenotypic expansion is highly variant, however similar
findings and levels of biological variance were observed in multiple independent cohorts of
mice (Figure 4.2 F). In contrast, loss of PD-1 did not affect the phenotypic limits of CD4
T cells (Figure 4.2 D-E). While changes in the relative frequency of several CD4 T cell
archetypes were observed, cells associated with these archetypes are detected in control
mice.
The subtle expansion of CD8 T cell phenotype limits due to loss of PD-1 appears to be
age-dependent and likely relies on the prior induction of an immune response. Consistent
with this notion, the enriched archetype in young Pdcd1-/- mice displays a similar, but less
extreme phenotype compared to the archetype 3 in adult mice (Figure 4.1 A-B, archetype
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Figure 4.1: (Caption next page.)
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Figure 4.1: (Previous page.) (A) Expression heat map of CD8 T cell archetypes identified
in 11-day old Pdcd1-/- and control mice. Relative mean intensity expression values are dis-
played, normalized to the maximum (99.5 percentile) and minimum (0.5 percentile) across
archetypes on a per marker basis. (B) CD8 archetypes identified in 11-day old Pdcd1-/-
and control mice. Frequencies of cells associated with each archetype are displayed on a
per mouse basis. *, p < 0.05, T-test with Holm-Sidak multiple testing correction. (C)
Expression heat map of CD4 T cell archetypes identified in 11-day old Pdcd1-/- and control
mice. Relative mean intensity expression values are displayed, normalized to the maximum
(99.5 percentile) and minimum (0.5 percentile) across archetypes on a per marker basis.
(D) CD4 archetypes identified in 11-day old Pdcd1-/- and control mice. Frequencies of cells
associated with each archetype are displayed on a per mouse basis. *, p < 0.05, T-test with
Holm-Sidak multiple testing correction.
5; Figure 4.2 E, archetype 3). Whether the expression of Sca1 by this archetype reflects
functional stem-like properties remains unknown. Visualization of the data by t-SNE sug-
gests that extension of phenotypic limits is independent of PD-L1 expression (Figure 4.3
A). This indicates that compensatory upregulation of PD-L1 is not the primary driver of
this effect.
4.2.2 Archetypes provide a different point of view compared to clusters
In contrast to findings of archetypal analysis, discussed above, clustering analysis does
not detect changes in phenotypic limits, highlighting important differences between these
computational approaches (Figure 4.3 B-C). While clustering analysis tends to focus on the
average expression of a group of cells, archetype analysis focuses on the most extreme of
groups of cells. In the context of limits of differentiation, we think of differentiated states as
being slightly away from the “major” body of the data. Thus, looking at archetypes helps
us directly assess the states at the most extremes. This analysis suggests that the changes
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Figure 4.2: (Caption next page.)
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Figure 4.2: (Previous page.) Loss of PD-1 leads to a minor expansion of CD8 T cell
phenotypic space. (A) t-SNE plots displaying equal number of T cells derived from adult
Pdcd1+/-, Pdcd1+/+ and Pdcd1-/- mice, overlaid with the expression of selected markers.
Dotted line highlights phenotypic expansion regions in Pdcd1-/- mice. (B) CD8 and CD4
T cell archetypes overlaid on t-SNE plots as shown in A; Pdcd1+/+ (green), Pdcd1+/-
(blue), and Pdcd1-/- (red) mice. (C) The frequencies of cells from each genotype associated
with CD8 archetypes are displayed. The number of cells within a volume defined by 2-
percentile diffusion distance from each archetype are displayed on a per mouse basis with
mean and standard deviation shown for each group. *, control (Pdcd1+/- and Pdcd1+/+;
blue) versus Pdcd1-/- mice (red); p < 0.05 2-way ANOVA with Sidak’s multiple testing
correction. Archetypes detected only in Pdcd1-/- mice are shaded red. (D) The frequencies
of cells associated with CD4 archetypes in Pdcd1-/- and littermate control mice are displayed.
(E) Expression heat map of CD8 (left) and CD4 (right) T cell archetypes identified in
adult 2-5 month old Pdcd1-/- and control mice. Relative mean intensity expression values
are displayed, normalized to the maximum (99.5 percentile) and minimum (0.5 percentile)
across archetypes on a per marker basis. Archetypes detected only in Pdcd1-/- mice are
shaded red. (F) The frequency of cells in proximity of the CD8 T cell archetype representing
an expansion phenotype identified across 3 biological replicate cohorts of adult Pdcd1-/- and
control mice. Cells derived from Pdcd1+/+ (green), Pdcd1+/- (blue), and Pdcd1-/- (red).
in phenotypic limits due to loss of PD-1 likely reflect an increase in variance in CD8 T cell
phenotypes, in which only boundary populations are impacted (Figure 4.3 D). This is in
contrast with shifts in population centroids that would be observable by clustering analysis
but depending on the nature of the shift may not be observable by archetype analysis.
Combined, these data suggest that negative costimulation has a generalizable role in
defining T cell phenotypic limits but that CTLA-4 and PD-1 impose distinct types of
constraints.
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Figure 4.3: (Previous page.) (A) t-SNE plot of T cells from Pdcd1-/- and control mice
overlaid with genotypes. t-SNE was performed including (left) or excluding (right) PD-L1
as a parameter. (B) Expression heat map of T cell clusters identified. Mean intensity
normalized between 0.5% and 99.5% of maximum is displayed. (C) Frequency of CD3+ T
cell clusters identified in Pdcd1-/-and littermate controls displayed on a per mouse basis with
mean and standard deviation. Clustering was performed including PD-L1 as a parameter
with k = 30. *, unpaired t-test assuming unequal variance with Benjamini and Hochberg
FDR Q = 1%. Only clusters over 0.5% total frequency are displayed. (D) Model situation
in which both archetypal and cluster analyses are able to detect changes in phenotypic space
due to a perturbation (top) or only archetypal analysis is able to do so (bottom).
4.2.3 Antibody blockade of PD-1 modulates T cell differentiation states
We also sought to address if similar dysregulation of T cell states persists under antibody
blockade of PD-1. To address this possibility, similar to anti-CTLA-4 study, discussed in
the previous chapter, we performed archetypal analyses on mass cytometry data of MC38
murine tumors treated with anti-PD-1 therapies [101]. Blockade of PD-1 led to enrichment
of a PD-1+PD-L1int CD8 T cell archetype (Figure 4.4 A; archetype 4). Similar to the case
of anti-CTLA-4 treatment, we find that cells associated with each archetype are detected in
the contexts of both control and therapy, which is again in contrast to the knockout studies.
As we discussed in CTLA-4 case, this less extreme effect on phenotypic limits could be a
result of incomplete loss of signaling due to antibody blockade (versus total loss of function
in the genetic systems) combined with the fact that immune cell states within the tumor
microenvironment are more diverse and have high phenotypic than in normal contexts [115].
Finally, we performed archetypal analyses on two cohorts of matched pre-therapy and
post-therapy peripheral blood samples from melanoma patients treated with anti-PD-1
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Figure 4.4: (Caption next page)
therapies [124]. These analyses identify CD8 T cell archetypes that are present at low levels
prior to therapy, similar to that of normal donors, but enrich following therapy (Figure 4.4
B-C). These findings support the notion that loss of function of PD-1 leads to dysregulation
of T cell differentiation.
4.3 Discussion
T cell differentiation enables the generation of a wide range of specialized cell types, how-
ever how the range of attainable cell states (i.e. phenotypes) is determined remains an
open question. In other words, how do cellular inputs precisely lead to the generation of
only specialized T cell populations to mediate effective immunological responses to a given
challenge? Our studies from the previous two chapters reveal that: 1) T cell negative cos-
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Figure 4.4: (Previous page.) (A) Expression heat map of MC38 tumor infiltrating CD8
T cell archetypes. Relative mean intensity expression values are displayed, normalized to
the maximum (99.5 percentile) and minimum (0.5 percentile) across archetypes on a per
marker basis (top). Frequencies of cells associated with MC38 tumor infiltrating CD8 T cell
archetype 4. *, p < 0.05 one-way ANOVA with Tukey’s multiple comparison (bottom). (B)
Expression heat map of CD8 T cell archetypes from peripheral blood of patients treated
with anti-PD-1 immune checkpoint blockade therapies. Data from the first cohort, A, are
displayed (top). Frequency of cells associated with CD8 T cell archetype1 from cohort A
of peripheral blood of melanoma patients at baseline (pre) and following (post) treatment
with anti-PD-1 therapies (bottom). Healthy donor and pre-post matched pairs of samples
from one cohort of patients are displayed on a per patient basis. Responder (R) and
non-responder (NR) patients are denoted. *, p < 0.05 one-way ANOVA with Tukey’s
multiple comparison. (C) Expression heat map of CD8 T cell archetypes from peripheral
blood of patients treated with anti-PD-1 immune checkpoint blockade therapies. Data from
the second cohort, B, are displayed (top). Frequency of cells associated with CD8 T cell
archetype 5 from cohort B of peripheral blood of melanoma patients being treated with
anti-PD-1 immune checkpoint blockade therapies (bottom).
timulation regulates the limits of T cell differentiation, a role related to, but distinct from
its regulation of T cell activation, 2) CTLA-4 enforces boundaries on CD4 T cell pheno-
types, 3) PD-1 subtly restrains CD8 T cell phenotypes, and 4) CTLA-4 constrains T cell
phenotypes by imposing maximal expression limits during the course of differentiation. Fur-
thermore, the computational approaches applied here may be broadly useful to characterize
phenotypic states and understand how molecular determinants of cellular differentiation are
impacted by genetic variation and other perturbations.
From a fundamental biology perspective, our results support the previously proposed
‘nuanced model’ of CD4 T cell differentiation [12]. In this model, T cell subsets occupy
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phenotypic states along a continuum, defined by interaction of lineage transcription factors,
rather than completely discrete lineages. In light of this, our data indicate that negative
costimulation constrains the boundaries of the T cell phenotypic continuum. It remains
unclear whether the same regulatory mechanisms control cell state boundaries and fate de-
cisions between such cell states. Additional investigation using complementary approaches
such as single-cell transcriptomics and epigenomics will shed more light on the complex
architecture of T cell states and the variables that control cellular plasticity.
Our studies reveal that CTLA-4 and PD-1-mediated negative costimulation constrain
divergent aspects of T cell differentiation. It remains unknown what downstream signals
mediate this regulation and how costimulatory signals are integrated with other inputs. Cell
extrinsic inputs (e.g. systemic cytokine levels) are likely to play a role in the regulation of
phenotypic limits and represent part of the downstream effects of loss of CTLA-4 and PD-1.
It remains unclear whether the same regulatory mechanisms control cell state boundaries
and fate decisions between such cell states. It also remains to be assessed whether the
expanded phenotypes represent stable terminally differentiated states, or rather transient
intermediate states not normally attainable. Additional investigation using complementary
approaches will be needed to precisely address these issues.
The effects of loss of CTLA-4 or PD-1 on T cell state are highly relevant in light of the
current landscape of clinical oncology. Our findings suggest that effects on differentiation,
skewing of T cell differentiation and alterations of phenotypic constraints may contribute
to mechanisms of immune checkpoint blockade therapies. For example, we identify a T cell
archetype that is analogous to ICOS+ Th1-like CD4 effector T cells, which have been shown
to expand following anti-CTLA-4 therapy in preclinical and clinical settings [101, 107, 108,
125]. Furthermore, analyses on matched pre- and post-anti-PD-1 therapy peripheral blood
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samples reveal CD8 T cell archetypes that enrich following therapy. While the therapeutic
signifcance of effects on phenotypic limits remains to be addressed in more detail, these
findings substantiate the notion that T cell differentiation is dysregulated due to antibody
blockade of CTLA-4 and PD-1. It stands to reason that other T cell costimulatory molecules
may also impose regulatory constraints on differentiation through distinct mechanisms.
Broadly, whether breaches of phenotypic limits due to loss of costimulatory regulation lead
to other changes in T cell function or identity remains an open question.
In summary, these studies reveal that negative costimulation regulates T cell differentia-
tion in addition to its well-appreciated function of attenuating activation. Negative costim-
ulation integrates with biological inputs from cytokine signaling and TCR signal strength to
regulate peripheral T cell differentiation. Such mechanistic insights from these and future
studies will be critical in guiding rational design of next-generation immunotherapeutic ap-
proaches and advancing our understanding of what biological cues and modes of regulation
allow the immune system to recognize such a wide range of threats while simultaneously
restraining self-reactivity.
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Chapter 5
Single-cell RNA-seq reveals a
continuum of cellular states during
EMT
The previous two chapters employed CyTOF to interrogate T cell differentiation states in
the absence of negative costimulation in otherwise healthy mouse cells. While CyTOF is
a very powerful technique - allows analysis of millions of cells with up to 40 parameters -
it does have shortcoming, most importantly the very fact that it is limited in the number
of cellular parameters that can be measured. In the case where the proteins of interest are
known and well-profiled (such as in T cells), it can be immensely useful as the power of
millions of cells can be harnessed to deeply investigate the biological process. However, in a
more general setting, it is of interest to generally explore all possible phenotype states a cell
can take. For this, it is critical that we measure all possible parameters that determine the
state of a cel. At present, we still have a lot more to do to achieve this dream but recently
proposed scalable single-cell RNA-sequencing (scRNA-seq) technique has been a big step
in the right direction [26, 27, 48].
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In this chapter, we will apply scRNA-seq to study cellular states during the process of
Epithelial-to-Mesenchymal Transition (EMT). EMT is a dynamic biological process where
epithelial cells undergo a dramatic change in their morphology, function and state to become
mesenchymal like. EMT is a very important process during wound healing and tissue repair,
and has been suggested to play role in metastasis of cancer [126, 127].
This chapter is mostly based on analysis presented in [69].
5.1 Background
The functional and phenotype state of a cell can be obtained by studying the expression
pattern of all messenger RNA (mRNA) present inside the cell. Since mRNA molecules get
translated into proteins, the collection of all mRNA molecules inside a cell is a gateway to
understanding the nature of a cell. scRNA-seq is a novel technology that attempts to mea-
sure the abundance of all mRNA molecules (collectively called the transcriptome) present
inside the cell. mRNA content of a cell contains multiple important biological attributes of a
cell such as metabolism, transcription activity, cell cycle and hypoxia. Therefore, analyzing
scRNA-seq data offers us the exciting opportunity to explore multiple facets of biological
systems de novo in an unsupervised fashion.
Although new, scRNA-seq has already spurred exciting sets of discoveries that have
shed additional insights into biology of various systems and diseases such as cancer [115,
128–132]. Here, we chose to study EMT, a cell state transition during which cells gradually
lose epithelial markers (including E-cadherin, Epcam, and epithelial cytokeratins), and
gain mesenchymal markers (including Vimentin, Fibronectin and N-cadherin) [133]. At
a transcriptional level, multiple drivers of EMT have been characterized and include the
transcription factors ZEB1, SNAIL (SNAI1), and TWIST1. However, knowledge of the
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EMT process has largely been derived from studies comparing the extreme states of EMT
(i.e., the beginning epithelial state with the endpoint mesenchymal state). Moreover, most
studies have been conducted in bulk where the state of individual cells is not resolved.
Hence, while the initial and the final outcome of EMT are well characterized, little is
known about intermediary states.
We induced transformed mammary epithelial cells (HMLE) to undergo the EMT via
transforming growth factor β (TGF-β) treatment (8 days) and measured using inDrops
[26]. We observed that induction of EMT is asynchronous; each cell progresses along the
transition at a different rate. Consequently, on days 8 and 10, we see that cells reside in all
phases along the continuum of the EMT.
However, a vexing challenge in single-cell genomics is that the observed expression counts
capture a small random sample (typically 5% - 15%) of the transcriptome of each cell [33,
134]. In the case of lowly expressed genes, this can lead to lack of detection of an expressed
gene, a phenomenon called “dropout”. This impacts the signal for every gene, leading to
loss of gene-gene relationships in the data, obscuring all but the strongest relationships.
Indeed, our raw data also displays no real structure as shown in Figure 5.1, lack of which
makes it difficult to perform a biologically meaningful characterization of cellular states.
An analogous way to understand the notion of “dropout” is to imagine the mRNA
abundance corresponding to all the genes inside a cell as a matrix with cells along the rows
and genes along the columns. In a perfect world this matrix would accurately quantify the
number of mRNA molecules of any specific gene in any specific cell. The idea of “dropout”
in such a case is not equivalent to randomly picking entries from the matrix and setting
them to zero. Instead, it is more akin to taking a “sandpaper” and randomly scrapping off
observed counts from every entry. In such a process, lowly expressed genes inevitably end
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Figure 5.1: (A) 3D scatterplots between canonical EMT genes CDH1, VIM, and FN1 before
MAGIC with cells colored by the level of ZEB1. (B) 3D PCA plots before MAGIC with
cells colored by levels of ZEB1.
up having zero counts, and the well-expressed genes with an undersampling of their actual
counts. To overcome this sparsity, most methods aggregate cells, collapsing thousands of
cells into a small number of clusters. While these approaches cope with sparsity to some
extent, they lose single-cell or single-gene resolution.
To address these issues, we developed MAGIC (Markov Affinity-based Graph Imputation
of Cells), a computational approach for recovering missing gene expression in single-cell
data. MAGIC leverages the large sample sizes in scRNA-seq (many thousands of cells)
to share information across similar cells via data diffusion. MAGIC imputes likely gene
expression in each cell, revealing the underlying biological structure. MAGIC uses signal-
processing principles similar to those used to clarify blurry and grainy images. MAGIC
was validated on several biological systems and found to be highly effective at recovering
gene-gene relationships and additional structures [69].
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5.2 Overview of MAGIC
The MAGIC algorithm relies heavily on the idea of scRNA-seq data lie on a low-dimensional
manifold embedded in high dimensions. This assumption is substantiated by the fact that
possible cell states are constrained by regulatory mechanisms creating interdependencies
between genes [9, 63]. The low dimensional manifold can be represented using a nearest
neighbor graph, where each node represents a cell, and edges connect most similar cells,
based upon gene expression. Building with the nearest neighbor distance graph, MAGIC
uses the Markov matrix (discussed in detail in Chapter 2.2-2.3) as a diffusion operator [67]
to learn the underlying manifold and map cellular phenotypes to this manifold, restoring
missing transcripts in the process.
MAGIC takes an observed scRNA-seq count matrix and recovers an imputed count
matrix representing the likely expression for each individual cell, based on data diffusion
between similar cells. For a given cell, MAGIC first identifies the cells that are most
similar and aggregates gene expression across these highly similar cells in a careful way to
impute gene expression that corrects for dropout and other sources of noise. However, due
to data sparsity, nearest neighbors in the raw data do not necessarily represent the most
biologically similar cells. Therefore, we use data diffusion to construct a weighted affinity
matrix representing a more faithful neighborhood of similar cells, and then use this matrix
to restore the data. With a sufficient number of cells, this process (illustrated in Figure 5.2)
increases weights on cells that share similarity across a majority of biological processes.
Owing to technical noise, the ability to distinguish between similarity due to biological
correspondence versus spurious chance is not possible. Mimicking scRNA-seq, if we ran-
domly subsample a fraction of the transcripts, the expression observed across identical cells
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Figure 5.2: (Caption next page.)
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Figure 5.2: (Previous page.) Steps of the MAGIC Algorithm. (i) The input data consist
of a matrix of cells by genes (middle) of the data (right). (ii) We compute a cell-by-cell
distance matrix. (iii) The distance matrix is converted to an affinity matrix (middle) using
a Gaussian kernel. A graphical depiction of the kernel function is shown (right). (iv) The
affinities are normalized, resulting in a Markov matrix (middle). The normalized affinities
are shown for a single point as transition probabilities (right). (v) To perform diffusion, we
exponentiate the Markov matrix to a chosen power t. (vi) We multiply the exponentiated
Markov matrix (left) by the original data matrix (middle) to obtain a denoised and imputed
data matrix (right).
can appear dissimilar. However, these cells likely share many neighbors, whereas spurious
edges connect cells that share few neighbors. Raising the Markov matrix to the power t
results in a matrix where each entry represents the probability that a random walk of length
t starting at cell i will reach cell j (Figure 5.2 v), a process akin to diffusion. While the
exponentiated Markov matrix increases the number of cell neighbors, unlike the effect of
increasing k in k-nearest neighbor based imputation, MAGIC does not bluntly smooth and
average over increasingly distant cells. Instead, exponentiation refines cell affinities, increas-
ing the weight of similarity along axes that follow data density, thus phenotypically similar
cells have strongly weighted affinities, whereas spurious neighbors are down-weighted.
In the imputation step, MAGIC learns from cells in each neighborhood through multi-
plying the transition matrix by the original data matrix (Figure 5.2 vi), effectively restor-
ing cells to the underlying manifold. In this data diffusion process, cells share information
through local neighbors in a process that is mathematically similar to diffusing heat through
the data, where raising the diffusion operator to the tth power is akin to a t-step random
walk through the data. Exponentiation is essentially a low-pass filter on the eigenvalues,
CHAPTER 5. SINGLE-CELL RNA-SEQ REVEALS A CONTINUUM OF CELLULAR
STATES DURING EMT 103
which serves to eliminate noise dimensions with small eigenvalues, while simultaneously
learning the manifold structure. Combined, MAGIC denoises and imputes the data us-
ing a weighted averaging operation using carefully constructed weights. While we average
data across cells, each individual cell retains a unique neighborhood, resulting in a unique
expression vector.
An alternative and perhaps a simpler way to understand MAGIC is to think of it as
a weighted averaging operation. For any given cell X, the algorithm first finds its closest
neighbors, that is, cells that are similar to X (obtained during construction of the k-nearest
neighbor graph). The cells in the neighborhood are each given a weight, depending on
how close (similar) they are to X, higher weight for cells that are more similar. Then,
the algorithm finds neighbors of each neighbor of X and weighs each depending on how
similar they are to X. By default, these “new” neighbors will have lower weights than the
immediate neighbors of X. The algorithm then finds next layer of neighbors and the process
is repeated for t iterations (represented in the powering of the Markov matrix). Finally,
the expression value for X for any given gene is the weighted sum of all the neighbors thus
constructed.
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5.2.1 MAGIC Algorithm
Data: Raw scRNA-seq count matrix, X of size N cells by M genes
Result: Denoised and imputed matrix Ximputed of size N cells by M genes
Step 1: Pre-process X;
Step 2: PCA of Xprocessed to obtain p components that capture > Q% variance in
X, where Q could be for example 80;
Step 3: Computed nearest neighbor distance graph D;
Step 4: Convert D to a symmetric affinity matrix A;
Step 5: Normalize A to obtain a Markov matrix M ;
Step 6: Xtemp = M
t ×Xprocessed;
Step 7: Ximputed = Rescale Xtemp, where rescaling is performed to have each gene
expressions be at the same level as the original data X,






Algorithm 1: MAGIC algorithm.
PCA is performed on the processed data for a couple of reasons. First, scRNA-seq
data can have thousands of features representing each single gene present in the system;
computing distances in such high dimensional noisy space in thousands to millions of cells is
formidable from a computational point of view. Thus, reducing the range of dimensions of
search space to those that explain most variability in the data is meaningful. Features that
vary the most can be indicative of the drivers of underlying biology. Secondly, PCA also
helps remove noise from the data. The components that correspond to lower eigenvalues
are more indicative of noise in the data, hence are ignored. Thus, computing distances after
PCA on the data is more robust.
CHAPTER 5. SINGLE-CELL RNA-SEQ REVEALS A CONTINUUM OF CELLULAR
STATES DURING EMT 105
5.2.2 MAGIC’s effectiveness on bulk data
To quantitatively evaluate the accuracy of MAGIC’s imputation, we created a valida-
tion dataset based on bulk transcriptomic data from 206 developmentally synchronized
Caenorhabditis elegans young adults, measured at regular time intervals during a 12-hour
developmental time-course using microarrays [135]. Due to the noise prevalent in early mi-
croarray experiments, similar to the analysis performed in the original publication of the
data, we select only genes that load to the first two PCA components of the data. This
results in a data matrix with 206 worms and 9861 genes.
We down-sampled this data to emulate the sparsity found in scRNA-seq data (Fig-
ures 5.3 A-B). The log-scaled expression levels were exponentiated, and then each entry
was downsampled using an exponential distribution such that the result had 80% and 90%
of the values set to 0. Then the data was log-scaled and normalized based on z-score. We
applied MAGIC to this synthetically “dropped out” data and then compared between the
original and imputed data (with parameters npca = 20, ka = 3, t = 5, see Chapter 2.3
for details on the parameters) . We note that this dataset is particularly challenging as it
only contains 206 samples, whereas MAGIC is primarily intended for datasets consisting of
thousands of samples, as is the case for most single-cell datasets.
Based on the expression matrix, the imputed data largely matches the original data
(Figure 5.3 A). To zoom into finer structure and illustrate MAGIC’s ability to recover
key trends in the data, we select two genes (C27A7.6 and C53D5.2) based on their non-
monotonic developmental time trends and compare the original and imputed shapes for
each of these trends. For each gene, we find close concordance in the developmental trend
between the original and imputed data (Figure 5.3 B).
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We quantitatively evaluate MAGIC’s accuracy by directly comparing the original and
imputed values. At dropout of 90%, the R2 increases from 7% to 43% and for 80% dropout,
the R2 increases from 13% to 53%. The correlation was performed entry-wise by vectorizing
each matrix. The agreement between the original and imputed data is even higher in the
case of gene-gene correlations than that of the univariate case. For example, the agreement
in gene-gene correlations between the original data and data with 90% of the values dropped
out is 0.12. MAGIC recovers most of the gene-gene correlations so that after imputation
we have a of 0.65. For 80% of the values at zero, MAGIC improves from 0.35 to 0.78.
5.3 Application of MAGIC to EMT data reveals underlying
structure
MAGIC unveiled a continuum of transitional states that comprise EMT. Before MAGIC,
the canonical decrease in CDH1 (E-cadherin) coinciding with an increase in VIM (Vi-
mentin) and FN1 (Fibronectin) is obscured. After MAGIC (npca = 20, ka = 10, t =
6, see chapter 2.3 and Algorithm 1 for details on parameters), this relationship is success-
fully recovered (Figure 5.4 A). ZEB1, a key transcription factor known to induce EMT
[136], progressively increases as VIM and FN1 increase. Another progression revealed by
MAGIC involves two branches that deviate from the main structure, which display an in-
crease in mitochondrial RNA, reflecting a progression into apoptosis (Figure 5.4 A). The
apoptotic state is supported by the rise of additional apoptotic markers in these cells (data
not shown).
We quantitatively evaluated the accuracy of MAGIC’s imputation on single-cell RNA-
sequencing data. For this, we created two synthetic datasets with drop out, where ground
truth is known. By directly comparing the original and imputed data, we found that MAGIC
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Figure 5.3: (A) The gene expression matrix with 206 worms sorted by developmental time
along the y axis, and genes (along columns) clustered hierarchically. Left: the original
matrix, Middle: the matrix after dropout resulting in 80% of the values set to 0, and Right:
restored values after MAGIC. (B) Scatterplots of gene expression (y axis) as a function of
developmental time (x axis) for C27A7.6 and C53D5.2. Left: the original gene expression
versus time, Middle: gene expression after dropout, Right: after MAGIC.
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Figure 5.4: (A) 3D scatterplots between canonical EMT genes CDH1, VIM, and FN1. Left:
before MAGIC. Middle: after MAGIC with cells colored by the level of ZEB1. Right: MT-
ND1. (B) 3D PCA plots before MAGIC (i) and after MAGIC (ii) with cells colored by
levels of ZEB1, MYC, and SOX4 respectively.
was able to correctly recover ground truth data both qualitatively and quantitatively (Fig-
ures 5.5 A-B). We used the MAGIC-imputed count matrix of the EMT data as the “ground
truth” of a synthetically created dataset and then re-created synthetic dropout. Starting
with data from HMLE cells 8-10 days after TGFβ treatment, we first imputed the data
with MAGIC (npca = 20, ka = 10, t = 6) and then we induced dropout by down-sampling
using an exponential distribution such that 0%, 60%, 80% and 90% of the values are set
to 0. We then re-imputed the data using MAGIC. We show that MAGIC can also capture
multivariate relations effectively - the agreement between the original and imputed data is
even higher in the case of gene-gene correlations than that of the univariate case (Figure 5.5
Aii).
With 90% zeros, the R2 between the original data and the down-sampled data is brought
down to 0.04 and MAGIC corrects the data so that the R2 rises back to 0.7 (Figure 5.5
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Figure 5.5: Validation of MAGIC on EMT data. (A) (i) Line plots showing the recovery of
values (R2 of imputed values with original values) after MAGIC at various diffusion times
t. The different curves show recovery for different levels of dropout (purple = 0%, yellow =
60%, red = 80%, blue = 90%). (ii) Shows line plots quantifying the recovery of gene-gene
correlations after MAGIC with various diffusion times. The original correlation matrix is
compared to the imputed correlation matrix and the match is quantified by R2. (B) (i)
2D scatterplot of canonical EMT genes E-cadherin and Vimentin, colored by ZEB1, before
artificial dropout. Bii) The plot of (Bi) after 80% dropout. Biii) sample scatterplot as (Bi)
after MAGIC, Biv) 3-D scatterplot of E-cadherin, Vimentin and Fibronectin after MAGIC.
Ai). We see that with 80% zeros, we have R2 of 0.09 after dropout, which is corrected to
0.81 after imputation. An important feature of MAGIC is that it is particularly good at
capturing the “shape” of the data (Figure 5.5 B). We note that the imputed data is less
noisy and more accurately adheres to a low dimensional manifold. However, MAGIC may
additionally remove some stochastic biological variation, as it removes unstructured, high
frequency variation.
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5.3.1 MAGIC outperforms traditional imputation techniques
We compare MAGIC to kNN-imputation and diffusion maps using a few known gene-
gene relationships from the EMT (Figure 5.6) dataset. Contrary to MAGIC, the simpler
kNN-imputation approach fails to recover the known gene-gene relationships (Figure 5.6,
peach). Unlike simple smoothing over a kNN-graph, by propagating data using the diffusion
operator, MAGIC is able to recover data using longer range, global features. In essence,
this pulls in noisy outlier data to the manifold and restores the structure.
A popular aggregation approach utilizes diffusion maps [67], which like MAGIC, com-
pute a diffusion operator that defines similarity between data points along a manifold (see
Chapter 2 for more details). However, diffusion maps find diffusion components (DCs), a
nonlinear equivalent to a PCA, which have been recently utilized to find pseudotime trends
in developmental systems [37, 38]. Moving average approaches have been successfully used
to observe gene trends along DCs, smoothing along a single diffusion component, one gene
at a time. This performs well when DCs correspond to tight developmental pseudo-time
trajectories, and only for developmentally related genes whose major component of vari-
ation is singular. Moreover, because smoothing occurs one gene at a time, the approach
cannot be used to reveal gene-gene relationships. MAGIC, by contrast, uses the diffusion
operator to propagate gene expression information between similar cells, taking all diffusion
components and genes into account simultaneously in its inference. The difference is illus-
trated in Figure 5.6, sky blue. Since, the EMT dataset does not follow a simple trajectory,
and therefore diffusion components fail to capture trends for even the most canonical TFs
in this process. For instance, ZEB1 or SNAIL versus VIM shows a fluctuating rather than
positive trend.
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Figure 5.6: Comparison of MAGIC to other imputation and smoothing methods shown on
EMT data (as in Figure 5.4), raw data (first column), and MAGIC imputed (second col-
umn). The other columns show kNN-based imputation, smoothing on diffusion components
1 to 2, and smoothing on VIM, respectively.
Combined, these results show that MAGIC outperforms other traditionally used tech-
niques to denoise and impute scRNA-seq data.
5.4 Characterizing Intermediate States during EMT using
Archetypes
A surprising revelation is that most of the cells (79%) reside in an intermediate state that
is neither epithelial, nor mesenchymal. Moreover, the intermediate cells are highly het-
erogeneous, occupying a multi-dimensional manifold that does not seem to follow a simple
one-dimensional progression. Thus, we characterized this structure and, in particular, its
boundaries. We used archetypal analysis [76] to characterize the extreme phenotypic states
and states that lie in between these extrema [78]. While archetypal analysis has been used to
characterize single-cell data [77], MAGIC learns a better-formed structure that is amenable
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to archetypal analysis (Figure 5.4 A-B). In fact, we find that MAGIC is an essential step
into finding meaningful archetypes (Figures 5.7). Before MAGIC the data is dominated by
noise and as a result there are no apparent extreme states. After MAGIC (Figure 5.8, 5.4)
we can observe the shape of the phenotypic landscape and clearly see “corners” or extreme
states in the data (compare to Figure 5.7). To find the archetypes of our EMT data we
use the Principal Convex Hull Analysis (PCHA) method [80] on the PCA projection of the
imputed data, which scales efficiently with the number of cells and has previously been used
successfully in single-cell data analysis [77]. The choice of PCA is motivated by the fact
that since PCA is a linear transformation, the convex hull of the data in PCA-dimensions
is a subset of the convex hull of the original data and therefore the archetypes obtained
are indeed extreme points of the original data. We observe that 90% of the variance of
the imputed data is explained by 10 PC components, allowing us to robustly estimate the
polytope in a dramatically reduced dimension that still captures the dominant dimensions
of variation.
More precisely, to perform archetypal analysis, we first computed the principal compo-
nents and the loadings of the imputed data, [U, Y ] = pca(Ximputed), where U ∈ RM×10 is
the principal component coefficient matrix and Y ∈ RN×10 is the matrix of the principal
components scores (projection of Ximputed onto U), N is the number of cells and M is the
number of genes. We note that the number of principle components, 10 in the EMT dataset,
is data dependent. The resulting Y was then fed into the PCHA algorithm to obtain 10
archetypes: K = pcha(Y, 10), where K ∈ R10×10. Finally, to estimate the approximate gene
expression level for each archetype, we project the thus obtained low-dimensional archetypes
onto the original gene space as Kfull = K×UT , where UT is the transpose of U . Figure 5.8
A shows the projection of the computed archetypes onto two different 3D plots. We then
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Figure 5.7: Archetype analysis on the same data as Figure 5.4, before MAGIC. 3D scatter-
plots annotated by red dots representing each of the 10 archetypes in the data. (Left) Canon-
ical EMT genes CDH1, VIM and FN1, and (right) 3D PCA plot. Note, two archetypes
pinpoint outlier cells and are removed from further analysis.
used the neighborhood of cells around each archetype to characterize the gene expression
profile for that archetype and find unique gene expression patterns for each AT (Figure 5.8
B).
5.4.1 Construction of archetypal neighborhoods
The construction of neighborhood around the archetypes - consisting of cells most similar to
the archetype - is substantiated by the fact that each archetype is a weighted sum of cells.
The neighborhoods were then constructed by assigning cells to their nearest archetype
based on the diffusion distance, as long as this distance is within a bounded proximity,
from the archetype. To assign similar cells to each archetype we define a neighborhood




(Ddiffusion(t, zi, zj)). Essentially, for an archetype, its neighborhood consists of
all the cells that are within the radius equal to half the distance to the nearest archetype.
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This choice of the radius guarantees that the neighborhoods span a similar range on the
manifold for each archetype.
This way of constructing “soft” clusters has certain advantages over traditional approach
of clustering the entire data into discrete groups. First of all, since the data seem to lie
along a continuum, an optimum partitioning of the cells into disjoint clusters is not possible.
Secondly, by only considering the vicinity of each archetype, the archetype and hence the
properties of cellular behavior around it can be more robustly studied. This highlights the
processes taking place at the extremes, which can be reflective of more interesting biology
than population aggregates such as a traditional clusters.
5.4.2 Differential gene expression using Earth Movers’ Distance
These archetypal neighborhoods now enable us to characterize the gene expression pro-
files as distributions around each archetype and compare these distributions between the
archetypes. For quantifying differences between distributions, we use earth mover?s dis-
tance (EMD) [137], a nonparametric measure of the distance between two distributions
that quantifies the flow required to morph one distribution to another. The choice of EMD
is particularly appealing for single-cell data because unlike traditional methods, to compare
expression levels of genes, such as mean and median, EMD does not collapse the single-cell
information onto a single number but instead uses the entire distribution of gene expression
across all cells. In 1-dimensions, it can be computed as the L1 norm of the cumulative
density functions, DEMD = ||CDF1 −CDF2||1, and has successfully been used to quantify
gene expression differences in single-cell data [102].
We find the genes whose expression maximally distinguishes each archetype against
background gene expression. For each archetype, the background is constructed using all
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cells that are not a member of the archetypal neighborhood, excluding apoptotic cells.
However, due to density differences in the data, simply combining the remaining cells over-
represents some archetypes and under-represents others. Therefore, we create a background
distribution by randomly subsampling an equal number of cells as each archetypal neigh-
borhood. Thus, for each archetype, we compute the EMD to background for each gene.
To ensure robustness, we perform this subsampling and EMD computation 100 times and
use the average score for each gene. Finally, we select the genes that have the largest aver-
age EMD distance to background as distinguishing features for each archetype. Note that
MAGIC is absolutely essential in getting distinct differentially expressed genes between the
different archetypes, compare Figure 5.8 B-C (differential expressed genes after MAGIC)
with Figure 5.7, 5.9 A-B (same analysis before MAGIC).
5.4.3 Results
We thus performed differential gene expression analysis to gain a more comprehensive char-
acterization of each AT (Figure 5.8 C). These archetypes fall into the following categories:
“epithelial”, AT6, AT7; “intermediary”, AT1 to AT5; “mesenchymal”, AT9; and “apop-
totic”, AT8, AT10. The epithelial ATs (AT6 and AT7) are defined by strong epithelial
marker expression including CDH1, CDH3, MUC1, and CD24. The transcriptional profile
of AT7 includes higher ESR2 and GATA3, commonly associated with the luminal mammary
epithelial cells, and higher CD24 and CDH1, suggesting a more differentiated epithelial phe-
notype than AT6. Of note, AT6 and AT7 express high levels of SOX4, recently shown to
be a master regulator of a TGF-β-induced EMT [138]. The mesenchymal AT9 is character-
ized by high expression of core EMT TFs SNAI1, ZEB1, SMAD4, TGFB1, and TWIST1
(Figure 5.8 C). Thus, AT9 likely represents cells that have undergone EMT in response to
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TGFβ.
Our analysis highlights five intermediate ATs (AT1 - AT5), which reside along a continu-
ous spectrum of phenotypes, supporting recent findings suggesting that cells undergoing the
EMT move through a series of partial and/or metastable cell states [133, 139]. AT2 shows a
similar gene expression profile as AT7, including upregulation of SOX4 and is closest to the
epithelial state. However, AT2 expresses a recently characterized partner in EMT, KLF5
[140]. AT3 is closest to the mesenchymal state, with SMAD3 and mesenchymal regulator
MSX1 upregulated. AT1, AT3, and AT4 all express a large number of chromatin modifiers,
including EZH2, and several CBX genes, suggesting that these might play a role in the re-
programming. AT1, AT4, and AT5 segregate from the other ATs with concomitant increase
in multiple embryonic genes (including TRIM28, FOXB1, HOXA5, HOXB2, and HOXA3).
Indeed, it has been postulated that epithelial cells undergoing EMT may revert to a more
primitive state before acquiring the ability to differentiate into a mesenchymal cell [141].
Together these data suggest AT1 and AT4, have entered into a marked reprogramming
phase of the EMT, while AT3 is further along this reprogramming phase, further supported
by the increasing levels of VIM, along this progression.
5.5 Discussion
Here, we presented MAGIC, an algorithm to alleviate sparsity and noise due to stochas-
tic mRNA capture in single-cell data. The cost of sequencing limits our ability to measure
large numbers of cells at depth, ensuring MAGIC’s utility even as scRNA-seq technology im-
proves. Unlike other imputation algorithms, which simply fill in “missing values”, MAGIC
uses diffusion of values between similar cells along an affinity-based graph structure, to
correct the entire data matrix and restore it to its underlying manifold structure. This
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diffusion is akin to low-pass filtering of the graph spectrum. Here, we extend this notion to
data without a priori knowledge, by learning a manifold structure de novo via the Markov
matrix and filtering on the manifold structure.
MAGIC assumes cell phenotypes can be approximately embedded in a substantially
lower dimensional structure, which can be of any shape and even comprised of well-separated
components. Cells are regulated to reside within the boundaries of a restricted portion of
the state space (i.e., a subspace). Moreover, gene-gene relationships ensure that these sub-
spaces exist as lower-dimensional objects relative to the full measurement space. MAGIC’s
key assumption is that such a subspace corresponds to low-frequency trends in the data
(technically the affinity graph representing the data) containing biological signals of inter-
est, while noise, including dropout, are high frequency. Thus, low-frequency batch effects
or artifacts will not be removed, and genes behaving in a noisy (high frequency) fashion
may be smoothed out.
Additionally, the number of cells affects the frequency of signals in the data. For in-
stance, the same signal (such as EMT) can be high frequency if only a few cells are under-
going EMT, but this signal is captured as the cell number increases. Our data contained
only 1% mesenchymal cells, but with thousands of cells, we recovered the process in detail,
including its regulatory process. Thus, while MAGIC is able to find gross structures us-
ing only hundreds of cells, increasing cell number enables MAGIC to find increasingly fine
structures and more signals in the data. In the case of EMT, MAGIC recovered a com-
plex structure that is not well represented by a simple trajectory. We applied archetypal
analysis to characterize this complex structure and reveal several previously unappreciated
intermediate states.
Combined with the archetype analysis, the idea of “soft” clustering of cells to each
CHAPTER 5. SINGLE-CELL RNA-SEQ REVEALS A CONTINUUM OF CELLULAR
STATES DURING EMT 118
archetype allowed us to identify genes that are substantially regulated during various states
along EMT. We used Earth Movers’ Distance (EMD) to identify the genes that are differ-
entially regulated near each of the archetypes compared to rest of the data. Compared to
traditional methods like mean and median, EMD uses the entire distribution of expression
to differentiate genes. Although applicable for any single-cell data, this method relies on
the fact that MAGIC elucidates the distribution of every gene that is obscured in the raw
data. Together, they form a powerful approach to investigate into gene expression pattern
in any scRNA-seq data.
Overall, we presented a host of powerful methods to impute, denoise, learn the geometry
and structure of the data and analyze differential gene expression patterns that can be widely
applicable to discern novel biology.
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Figure 5.8: (Previous page.) MAGIC recovers state space in EMT data. (A) 3D scatterplots
after MAGIC, red dots represent each of the 10 archetypes in the data. Plotted by (left)
CDH1, VIM, and FN1, and (right) PCA. (B) Left: Archetypal neighborhoods, cell colored
by archetype, gray cells are not associated with any archetype. Histograms represent dis-
tributions of genes in archetypal neighborhoods, color-coded by the colors shown in the
leftmost plot. (C) A subset of differentially expressed genes for each archetype (columns)
including highlighted genes, transcription factors, and chromatin modifiers.
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Figure 5.9: Raw data lacks structure for archetypal analysis. Same data is used as in
Figure 5.4. (A) Leftmost plot shows 3D PCA plot of archetypal neighborhoods, with each
cell colored by its associated archetype, gray cells are not associated with any archetype.
The remaining panels show histograms representing the distributions of various genes in
archetypal neighborhoods, color-coded by the colors shown in the leftmost plot. Most of
the data is zero and does not capture the heterogeneity captured in the same analysis after
MAGIC (Figure 5.8 B).(D) A subset of differentially expressed genes for each archetype
including the set of highlighted genes from Figure 5.8 C. Here we see little difference across
the archetypes found on this data.
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Chapter 6
Conclusion & future perspectives
6.1 Summary
In this dissertation, we applied various computational tools to analyze single-cell data and
address important questions in immunology pertaining to T cells and biology of Epithelial-
to-Mesenchymal Transition. All our analysis relied on the fundamental assumptions that
measuring cellular contents (proteins and mRNA) can help us learn cellular behavior. They
provided a means to quantify cellular phenotype, which we used to understand the type,
state and functional ability of a cell.
Today single-cell technologies facilitate profiling of various constituents in a biological
sample at the single-cell level. Here, we applied two such technologies namely CyTOF (Cy-
tometry by Time Of Flight) and single-cell RNA-sequencing (scRNA-seq), which measure
the expression levels of multiple proteins or genes in thousands of individual cells simul-
taneously. The resulting data is high-dimensional and is complex with proteins (or genes)
displaying non-linear behavior. This added complexity is due to the biological constraints
a cell has in place such as feedback mechanisms and checkpoints. Analysis of such com-
plex data requires methods that take into account the dependencies among the measured
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analytes and provides a comprehensive picture of cellular behavior in the system.
Subsequently, we discussed some methods to analyze such complex data types. Under-
lying the methods is a common assumption that the cells reside along a manifold that is
of much smaller dimensionality embedded in a high-dimensional ambient space. This as-
sumption is biologically substantiated because most of the genes are co-regulated and hence
display correlated structure. This indicates dependencies between the measured parameters
and that only a few independent variables drive the underlying process. Under this realm,
we discussed the notion of non-linear dimensionality reduction. We paid special focus on
diffusion maps, which has been used successfully to study biological systems, especially to
align cells along a developmental trajectory. Similarly, we discussed archetypal analysis
to understand the global geometry of the data. In particular, when the data displays a
continuum structure archetypes can help us understand the extreme phenotypes and state
of the data. The most extreme phenotypes in data have previously been interpreted as the
most optimal state attainable by cell of that phenotype [77]. In this work, while we do not
interpret the output of archetypal analysis in such a way, we use the notion that archetypes
are cells at the boundaries of the data.
We applied archetypal analysis to study T cell differentiation under genetic loss of
CTLA-4 and PD-1 in other wise healthy mice. Complementary to clustering analysis,
under loss of CTLA-4, archetypal analysis revealed the presence of knockout specific cells
past normal phenotypic boundary in CD4+ T cells. We observed three archetypes, a CD4+
regulatory type and two effector types that resembled the expanded population. Archetype
6 showed FoxP3+ regulatory phenotype while archetype 7 showed ICOS+TBET+ Th1-like
phenotype and archetype 5 showed ICOS+GATA3+ effector type phenotype. Interestingly,
there was no breach in the phenotypic manifold in CD8+ T cells under loss of CTLA-4,
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although there was substantial modulation in the frequency of T cells in both the compart-
ments.
We argued that the observed expansion is not a result of T cell activation. For this, we
activated the T cells under loss of CTLA-4 using ovalbumin and characterized the observed
subpopulation into three categories: Homeostatic populations that are detected in all mice,
activation dependent populations that are detected in Ctla4-/- and CTLA-4 competent mice
upon immunization and phenotypically expanded subsets that are present in Ctla4-/- but
not in control mice under any condition. We found three notable clusters 12, 15 and 16 in
the phenotypically expanded category. Assuringly, clusters 12 and 16 showed a very similar
phenotype to archetype 7 and 5 respectively. These results suggested that the expansion
observed in the effector population is not driven by activation alone.
In order to understand the molecular mechanisms leading up to the extension of the
phenotype space, we constructed differentiation paths from na¨ıve archetype to of the ex-
panded archetypes. For this, we used shortest path distances along a nearest neighbor graph
constructed using diffusion distances between cells. Our analysis revealed that CTLA-4 im-
poses restriction on limits of expression of certain key proteins and in its absence, cells are
allowed to achieve previously unattainable expression levels and thus expanded states. Our
observations argue against the theory that loss of CTLA-4 gives rise to alternative signaling
pathways that are otherwise dormant in the presence of CTLA-4 signaling. We applied a
similar set of analysis to pinpoint lineage commitment time during T cell differentiation un-
der the loss of CTLA-4, and observed that commitment occurs prior to breach in phenotypic
manifold, arguing that loss of CTLA-4 does not dysregulate this process.
Our observations were further supported by functional properties of the expanded sub-
sets observed via cytokine profiling. Our data indicated that CTLA-4 imposes limits on
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cytokine expression even in already committed T cells. We found that loss of CTLA-4
led to increase in maximal cytokine expression in CD4+ effector but not in regulatory or
CD8+ T cells, providing further support to our assertions from CyTOF data. Application
of archetypal analysis to tumor infiltrating T cells under anti-CTLA-4 checkpoint blockade
also revealed that loss of CTLA-4 led to an expansion in CD4+ T cells with no noticeable
changes in CD8+ T cells. However, unlike the case of genetic loss of CTLA-4, checkpoint
blockade, the expanded states were also occupied by control cells. This could be a result
of checkpoint blockade representing only a partial loss of CTLA-4, or the fact that tumor
infiltrating immune cells have greater diversity of states.
On the other hand, loss of PD-1 resulted in subtle extension of the phenotype space of
CD8+ T cells with no impact on CD4+ T cells. Notably, this effect was age-dependent
and varied slightly between cohorts. Similar analysis of T cells under anti-PD-1 checkpoint
blockade revealed a consistent effect of partial loss of PD-1. We found that anti-PD-1
blockade led to dysregulation in T cell differentiation in the CD8+ compartment, with no
substantial effect in the CD4+ compartment. In both these studies, archetype analysis
allowed us to compute the most extreme cells present in the data and by analyzing the
distribution of cells of different genotype near the archetypes, we were able to argue that
loss of CTLA-4 led to CD4 T cells and loss of PD-1 led to CD8 T cells occupying states
that are otherwise impossible under normal circumstances. While further investigations are
required to truly decipher the nature and mechanism of their impact on T cell differentiation,
our study sheds more light in the complex biology of T cell activation and differentiation.
We then switched gears to study Epithelial-to-Mesenchymal Transition using scRNA-
seq. A major hindrance in the analysis of scRNA-seq data is the massive undersampling
of mRNA molecules present inside the cell, also known as “dropout”. This stems from
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the lack of efficiency in mRNA capture rate and results in the loss of relationship between
genes in the data. Although, highly expressed genes are still well represented, they are
of less interest because they often constitute the background behavior of the cell (such as
ribosomal genes). The ones that are most impacted are the lowly expressed genes (such
as transcription factors like SNAI in the EMT study), which often are the drivers of the
biological processes. In this regard, we presented the MAGIC algorithm, which utilizes
the Markov matrix to run diffusion process on a cell-by-cell graph to impute and denoise
expression levels. MAGIC denoises the data by sharing information between cells in a care-
fully constructed neighborhood. During the process of constructing neighborhood around
each cell, MAGIC learns the underlying manifold of the data and tries to restore the gene
expression levels of the cells to this manifold.
We applied MAGIC to cells undergoing Epithelial-to-Mesenchymal Transition to uncover
the underlying structure of data. Prior to MAGIC, the genes showed little to no structure,
mostly because many of the genes of interest - such as SNAI - were expressed in less than
10 cells. Post-MAGIC, the structure of the data became clearer and gene-gene relationship
was restored. We validated that MAGIC outperforms other traditionally used techniques
for imputation of scRNA-seq data, and also established the accuracy of MAGIC.
Application of MAGIC on EMT data revealed that the cells occupy a continuum of cell
states during the process. We found that there were cells in all stages of transition. This
provided us a unique opportunity to characterize the cells stages during the transition. Pre-
vious studies on EMT have focused primarily on the ends of the transition - epithelial cells
only or mesenchymal cells only. Here we were able to perform an unsupervised analysis of
the entire transition across the whole transcriptome. Since the data displayed a continuous
structure, we chose to apply archetypal analysis to study the extreme states during the
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process. We found 10 archetypes, with all spanning major stages during the transition.
Furthermore, we constructed ‘soft clusters” around each archetype by assigning the cells
in the immediate vicinity to the archetypal cluster. This allowed us to explore the gene
expression distribution around each archetype providing more robustness to our study.
We then used the discrepancy in gene expression distribution around each archetype to
identify cellular processes active in each of the soft clusters. In particular, we used Earth
Movers’ Distance (EMD) to distinguish genes that are highly or lowly expressed near each of
the archetypes compared to rest of the data. Compared to traditional methods such as mean
or median that tend to collapse the single-cell information into a single number, EMD uses
the entire distribution of gene expression while maintaining single-cell level granularity.
Using EMD, we characterized the previously unappreciated intermediate stages of EMT
and found important processes such as stemness and chromatin modification during the
intermediate stages leading up to the mesenchymal state.
In conclusion, we used various computational tools to derive novel insights into the biol-
ogy of cells in two different contexts. We believe that our findings and the methods applied
to obtain those will foster future investigations into these important cellular processes and
beyond.
6.2 My contributions to the projects discussed
In this thesis, I presented my work on two major collaborative projects I undertook during
my PhD studies, both projects share the main computational thread of my thesis, the use
of diffusion maps and archetypes to characterize the geometry of single-cell phenotypes. I
model the phenotypic space occupied by cells as a low-dimensional manifold embedded in
high dimensions and use diffusion maps to extract its structure. I also introduce the concept
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of archetype analysis to analyze cells along a continuum of states in the phenotype space.
Archetype analysis enables the characterization of the extreme states in the data, following
which we use diffusion maps to then understand the structure of data at those extremes.
Using this framework I extract novel biological insights in different systems.
In collaboration with Dr. Spencer Wei, an experimental immunology postdoc from Dr.
Jim Allison’s lab at MD-Anderson MD Anderson Cancer Center, Houston, Texas, we studied
the Impact of loss of negative costimulation on T cell differentiation. I led the computational
work for this project, including developing and implementing all computation methods and
applying these to analyze the data. This includes conceptualization of the idea of breach of
phenotypic manifold and application of archetype analysis to address that. I also adapted
diffusion maps to study the manifolds and a computational framework to study protein
expression patterns along the manifold.
The second project involved the analysis of cells undergoing Epithelial-to-Mesenchymal
Transition using scRNA-seq, which was started by Dr. Smita Krishnaswamy and Dr. David
van Dijk while both were postdocs in the Pe’er lab. I joined the project after the MAGIC
algorithm was conceived and implemented. Nevertheless, I conceived, implemented and
performed all analysis illustrating how archetype analysis can be applied to interpret sparse
single-cell RNA-seq data. This includes the conceptual and computational framework for
data analysis involving the notion of soft-clustering and using distribution based distance
metric (EMD here) to compare between the archetypal clusters, as well as using archetype
analysis to study cells along the continuum. Additionally, I performed all the robustness
analysis and MAGIC’s performance evaluation of MAGIC, including its application to syn-
thetic datasets. Thus providing usage guidelines and best practices for parameter selection.
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6.3 Putting contributions of this thesis in context
This thesis makes several contributions to the emerging field of single-cell biology from both
computational and biological point of view. On the computational side, our work supports
the notion of cells occupying a continuous manifold in gene expression space as being an
important feature of biological systems. In a general sense, a continuum would arise when
there is cross-talk and plasticity between cell states. Such realization can shed light on
potentially unappreciated aspect of intermediate states during the phenomenon. On the
other hand, a cluster-like structure can arise when cells have fully transitioned into distinct
types, indicating modular functionality and independence between the populations. In our
work, we then put forward the use of archetype analysis to analyze data along a continuum
and complement traditionally used clustering analysis. Generally, archetype analysis can
be used to understand the differences between a control and perturbed system pertaining
to the changes along the boundary of the data, which is not directly addressable by other
computational approaches. Such analyses can be useful in the context of diseases such as
cancer to characterize the extent of heterogeneity the diseased state occupies compared to
a healthy state. For example, the volume of the archetypal polytope can reflect extent of
phenotypic variation a particular group of cells occupy. Coupled with archetype analysis,
we used the diffusion distance based framework in a novel way to construct differentiation
paths or pseudotime alignment of cells from one state to another and also presented a
way to characterize cell fate choices along the continuum. With the growing appreciation of
biological processes not being discrete entities but a more continuous and fuzzy like structure
with inter-related phenotypes interacting with each other [12, 71, 142], the importance of
methods to analyze such continuous data is prominent, and archetype analysis can play
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a key role. In addition, the computational strategies presented here can be adapted and
improved to understand molecular changes between any two archetypes (extreme states in
any data) and extract novel biological insights.
In the context of scRNA-seq, we presented MAGIC, a novel algorithm to denoise and
impute gene expression data. It is already being actively utilized in numerous studies
involving scRNA-seq data and we believe MAGIC and the ideas it builds on will contribute
to the general analysis of wide range of single-cell technologies in the future. The notion
of sharing information on a carefully constructed neighborhood via a diffusion process is a
flexible strategy we have put forward and can be utilized in any kind of single-cell data.
MAGIC also enables additional computations on scRNA-seq data, which would not have
been applicable otherwise. For example, we showed again how archetypal analysis post-
MAGIC can be a powerful technique to understand data along a continuum. In addition, we
proposed using MAGIC combined with EMD to discriminate highly versus lowly expressed
genes in different parts of the data using the full gene expression distribution at the single-
cell level. These strategies together comprise a framework that can be used to systematically
and quantitatively analyze a scRNA-seq data of any biological system.
From a biological point of view, our work makes fundamental contributions to our
current knowledge of T cell biology. It is well-known that negative costimulatory molecules
such as CTLA-4 and PD-1 have important role in T cell activation [84], but their impact in T
cell differentiation was unknown. Our studies highlight a previously unappreciated aspect of
negative costimulation and argue that these molecules constrain the limits of differentiation.
In particular, CTLA-4 restrains the differentiation of CD4+ T cells and PD-1 restrains the
differentiation of CD8+ T cells. From a broader perspective, our studies revealed that T cells
undergoing differentiation lie along a continuous manifold, which opposes their traditional
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representation of being distinct lineages, which would have reflected a more disjoint clusters-
like pattern. This supports the notion of T cell subsets along a continuum of interrelated
phenotypic states, delineated by ratios of lineage transcription factors expression. This fits
well with the growing appreciation of plasticity of CD4 effector T cell differentiation [12].
From a practical point of view, our observations are highly relevant in the present context
of cancer treatment. While checkpoint blockade therapy has seen unprecedented success,
the underlying mechanisms of action still remain largely unknown. Our studies aim to
address this question in terms of impact of negative costimulation in T cell differentiation.
We believe that further studies into the biology of checkpoint blockade will unravel the
molecular and mechanistic underpinnings of the process and will guide us towards rationale
design of next generation of immunotherapy treatments with more efficacy.
Similarly, our analysis of EMT data also highlights previously uncharted aspects of the
system. EMT is important during wound healing and has been proposed to play role in some
cancers. However, most previous studies were limited to analysis of ends of the transition
(epithelial state or mesenchymal state only). Our work proposes that the transitional state
comprises cells occupying a diverse set of phenotypic states. We found subpopulations of
cells during the transitional state that displayed stemness like characteristics while other
subpopulations showed high expression of genes involved in chromatin modifications. From
a general point of view, our data revealed cells occupying states along a continuum, further
enhancing the notion that the transition is more of a gradual process.
Together, we hope that the computational methods and biological insights from our
work will prove to be useful in future studies investigating various aspects of cells in other
contexts using single-cell data.
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6.4 A peek into ongoing work
scRNA-seq data facilitates an unsupervised analysis of a biological system, and is partic-
ularly exciting in the context of perturbation. A perturbation could be an agent (such as
chemicals) used to induce cells to undergo certain changes or a disease state where the cell
might experience alterations in part of its natural phenotype. Often perturbations cause a
dramatic shifts in cellular state and phenotype, a prime example is due to loss of Ctla4-/-
and Pdcd1-/- as we discussed here. Particularly in the context of development or differenti-
ation, a perturbation can instigate the cells to occupy paths that are almost orthogonal to
their natural course. For example, it has been established that certain transcription factors
are responsible for maintaining the normal development of myeloid cells[60]. Dysregulation
in the behavior of any such major transcription factor can disturb the normal developmen-
tal trajectory of the cells and induce them to explore alternative regions in the phenotype
space. This has implications in diseases such as leukemia [60]. In a dysregulated case,
it would be expected that cells would still follow a developmental path albeit a different
one, but understanding the source and mechanisms underlying the divergence from healthy
development would serve as valuable information in our understanding of leukemia.
From a computational point of view, a comparative analysis of cells under control and
under perturbation both undergoing development can be tricky. Since the cells in the
two conditions could be collected on different days in different situations, a phenomenon
known as “batch effect” can severely hamper the analysis. A batch effect is often defined
as a technical source of variation observed between samples. A typical example of batch
effect in scRNA-seq data is shown in Figure 6.1, where CD4 T cells collected from mice of
identical genotype on two different days are shown. Interestingly, it is not always obvious if
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Figure 6.1: tSNE plot showing CD4 T cells from the spleen collected on two different days
from two mice of identical genotype indicates massive batch effect.
the discrepancy seen between samples is due to batch effect. Therefore, a major challenge
is to build a computational tool to automatically correct for batch effects if any present and
align similar trajectories accordingly.
Our interest is geared towards understanding the similarities and dissimilarities created
by perturbation on developmental systems. As we have discussed, such data sets live on a
low dimensional biological manifold even though there are many more parameters measured.
To achieve this, the first hurdle will be to align the similar regions of control and perturbed
biological manifolds, thereby taking care of any possible batch effect. While methods have
been proposed to align manifolds, they typically tend to be either supervised or designed
for systems where cells occupy discrete clusters or make the assumption that there is some
region of similarity present between the manifolds[143, 144]. We seek to develop an unsu-
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pervised approach to align biological manifolds of cells undergoing continuous phenotypic
changes, while being agnostic of any major assumption on similarity of cell types.
A recent work from our lab has addressed the problem to align different time points
during mammalian gut endoderm development [71]. As a part of ongoing work, we hope
to build up on this method, introducing improvements and integrating other tools to help
address the issue of manifold alignment in developmental systems in a more general setting.
We now discuss the method with some novel improvements we are currently working on.
The underlying computational mechanism will again rely on the eigenspectrum of Markov
matrices, which as we have extensively discussed here have been successfully used in single-
cell data analysis. In particular, we seek to build a single Markov matrix that represents
cells from both conditions - the matrix will incorporate information about the similarities
and dissimilarities between the batches. Creating a universal Markov matrix will enable
the visualization, imputation and ordering of cells along a pseudo-time across conditions,
while mitigating technical issues due to batch effect. This can be a very powerful technique
as it would allow a direct comparisons between trajectories of cells that are in two different
conditions and can potentially facilitate pinpointing the timing and nature of molecular
behavior that is altered during perturbation.
The universal Markov matrix will have two parts to it. First, it must contain information
of similarity between cells in control only and between cells in treatment only. Second, it
must have information of similarity between cells across conditions. For within condition
similarity, we will construct a k-nearest neighbor graph (where k << total number of cells)
between cells in the same condition, which will be converted into an affinity matrix via a
Gaussian kernel (see Chapter 2 for details). For across conditions, we will identify cells as
being similar if they are mutual nearest neighbor of each other. Mutual nearest neighbor
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Figure 6.2: A synthetic depiction of the universal Markov matrix. Blue represents the rela-
tionship between cells within condition 1 only, purple represents cross-condition relationship
while coral represents relationship between cells within condition 2 only.
is a powerful unsupervised approach to identify cells that share similar phenotype and has
been used to correct batch effects in scRNA-seq data previously [143]. Once the mutual
nearest neighbor graph across conditions has been identified, it will also be converted into
an affinity matrix via a Gaussian kernel. These affinity matrices will then be combined and
normalized to obtain the universal Markov matrix (see Figure 6.2).
The construction of within data affinity matrix is straightforward, we simply exponen-
tiate the distance between two cells,
exp








where xi and xj represent the i
th and jth cell that are nearest neighbors of each other and
σx is the scaling factor in condition 1 and yi and yj represent the i
th and jth cell and σy
is the scaling factor in condition 2. In the case of cross-condition affinity between mutual
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nearest neighbors, finding the right scaling factor is the key to an appropriate affinity value.
This is motivated by the fact that the affinity is always bounded by 1. For this, to illustrate
the idea we build up from the simplest case possible. Suppose the two samples (S1 and S2)
are identical, that is, there is no discrepancy what-so-ever, which means that the mutual
nearest neighbors (mnn) within S1 (S1→ S1) are the same as the mutual nearest neighbors
in S2 (S1 → S2). In other words,
distance to a mnn within first data = distance to a mnn in the second data. (6.2)
This should reflect a correlation of 1 between the distances to a mnn within S1 against
distances for the same cells (in S1) to a mnn in S2. Thus under no batch effect, the plot of
mutual nearest neighbor distances within S1 against distances to mutual nearest neighbors
in S2 should have a correlation of 1. Extrapolating on this, under the assumption that
batch effects are locally linear, we claim that technical batch effect should not affect the
correlation substantially. Indeed, a high correlation would suggest the presence of mild
batch effect that can be corrected, while a low correlation would suggest the discrepancy
between samples is primarily biological. Using this idea, we can define the scaling factor
for a given cell in S1 with a corresponding mnn in S2 as the value on the line of best fit in
the correlation plot described above.
While appealing, this approach can be erroneously affected by spurious mutual nearest
neighbors present between conditions. To overcome this, we propose to weigh the affinity
between cells in different conditions based on similarity of their corresponding local neigh-
borhoods. To elaborate, once the affinity across conditions has been established, we propose
to weigh this condition by the correlation value between distances to the kath mnn within
S1 and distances to the kath mnn between S1 and S2. Thus, when the correlation is weak,
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which is likely to be the case when there is no batch effect but a real biological discrepancy,
the low correlaton value down weighs the affinity preventing erroneous mixing of cells. On
the other hand, when the correlation is strong, which indicates presence of a technical batch
effect, it permits mixing of cells of similar phenotype from the two samples. This idea is
illustrated in the sketch of the algorithm as shown in Figure 6.3.
The proposed method is agnostic to the presence of cells of similar phenotype between
the samples. A preliminary application of the method on curated scRNA-seq data seems
promising. We took publicly available mouse PMBC dataset [64] and identified B-cell
population using PhenoGraph and the expression level of CD19 gene. We then subsampled
cells from the identified population and added Gaussian noise to mimic a batch effect. We
applied our method assuming the original data as one sample and the noise-added cluster
of B-cells as the second sample to construct a universal Markov matrix followed by MAGIC
using the thus constructed Markov matrix, see Figure 6.4. We find that our approach
successfully aligns the B-cells between the two samples, while leaving the other regions
undisturbed.
With this as a starting point, we hope to build a method that can robustly align biolog-
ical manifolds in regions of similarity while preserving their uniqueness. More importantly,
we hope to include ideas from a recently proposed method called RNA velocity [145] to give
directionality to the learned developmental progressions.
6.5 Outlook
Single-cell RNA-sequencing is being actively applied to various biological systems and as
a result is revealing novel insights. However, a growing amount of data necessitates the
development of robust and scalable algorithms that can help us probe into the data more
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Before Correction After Correction
Figure 6.4: tSNE plot showing the batch effect in curated scRNA-seq PBMC data (left).
The red cells are subsampled from the green cells with noise added. tSNE plot showing
the correction in batch effect achieved by the method proposed in Figure 6.3. The red and
green cells nicely align as would be expected.
efficiently and extract meaningful information from them. With international consortiums
such as the Human Cell Atlas [3] on the horizon that target to profile every cell type in a
human, there is an acute need for computational methods that are generalizable and adapt-
able to various settings. While the general framework of graphs and spectral graph theory
based algorithms as discussed in this thesis provide a foundation for the next generation
of algorithms, ideas from several other disciplines can also be transformative in single-cell
data analysis. The emerging field of deep learning [146] and methods built on Bayesian
frameworks can provide a broader set of tools to analyze single-cell data. Deep learning
methods are scalable to the growing amount of data and similar to Bayesian methods are
often flexible enough to be adaptable to any biological setting [115, 147]. Together, they
can supplement current approaches to analyze single-cell data.
In addition to sequencing, the field of single-cell biology is witnessing an explosion of
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novel technologies that are probing different aspects of the same cell. Dubbed as “multi-
omics” these technologies offer the opportunity to investigate different parts of a single-
cell, such as transcriptome combined with epigenome or transcriptome combined with
metabolome, proteome combined with spatial location of cell in the tissue and so on [148,
149]. This is an important step towards the perfect holistic measurement of a cell, which
would quantify all aspects of the cell, including transcriptome, metabolome, proteome along
time in the spatial context of the cell in the tissue. Thus obtained multi-view of a single-cell
will certainly enhance our understanding of biological systems. For example, analysis of
data from CITE-SEQ which aims to quantify both the transcriptome and protein levels of
a select molecules has allowed a finer discrimination between immune cells, not attainable
from a single modality only [150]. In addition to novel biology, this emerging field is a fer-
tile playground for novel computational methods that can harness the multiple view of the
same cell. We hope that ideas from methods such as MAGIC will play an indispensable role
in denoising (and perhaps imputing) data from such technologies. Similarly, technologies
to capture spatial features of the cell in addition to measuring the expression of certain
proteins or genes inside the cell [29] are also emerging at an unprecedented rate. Cells react
to the changes in their microenvironment, so characterizing the environment of a cell, can
provide crucial information in our understanding of why a cell behaves the way it does.
Supportive of this, new data suggest that a decent part of the variation in expression a cell
displays can be attributed to its environment [151]. This notion of cell environment playing
a role in cellular activity is specially relevant in the context of immune cells as they interact
with infected cells or pathogens during diseases.
Such emerging technologies combined with novel computational tools provide us with
the hope that we can continue to unravel the biological mysteries of the cell. Thus obtained
CHAPTER 6. CONCLUSION & FUTURE PERSPECTIVES 141
basic scientific knowledge can then be translated to clinical settings and used to save the
lives of patients and develop preventive measures to fight against diseases. It is however
important to stress that technologies and computation must go together with the known
biology of the system to help us better understand the nature of cell.
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Appendix A
Experimental design for knockout
studies
Here we will briefly describe the experimental design procedures undertaken for the Ctla-4-/-
and Pdcd1-/- studies.
A.1 Mice
Ctla-4tm1 All mice were previously generated [152]. A heterozygous x heterozygous breeding
scheme was used to generate experimental mice. Both heterozygous and wild-type litter-
mates were analyzed as controls. Pdcd-1 knockout mice (Pdcd1tm1.1Shr) were generated
previously [123] and purchased from The Jackson Laboratory (021157). Mice were back-
crossed once to C57BL/6J and then backcrossed to homozygous Pdcd-1 mice to generate
experimental mice. C57BL/6J mice were purchased from The Jackson Laboratory. The
ages of mice analyzed in each experiment are denoted in the relevant figures. Experiments
involving ‘young’ mice analyze mice ranging from 11-21 days and experiments involving
aged adult mice analyze mice ranging from 2-6 months of age.
Mice were housed in an AAALAC-accredited specific pathogen free animal facility at
The University of Texas MD Anderson Cancer Center in accordance with institutional
guidelines and all animal experiments were performed in accordance with The University of
Texas MD Anderson Cancer Center Institutional Animal Care and Use Committee (IACUC)
guidelines.
A.2 Genotyping
Genotyping of Ctla-4tm1 All mice was performed by PCR as previously described [152] us-
ing primers (5’ AAACAACCCCAAGCTAACTGCGACAAGG 3’, 5’ CCAGAACCATGCC-
CGGATTCTGACTTC 3’, 5’ CCAAGTGCCCAGCGGGGCTGCTAAA 3’). The expected
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band sizes for the wild-type and mutant alleles are 75 and 150 bp, respectively.
Pdcd-1 knockout mice were genotyped by PCR using primers PD1 KO common 24743 (5’
CACTATCCCACTGACCCTTCA), PD1 KO WT rev (5’ AGAAGGTGAGGGACCTCCAG),
and PD1 KO Mut rev (5’ CACAGGGTAGGCATGTAGCA). The expected band sizes for
the wild-type and mutant alleles are 418 and 350 bp, respectively.
A.3 In vivo assessment of cellular proliferation
Cellular incorporation of 5’ iododeoxyuridine (IdU) was used as to identify actively prolifer-
ating cells in vivo. 50µl of 5mg/ml IdU diluted in PBS were administered by intraperitoneal
injection (i.p.) 30 minutes prior to sacrifice of animals. For animals older than 8-weeks,
100µl of IdU solution was injected. Samples were stained with antibody cocktails (described
in greater detail below) and analyzed on a mass cytometer. IdU+ cells were identified using
absolute signal based both the distribution of IdU (bimodal) and prior experimental data
that defined an approximate background level of IdU.
A.4 Immunization
Young (between 9 and 15 days old) Ctla-4-/-, Ctla-4+/-, and Ctla-4+/+ littermate mice were
randomized in a 1:1 ratio to the unimmunized group or immunized with 50µg ovalbumin
emulsified in Complete Freund’s Adjuvant (CFA) for a final concentration of 50% CFA
(InvivoGen). Immunization was performed by injecting 100µl of OVA-CFA emulsion sub-
cutaneously in the flank. Notably, no overt phenotype is observed in Ctla-4-/- mice at this
age, which allows for randomization. Unimmunized and immunized mice were co-housed
for the duration of the experiment. The draining inguinal lymph node was harvested for
analysis 6 days post-immunization (days 15 to 21, depending on age at immunization) and
analyzed by mass cytometry.
A.5 Mass cytometry antibodies
Metal conjugated antibodies were purchased from Fluidigm or purified unlabeled antibodies
(in BSA and carrier free format) were metal-labeled in house using X8 polymer conjugation
according to manufacturer’s protocol (Fluidigm). Antibody conjugations were performed
at 100µg or 200µg scale and the resultant conjugated antibodies diluted to a final concen-
tration of 0.5mg/ml in antibody stabilizer supplemented with 0.05% sodium azide (Candor
Biosciences). Platinum conjugations were performed using a modified protocol as previ-
ously described [153]. Antibodies were washed thrice in R buffer (Fluidigm) on a 50kDA
spin column (EMD Millipore) and then incubated in 4mM TCEP diluted with R buffer
for 30 minutes at 37oC. Antibody was then washed twice with C buffer and incubated
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with 100µM (400µl) of desired monoisotopic cisplatin (Fluidigm) for 90 minutes at 37oC.
Antibody was then washed with W buffer four times prior to elution in antibody stabilizer
solution. Mass cytometry panels are detailed in figures below. We designed staining panels
with the specific goals of enabling comprehensive classification of peripheral T cell popula-
tions and identification of alterations in T cell differentiation. As such these mass cytometry
panels included activation markers (e.g. CD44, CD62L, PD-1, CD69, ICOS), surface dif-
ferentiation markers (e.g. KLRG1, CD127), and importantly, lineage defining transcription
factors (e.g. TBET, EOMES, GATA3, BCL6, RORγT) as well as additional transcription
factors involved in T cell differentiation (e.g. BATF, HELIOS, IRF4, RUNX3).
A.6 Analysis of peripheral lymph nodes by mass cytometry
Single cell suspensions of peripheral lymph nodes were isolated and pooled from each sam-
ple. For analyses relating to Figures 3.2 and 3.4, inguinal, axillary, and brachial lymph
nodes from 13-day old Ctla-4 knockout mice were dissected for analysis. For analyses of
unimmunized and immunized mice draining (inguinal) lymph nodes were dissected for anal-
ysis. For analyses of Pdcd-1 knockout mice, inguinal, axillary, and brachial lymph nodes
were dissected and pooled for analysis. Lymph nodes were mashed through a 70µm filters
into RPMI-1640 supplemented with 10% FBS using the back of a plastic syringe. Once pre-
pared, single cell suspensions were processed for mass cytometry analysis using a protocol
similar to that previously described for analyses of tumor infiltrating lymphocytes [101].
Briefly, single cell suspensions were washed twice with FACS buffer and total cell con-
centration determined using a Cellometer (Nexelcom). 2.5 × 106 cells were incubated at
4oC for 10 minutes with 2% of each bovine, murine, rat, hamster, and rabbit serum PBS
supplemented with 25µg/mL 2.4G2 antibody. Cells were then washed and incubated with
the surface antibody cocktail at 4oC for 30 minutes in a 50µL total volume. At the end
of the surface staining incubation, cells were incubated with 2.5µM 194Pt monoisotopic
cisplatin for 4oC for 1 minute prior to washing by adding 50µl of 5µM 2X solution. 600µl
FACS buffer was then immediately added and cells were washed twice more. Samples were
then individually barcoded using palladium metal barcoding reagents according to manu-
facturer’s protocol (Fluidigm). An entire single use barcode aliquot was used per sample.
Following the barcoding and wash step, samples were then combined. The combined sample
was then fixed and permeabilized using the FoxP3 fix and permeabilization kit according
to manufacturer’s protocol (eBioscience). Following the 30 minute fixation and associated
wash steps, the sample was then incubated with the intracellular stain antibody cocktail
for 30 minutes at room temperature. Cells were then washed twice with FoxP3 permeabi-
lization buffer, twice with FACS buffer, and incubated overnight in 1.6% PFA PBS with
62.5nM Iridium nucleic acid intercalator (Fluidigm). Cells were then washed twice with
0.5% BSA PBS, filtered, and washed twice with 0.1% BSA water prior to analysis. Sam-
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Table A.1: Mass cytometry panel used for analyses of Ctla-4 knockout mice.
Target Clone Metal Tag Stain Dilution Source Cat. # Note
CD45 30-F11 89Y Surface 200 Fluidigm 3089005B
iodo-deoxyuridine N/A 127I N/A N/A Sigma I7125-5G
MHC II M5/114.15.2 139La Surface 150 Biolegend 107637
NK1.1 PK136 141Pr Surface 150 Biolegend 108743
KLRG1 2F1 142Nd Surf 100 BD 562190
TCRb H57-597 143Nd Surf 100 DVS 3143010B
Ikaros 2A9/Ikaros 144Nd IC 100 Biolegend 653302
CD4 RM4-5 145Nd Surface 200 Fluidigm 3145002B
CD8a 53-6.7 146Nd Surface 150 Fluidigm 3146003B
Aiolos 8B2 147Sm IC 200 Biolegend 653202
CD27 LG.3A10 148Nd Surface 150 Biolegend 124202
CD25 3C7 150Nd Surface 125 Fluidigm 3150002B
IRF4 IRF4.3E4 151Eu IC 125 Biolegend 646402
CD3 145-2C11 152Sm IC 300 Fluidigm 3152004B
CCR4 2G12 153Eu Surf 100 Biolegend 131202 Low signal
BATF D7C5 154Sm IC 225 Fluidigm 3154012A
ICOS 7E.17G9 155Gd Surface 200 eBioscience 14-9942-85
CD69 H1.2F3 156Gd Surface 150 Biolegend 104533
CXCR5 2G8 158Gd Surface 75 BD 551961 Low signal
PD-1 29F.1A12 159Tb Surface 300 Fluidigm 3159024B
CD62L MEL-14 160Gd Surface 300 Fluidigm 3160008B
CXCR3 CXCR3-173 161Dy Surface 200 Biolegend 126502
CD24 M1/69 162Dy Surf 150 Biolegend 101829
CTLA-4 UC10-4B9 163Dy IC 100 Biolegend 106302 Low signal
Runx3 R3-5G4 164Dy IC 200 BD 564813
FOXP3 FJK-16s 165Ho IC 200 Fluidigm 3165024A
CD19 6D5 166Er Surf 150 Fluidigm 3166015B
GATA3 L50-823 167Er IC 200 BD 558686
BCL6 K112-91 168Er IC 200 BD 561520
CD117 2B8 169Tm Surface 125 Biolegend 105829
CD127 A7R34 170Er Surface 125 Biolegend 135029
CD44 IM7 171Yb Surf 350 Fluidigm 3171003B
Helios 22F6 172Yb IC 200 Biolegend 137202
TBET 4B10 173Yb IC 125 Biolegend 644825
RORγT Q31-378 174Yb IC 300 BD 562663
TCF1 S33-966 175Lu IC 100 BD 564217
EOMES Dan11mag 176Yb IC 150 eBioscience 14-4875-82
Live/Dead N/A 194Pt Surface N/A Fluidigm 201194
Lag3 C9B7W 198Pt Surf 100 Biolegend 125202 Low signal
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Table A.2: Mass cytometry panel used for analyses of Pdcd-1 knockout mice.
Target Clone Metal Tag Stain Dilution Source Cat. # Note
CD45 30-F11 89Y Surface 200 Fluidigm 3089005B
iodo-deoxyuridine N/A 127I N/A N/A Sigma I7125-5G
MHC II M5/114.15.2 139La Surface 150 Biolegend 107637
NK1.1 PK136 141Pr Surface 150 Biolegend 108743
CD11c N418 142 Nd Surf 100 Biolegend 117341
TCRb H57-597 143Nd Surf 100 DVS 3143010B
Ikaros 2A9/Ikaros 144Nd IC 100 Biolegend 653302
CD4 RM4-5 145Nd Surface 200 Fluidigm 3145002B
CD8a 53-6.7 146Nd Surface 150 Fluidigm 3146003B
Aiolos 8B2 147Sm IC 200 Biolegend 653202
CD27 LG.3A10 148Nd Surface 150 Biolegend 124202
CD25 3C7 150Nd Surface 125 Fluidigm 3150002B
IRF4 IRF4.3E4 151Eu IC 125 Biolegend 646402
CD3 145-2C11 152Sm IC 300 Fluidigm 3152004B
PD-L1 10F.9G2 153Eu Surf 200 Fluidigm 3153016B
BATF D7C5 154Sm IC 225 Fluidigm 3154012A
ICOS 7E.17G9 155Gd Surface 200 eBioscience 14-9942-85
CD69 H1.2F3 156Gd Surface 150 Biolegend 104533
CXCR5 2G8 158Gd Surface 75 BD 551961 Low signal
PD-1 29F.1A12 159Tb Surface 300 Fluidigm 3159024B
CD62L MEL-14 160Gd Surface 300 Fluidigm 3160008B
CXCR3 CXCR3-173 161Dy Surface 200 Biolegend 126502
CD24 M1/69 162Dy Surf 150 Biolegend 101829
Sca1 D7 163Dy Surf 1600 Biolegend 108135
Runx3 R3-5G4 164Dy IC 200 BD 564813
FOXP3 FJK-16s 165Ho IC 200 Fluidigm 3165024A
Bcl2 BCL/10C4 166 Er IC 175 Biolegend 633502
GATA3 L50-823 167Er IC 200 BD 558686
BCL6 K112-91 168Er IC 200 BD 561520
CD117 2B8 169Tm Surface 125 Biolegend 105829
CD127 A7R34 170Er Surface 125 Biolegend 135029
CTLA-4 UC10-4B9 171Yb IC 100 Biolegend 106302
Helios 22F6 172Yb IC 200 Biolegend 137202
TBET 4B10 173Yb IC 125 Biolegend 644825
RORγT Q31-378 174Yb IC 300 BD 562663
TCF1 S33-966 175Lu IC 100 BD 564217
EOMES Dan11mag 176Yb IC 150 eBioscience 14-4875-82
Live/Dead N/A 194Pt Surface N/A Fluidigm 201194
CD19 6D5 195Pt Surf 150 Biolegend 115547
H-2K b/H-2D b 28-8-6 196Pt Surf 250 Biolegend 114602
KLRG1 2F1 198Pt Surf 175 BD 562190
CD44 IM7 209Bi Surf 450 Fluidigm Custom
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Table A.3: Mass cytometry panel used for analyses of the immunized mice.
Target Clone Metal Tag Stain Dilution Source Cat. # Note
CD45 30-F11 89Y Surface 200 Fluidigm 3089005B
iodo-deoxyuridine N/A 127I N/A N/A Sigma I7125-5G
MHC II M5/114.15.2 139La Surface 150 Biolegend 107637
NK1.1 PK136 141Pr Surface 150 Biolegend 108743
KLRG1 2F1 142Nd Surf 100 BD 562190
TCRb H57-597 143Nd Surf 100 DVS 3143010B
Ikaros 2A9/Ikaros 144Nd IC 100 Biolegend 653302
CD4 RM4-5 145Nd Surface 200 Fluidigm 3145002B
CD8a 53-6.7 146Nd Surface 150 Fluidigm 3146003B
Aiolos 8B2 147Sm IC 200 Biolegend 653202
CD27 LG.3A10 148Nd Surface 150 Biolegend 124202
CD25 3C7 150Nd Surface 125 Fluidigm 3150002B
IRF4 IRF4.3E4 151Eu IC 125 Biolegend 646402
CD3? 145-2C11 152Sm IC 300 Fluidigm 3152004B
PD-L1 10F.9G2 153 Eu Surf 200 Fluidigm 3153016B
BATF D7C5 154Sm IC 225 Fluidigm 3154012A
ICOS 7E.17G9 155Gd Surface 200 eBioscience 14-9942-85
CD69 H1.2F3 156Gd Surface 150 Biolegend 104533
CXCR5 2G8 158Gd Surface 75 BD 551961 Low signal
PD-1 29F.1A12 159Tb Surface 300 Fluidigm 3159024B
CD62L MEL-14 160Gd Surface 300 Fluidigm 3160008B
CXCR3 CXCR3-173 161Dy Surface 200 Biolegend 126502
CD24 M1/69 162Dy Surf 150 Biolegend 101829
Sca1 D7 163Dy Surf 1600 Biolegend 108135
Runx3 R3-5G4 164Dy IC 200 BD 564813
FOXP3 FJK-16s 165Ho IC 200 Fluidigm 3165024A
Bcl2 BCL/10C4 166 Er IC 175 Biolegend 633502
GATA3 L50-823 167Er IC 200 BD 558686
BCL6 K112-91 168Er IC 200 BD 561520
CD117 2B8 169Tm Surface 125 Biolegend 105829
CD127 A7R34 170Er Surface 125 Biolegend 135029
c-maf sym0F1 171Yb IC 200 eBioscience 50-9855-82
Helios 22F6 172Yb IC 200 Biolegend 137202
TBET 4B10 173Yb IC 125 Biolegend 644825
ROR?T Q31-378 174Yb IC 300 BD 562663
TCF1 S33-966 175Lu IC 100 BD 564217
EOMES Dan11mag 176Yb IC 150 eBioscience 14-4875-82
Live/Dead N/A 194Pt Surface N/A Fluidigm 201194
CD19 6D5 195Pt Surf 150 Biolegend 115547
H-2K b/H-2D b 28-8-6 196Pt Surf 250 Biolegend 114602
KLRG1 2F1 198Pt Surf 175 BD 562190
CD44 IM7 209Bi Surf 450 Fluidigm Custom
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ples were diluted to a concentration of approximately 0.75 × 106/ml in water with 10%
EQ4 beads for acquisition. Samples were analyzed using a Helios mass cytometer using the
Helios 6.5.358 acquisition software (Fluidigm).
A.7 Mass cytometry data processing
Mass cytometry data files were concatenated and normalized to EQ4 bead signal using the
Helios 6.5.358 acquisition software (Fluidigm). Normalized data were then debarcoded to
deconvolve individual samples using the Helios 6.5.358 acquisition software or stand-alone
Debarcoder software (Fluidigm). Data files associated with individual samples were then
utilized for downstream analyses. To transform the counts into real numbers, the data were
arcsinh transformed with a cofactor of 4 [28, 101] as,
Transformed data = arcsinh (Raw data/4) . (A.1)
Data were manually gated Live CD45+ Lin- CD3+ T cells using FlowJo (TreeStar). Cluster-
ing was applied to further remove any non CD4 or CD8 T cell cells for input into archetypal
analysis.
A.8 In vitro restimulation assays
Single cell suspensions of lymph node tissue were obtained from 11-12 day old Ctla-4
knockout and littermate control mice. Inguinal, axillary, and brachial lymph nodes were
pooled from each mouse. 5 × 105 cells were plated in U-bottom 96-well cell culture plates
in 100µl RPMI-1640 supplemented with 10% FBS, L-glutamine, and P/S. Phorbol 12-
myristate 13-acetate (PMA)/ionomycin cell stimulation cocktail (ThermoFisher, 00-4970-
93) and monesin/Brefeldin A protein transport inhibitor cocktail (ThermoFisher, 00-4980-
93) were added to the culture per manufacturer’s recommendation (diluted to 1X from 500X
stock concentrations). Unstimulated (no PMA/Ionomycin or protein transport inhibition)
samples from both control and KO genotypes were also plated as control samples. Samples
from individual mice were plated in technical triplicate. Cells were restimulated for 4 hours
at 37 degrees and then transferred to ice for further staining and processing as described
below.
A.9 Flow cytometry
For flow cytometry analysis of restimulated lymphocytes, cells were blocked using PBS
with 2% of each fetal bovine, mouse, rabbit, rat, and hamster serum and 25µg/ml 2.4G2.
Cells were washed once with FACS buffer and stained with surface stain cocktail containing
live/dead stain fixable blue for 30 minutes at 4 degrees Celsius. Following two FACS buffer
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washes, cells were fixed using BD cytofix/cytoperm kit for 20 minutes at 4 degree Celsius
per manufacturer’s protocol. Following two washes with permeabilization wash buffer, cells
were stained with an intracellular stain antibody cocktail for 30 minutes at 4 degrees Celsius.
Cells were then washed twice with permeabilization buffer and subsequently FACS buffer.
Samples were then analyzed using a LSR II (BD). Surface antibodies included CD3 BV785
(clone 145-2C11, BD 564379), PD-1 BV421 (clone 29F.1A12, Biolegend 135221), CD19
BV510 (clone 6D5, Biolegend 115545), CD44.2 BV711 (clone 104, BD 563685), ICOS FITC
(clone 7E.17G9, eBioscience 11-9942-82), CD4 AF532 (clone RM4-5, Biolegend 100548),
CD25 AF700 (clone PC61.5, eBioscience 56-0251-82), and CD8a APC-Cy7 (clone 53-6.7,
Biolegend 100714). Intracellular antibodies included IL-2 BV605 (clone JES6-5H4, Biole-
gend 503829), TNFa PerCP-Cy5.5 (clone MP6-XT22, Biolegend 506322), IFNγ PE (clone
XMG1.2, eBioscience 12-7311-82), IL-17A PE-CF594 (clone TC11-18H10, BD 562542), and
IL-10 APC (clone JES5-16E3, eBioscience 17-7101-82).
For analysis of restimulation flow cytometry data, a conventional gating strategy was
utilized to identify subpopulations of CD4 T cells that enrich for cells (i.e. phenotypes)
that are associated with phenotypically expanded populations identified in mass cytometry
experiments. Guided by phenotypes observed in mass cytometry analyses cells were gated
as live/dead- CD45+ CD19- CD3+ CD8- CD4+ CD44+ CD25- and then subsequently
subgated as ICOS+PD-1-, ICOS+PD-1+ ,ICOS-PD-1+, or ICOS-PD-1-. Subpopulations
with ICOS+PD-1-, ICOS+PD-1+ enrich for CD4 archetypes 7 and 5, respectively (See
Figure 3.4). Cells positive for each cytokine were then identified within each subpopulation.
Gating for individual cytokines was guided by the cytokine expression levels observed in
unstimulated samples. Similar analyses were employed to interrogate the cytokine profile
of regulatory (here defined as CD25+) CD4 T cells as well as CD8 T cells. The relative
frequency and mean fluorescence intensity (MFI) were calculated using FlowJo. Values were
averaged from three technical replicates from each mouse. Mean cytokine expression levels
were then displayed on a per mouse basis in a radar plot using Excel.
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Appendix B
Experimental design for the EMT
study
Here we discuss the experimental design and data pre-processing done for the HMLE cell
line used in the study presented in Chapter 5.
B.1 Experimental Model and Subject Details
We used female HMLE breast cancer cell lines in this study. The cell lines were not au-
thenticated. HMLE and all derived cell lines used in this work were cultured in MEGM
(Mammary Epithelial Cell Growth Medium) media (Lonza, USA, CC-3051) at 37oC. Cells
were cultured in round tissue culture dishes 10cm in diameter (Corning, USA) and split to
a ratio of 1:7 every 2 to 3 days or once they reached 80% confluence on a plate. All cell
dissociations were performed using TrypLE (Ambion, USA) reagent.
B.2 TGF-β induction of EMT
EMT was induced in HMLE cells by addition of Recombinant Human TGF-β1 (HEK293
cell derived) (PeproTech, USA 100-21) to a final concentration of 5ng/ml. HMLE cells
transfected with FUW plasmid, a tetracycline operator, and minimal CMV promoter were
used. All cells under induction were passaged once they reached 80% confluence.
B.3 Single-cell RNA-seq profiling of EMT
Single-cell RNA-seq was performed using the InDrops platform [26, 154], a droplet microflu-
idics based single-cell isolation and mRNA barcoding technology. Briefly, the cell culture
flasks containing HMLE cells were treated with 2 mL TrypLE Express Enzyme (1X) no-
phenol-red for 10 min at 37oC, washed three times with 1X PBS containing 0.05% (w/v)
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BSA, and strained through 40µm size mesh. The resulting suspension of single-cells was
supplemented with 16% (v/v) Optiprep and 0.05% (w/v) BSA and encapsulated into 3 nL
droplets together with custom-made DNA barcoding hydrogel beads and RT/lysis reagents.
The cell encapsulation was set at ∼ 30, 000 cells per hour using a cell barcoding chip (v2)
(Droplet Genomics), and over 75% of cells entering microfluidics chips were co-encapsulated
with one DNA barcoding hydrogel bead. After loading cells, hydrogel beads and RT/lysis
reagents into microfluidic droplets, the composition of a RT reaction under which cDNA
synthesis was carried out was 155 mM KCl, 50 mM NaCl, 11 mM MgCl2, 135 mM Tris-
HCl [pH 8.0], 0.5 mM KH2PO4, 0.85 mM Na2HPO4, 0.35% (v/v) Igepal-CA630, 0.02%
(v/v) BSA, 4.4% (v/v) Optiprep, 2.4 mM DTT, 0.5 mM dNTPs, 1.3 U/ml RNAsIN Plus,
and 11.4 U/ml SuperScript-III RT enzyme. After cell encapsulation the tube containing
the emulsified components was exposed to 365 nm light to photo-release DNA barcoding
primers attached to the hydrogel beads. The RT reaction was initiated by transferring the
tube to 50oC for 1-hour and terminated by incubating for 15 min at 75oC. Post-RT droplets
were chemically broken to release barcoded cDNA, which was then purified and amplified.
At the final step, libraries were amplified using trimmed PE Read 1 primer (PE1): 5’-
AATGATACGGCGACCACCGAGATCTACACTCTTTCCCTACACGA and indexing PE
Read 2 primer (PE2): 5’-CAAGCAGAAGACGGCATACGAGAT[index]GTGACTGGAGT
TCAGACGTGTGCTCTTCCGATCT, where [index] encoded one of the following sequences:
CGTGAT, ACATCG, GCCTAA, TGGTCA, CACTGT or ATTGGC. Multiplexing of PCR
libraries allowed for the pooling of different samples onto one lane of Illumina HiSeq2500
flow cell when desired. To prepare the cells for scRNA-seq experiments, they were cultured
to 70% confluence and dissociated from the plate with the addition of 3ml of trypsin for 5
mins at 37oC. After dissociation cells were kept at +4oC at all times in MEGM-complete
media. Two 1x PBS (Ambion, USA) washes were performed on the dissociated cells and
cell viability was evaluated using trypan blue staining prior to scRNA-seq. All InDrops
experiments were performed with cell viability exceeding 90%.
B.4 Processing data
The obtained inDrops samples was then processed using the SEQC pipeline [115]. The
resulting count matrix was then normalized for downstream analysis. Normalization is
particularly important in the case of scRNA-seq to ensure that distances between cells reflect
biology rather than experimental artifact. We performed median library size normalization
on the cells, which is a typical type of normalization performed on the data. scRNA-seq
data entails substantial cell-to-cell variation in library size (number of observed molecules)
which is largely due to technical variation occurring due to multiple enzymatic steps, such as
lysis efficiency, mRNA capture efficiency and the efficiency of multiple amplification rounds
[134]. For example, the cell barcode associated with each cell can have a substantial effect
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on the PCR efficiency and subsequently the number of transcripts in that cell. Therefore, we
normalize transcript abundances (library size), so that each cell will have an equal transcript
count.
Given a N ×M data matrix X, with N cells and M genes, the normalized data matrix










This effectively eliminates cell size as a signal in the measurement for the purposes of
constructing the affinity matrix and thus the resulting weighted neighborhood is not biased
by cell size.
